Document:

Exhibit 10.69

 

Exhibit 10.69

AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

 

 

TABLE OF CONTENTS

TO THE

AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

	 	 	 	 	 
	ARTICLE I DEFINITIONS
	 	 	2	 
	ARTICLE II FORMATION AND AGREEMENT OF LIMITED PARTNERSHIP
	 	 	2	 
	SECTION 2.1 Partnership Formation; Effective Date
	 	 	2	 
	SECTION 2.2 Name of Partnership
	 	 	2	 
	SECTION 2.3 Purposes and Investment Objectives
	 	 	2	 
	SECTION 2.4 Registered Agent and Office; Principal Place of Business
	 	 	3	 
	SECTION 2.5 Commencement and Term
	 	 	3	 
	ARTICLE III PARTNERS AND CAPITAL CONTRIBUTIONS
	 	 	3	 
	SECTION 3.1 Capital Contributions of Partners
	 	 	3	 
	SECTION 3.2 Liability of Partners-For Capital
	 	 	4	 
	SECTION 3.3 Maintenance of Capital Accounts; Withdrawals of Capital; Withdrawals from
the Partnership
	 	 	4	 
	SECTION 3.4 Interest on Capital Contributions or Capital Accounts
	 	 	5	 
	SECTION 3.5 Additional Funding
	 	 	5	 
	SECTION 3.6 Enforcement of Commitments
	 	 	6	 
	SECTION 3.7 Tax Treatment of Conversion
	 	 	6	 
	ARTICLE IV NAMES AND ADDRESSES OF PARTNERS
	 	 	7	 
	ARTICLE V MANAGEMENT OF THE PARTNERSHIP
	 	 	7	 
	SECTION 5.1 General Authority and Powers of the General Partner
	 	 	7	 
	SECTION 5.2 Restrictions on Authority of the General Partner
	 	 	10	 
	SECTION 5.3 Duties of the General Partner
	 	 	10	 
	SECTION 5.4 Delegation by the General Partner
	 	 	11	 
	SECTION 5.5 Right to Rely Upon the Authority of the General Partner
	 	 	11	 
	SECTION 5.6 Partnership Expenses
	 	 	11	 
	SECTION 5.7 No Management by Limited Partners
	 	 	13	 
	SECTION 5.8 Consent by Limited Partners to Exercise of Certain Rights and Powers by the
General Partner
	 	 	14	 
	SECTION 5.9 Other Business of Partners
	 	 	14	 
	SECTION 5.10 General Partner’s Standard of Care
	 	 	15	 
	SECTION 5.11 Limitation of Liability
	 	 	15	 
	SECTION 5.12 Indemnification of the General Partner
	 	 	16	 
	SECTION 5.13 Election and Replacement of Investor Representatives; Appointment of
Hospital Representative
	 	 	16	 
	SECTION 5.14 Role of and Decisions by Investor Representatives
	 	 	16	 
	SECTION 5.15 Purchase of Goods and Services from the General Partner
	 	 	17	 
	SECTION 5.16 Decisions by the General Partner
	 	 	17	 
	ARTICLE VI DISTRIBUTIONS AND ALLOCATIONS
	 	 	17	 
	SECTION 6.3 Losses
	 	 	19	 
	SECTION 6.4 Code Section 704(c) Tax Allocations
	 	 	19	 
	SECTION 6.5 Miscellaneous
	 	 	20	 
	ARTICLE VII DISSOLUTION, WINDING UP AND LIQUIDATING DISTRIBUTIONS
	 	 	21	 
	SECTION 7.1 No Termination by Certain Acts of Partner
	 	 	21	 
	SECTION 7.2 Dissolution
	 	 	21	 

i

 

	 	 	 	 	 
	SECTION 7.3 Dissolution and Final Liquidation
	 	 	21	 
	SECTION 7.4 Termination
	 	 	23	 
	SECTION 7.5 Payment in Cash
	 	 	23	 
	SECTION 7.6 Goodwill and Trade Name
	 	 	23	 
	SECTION 7.7 Termination of Noncompetition Covenants
	 	 	23	 
	ARTICLE VIII REMOVAL OR WITHDRAWAL OF GENERAL PARTNER AND PARTNERS AND
TRANSFER OF PARTNERS’ PARTNERSHIP AND/OR ECONOMIC INTERESTS
	 	 	23	 
	SECTION 8.1 General Partner-Transfers
	 	 	23	 
	SECTION 8.2 Partners’ Right to Continue When Partnership has no General Partner
	 	 	24	 
	SECTION 8.3 Relationship with Substitute General Partner
	 	 	24	 
	SECTION 8.4 Investor Limited Partners-Restriction on Transfer
	 	 	24	 
	SECTION 8.5 Hospital Limited Partne- Restriction on Transfer
	 	 	25	 
	SECTION 8.6 Condition Precedent to Transfer of Economic Interest and/or Partnership
Interest
	 	 	27	 
	SECTION 8.7 Substitute Partner Conditions to Fulfill
	 	 	27	 
	SECTION 8.8 Allocations Between Transferor and Transferee
	 	 	27	 
	SECTION 8.9 Rights, Liabilities of, and Restrictions on Assignee
	 	 	28	 
	SECTION 8.10 Death of a Partner
	 	 	28	 
	SECTION 8.11 Repurchase of Interests in Certain Event
	 	 	29	 
	SECTION 8.12 Permissible Transfers by Limited Partners
	 	 	29	 
	SECTION 8.13 Sale of Partnership
	 	 	29	 
	ARTICLE IX RECORDS, ACCOUNTINGS AND REPORTS
	 	 	29	 
	SECTION 9.1 Books of Account
	 	 	29	 
	SECTION 9.2 Access to Records
	 	 	30	 
	SECTION 9.3 Bank Accounts and Investment of Funds
	 	 	30	 
	SECTION 9.4 Fiscal Year
	 	 	30	 
	SECTION 9.5 Accounting Reports
	 	 	31	 
	SECTION 9.6 Tax Returns
	 	 	31	 
	ARTICLE X MEETINGS AND VOTING RIGHTS OF PARTNERS
	 	 	31	 
	SECTION 10.1 Meetings
	 	 	31	 
	SECTION 10.2 Voting Rights of Partners
	 	 	32	 
	ARTICLE XI AMENDMENTS
	 	 	32	 
	SECTION 11.1 Authority to Amend by General Partner
	 	 	32	 
	SECTION 11.2 Restrictions on General Partner’s Amendments: Amendments by Limited
Partners
	 	 	33	 
	SECTION 11.3 Amendments to Certificate
	 	 	33	 
	ARTICLE XII MISCELLANEOUS
	 	 	34	 
	SECTION 12.1 Revocable Limited Power of Attorney
	 	 	34	 
	SECTION 12.2 Waiver of Provisions
	 	 	34	 
	SECTION 12.3 Interpretation and Construction
	 	 	34	 
	SECTION 12.4 Governing Law
	 	 	34	 
	SECTION 12.5 Partial Invalidity
	 	 	34	 
	SECTION 12.6 Binding on Successors
	 	 	34	 
	SECTION 12.7 Notices and Delivery
	 	 	34	 
	SECTION 12.8 Counterpart Execution; Facsimile Execution
	 	 	35	 
	SECTION 12.9 Statutory Provisions
	 	 	35	 
	SECTION 12.10 Waiver of Partition
	 	 	35	 
	SECTION 12.11 Change In Law
	 	 	35	 
	SECTION 12.12 Investment Representations of the Partners
	 	 	36	 
	SECTION 12.13 Authorization and Release of Investor Representatives
	 	 	37	 
	SECTION 12.14 Referrals to Hospital and Ownership of Shares of Common Stock of MedCath
Holdings, Inc. and/or MedCath Incorporated
	 	 	37	 

ii

 

	 	 	 	 	 
	SECTION 12.15 Acknowledgments Regarding Legal Representation
	 	 	37	 
	SECTION 12.16 Exhibits
	 	 	37	 

iii

 

AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

     THESE SECURITIES ARE BEING ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933 AND THE TEXAS SECURITIES ACT IN RELIANCE UPON THE REPRESENTATION OF EACH
PURCHASER OF THE SECURITIES THAT THE SAME ARE BEING ACQUIRED FOR INVESTMENT PURPOSES. THESE
SECURITIES MAY ACCORDINGLY NOT BE RESOLD OR OTHERWISE TRANSFERRED OR CONVEYED IN THE ABSENCE OF
REGISTRATION OF THE SAME PURSUANT TO THE APPLICABLE SECURITIES LAWS UNLESS AN OPINION OF COUNSEL
SATISFACTORY TO THE PARTNERSHIP IS FIRST OBTAINED THAT SUCH REGISTRATION IS NOT THEN NECESSARY.
ANY TRANSFER CONTRARY HERETO SHALL BE VOID.

     THIS AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT of Harlingen Medical Center, Limited
Partnership, a North Carolina Limited Partnership is made and entered into on the                      day of
July, 2007 (the “Effective Date”) by and among the Persons whose names, addresses and taxpayer
identification numbers are listed on the Information Exhibit.

RECITALS

     A. The Partnership was formed in accordance with the original Limited Partnership Agreement of
the Partnership by and among the General Partner and the original Investor Limited Partners (as
amended by an Amendment to Limited Partnership Agreement dated July 3, 2001 and a Second Amendment
to Limited Partnership Agreement dated September 26, 2001, the “Original Limited Partnership
Agreement”);

     B. The Partnership owns and operates a general acute care hospital which is located in
Harlingen, Texas and provides medical care and surgery services agreed upon by the General Partner
and the Investor Representatives;

     C. It is intended that the hospital will continue to be a low-cost, high quality provider of
medical services within the Harlingen, Texas area in a manner which is consistent with the national
health care policy of lowering the costs of health care;

     D. In lieu of the procedures set forth in that certain Convertible Note Purchase Agreement
(the “Convertible Note Purchase Agreement”) dated December 27, 2005 by and between the Partnership
and the Hospital Limited Partner, the Hospital Limited Partner has agreed to convert certain loans
made to the Partnership (the “Convertible Loans”) into the percentage Partnership Interest
reflected on the Information Exhibit for the Hospital Limited Partner and to be admitted as
a Limited Partner of the Partnership;

     E. The Capital Contributions, Convertible Loans and involvement of the Limited Partners are
necessary to enable the Partnership to achieve its objectives; and

     F. The Partners desire to amend and restate the Original Limited Partnership Agreement to
reflect the new percentage Partnership Interests set forth on the Information Exhibit, to
reflect the

 

 

assignment of the general partner interest to a new General Partner, and to set forth
the respective rights and obligations of the parties hereto.

     NOW THEREFORE, in consideration of the foregoing, the parties hereby amend in its entirety and
restate the Original Limited Partnership Agreement to read as follows:

ARTICLE I

DEFINITIONS

     Unless otherwise indicated, capitalized words and phrases in this Limited Partnership
Agreement shall have the meanings set forth in the attached Glossary of Terms.

ARTICLE II

FORMATION AND AGREEMENT OF LIMITED PARTNERSHIP

     SECTION 2.1 Partnership Formation; Effective Date.

     The Partnership was formed on June 1, 1999 upon the filing of the Certificate of Limited
Partnership with the Secretary of State of North Carolina in accordance with the provisions of the
Act. The General Partner shall execute or cause to be executed all other such certificates or
documents, and shall do or cause to be done all such filing, recording, or other acts, as may be
necessary or appropriate from time to time to comply with the requirements of law for the
continuation and/or operation of a limited partnership in the State of North Carolina, and other
documents to reflect the admission of additional Partners to the Partnership. Any costs incurred
by the General Partner in connection with the foregoing shall be reimbursed promptly upon the
completion of such action. This Agreement shall be effective as of the date set forth in the
introductory paragraph hereof.

     SECTION 2.2 Name of Partnership.

     The name of the Partnership is Harlingen Medical Center, Limited Partnership.

     SECTION 2.3 Purposes and Investment Objectives.

     The principal purposes of the Partnership are as follows:

     (a) To develop, own and operate the Hospital and related facilities and provide related
services, including, but not limited to, the following:

     (i) Services and facilities to meet all requirements of the State of Texas,
Medicare, JCAHO and other credentialing or licensing bodies or agencies in order to
have the Hospital licensed as a general acute care hospital and to perform medical
and surgical services and to be eligible to obtain appropriate reimbursements
therefore;

     (ii) All appropriate support services and systems; and

     (iii) Appropriate Equipment and services with respect to the facilities
described above and as otherwise reasonably necessary or appropriate.

2

 

     (b) Any other purpose reasonably related to (a) above.

     SECTION 2.4 Registered Agent and Office; Principal Place of Business.

     The registered agent and office of the Partnership shall be as indicated in the Certificate of
Limited Partnership, as amended from time to time. The principal place of business of the
Partnership shall be at such location in Harlingen, Texas as selected by the General Partner from
time to time. The General Partner shall promptly notify the Partners of any changes in the
Partnership’s registered agent, registered office, or principal place of business.

     SECTION 2.5 Commencement and Term.

     The Partnership commenced on the filing of the Certificate of Limited Partnership in the
Office of the Secretary of State of North Carolina, as required by Section 2.1 hereof, and shall
continue until December 31, 2060, unless sooner terminated or dissolved as provided herein;
provided, however, that the termination date may be extended for up to an additional forty (40)
years in five (5) year increments upon the election of the General Partner. In the event the
General Partner does not elect to extend the term hereof, the Investor Representatives may instead
elect to extend the term hereof, subject to the General Partner’s consent which shall not be
unreasonably withheld or delayed.

ARTICLE III

PARTNERS AND CAPITAL CONTRIBUTIONS

     SECTION 3.1 Capital Contributions of Partners.

	 	(a)	 	The initial Capital Contributions of HHM, HPHI and the Investor
Limited Partners equaled the greater of:

	 	 	 	(i) $8,000,000.00; or
	 
	 	 	 	(ii) 10% of Project Costs.

	 	(b)	 	Such initial Capital Contribution were made as follows:

	 	(i)	 	HHM owns a 1% General Partnership Interest in
the Partnership and contributed to the Partnership for its General
Partnership Interest at least 1% of the aggregate amount of such
initial Capital Contributions.
	 
	 	(ii)	 	HPHI owns a 50% Limited Partnership Interest in
the Partnership and contributed to the Partnership for its Limited
Partnership Interest at least 50% of the aggregate amount of such
initial Capital Contributions.
	 
	 	(iii)	 	The Investor Limited Partners own in the
aggregate up to a 49% Limited Partnership Interest and contributed to
the Partnership for their Limited Partnership Interest an amount equal
in the aggregate to at least 49% of such initial Capital Contributions.

	 	 	 	The specific amounts of initial Capital Contributions actually made were
finally reflected in the books and records of the Partnership.

3

 

	 	(c)	 	As of the date that each original Limited Partner subscribed
for a Partnership Interest, such Limited Partner made an initial Capital
Contribution to the Partnership assuming that total initial Capital
Contributions equaled $8,000,000.00. Once the General Partner finally
determined the amount of Project Costs, if 10% of such Project Costs exceeded
$8,000,000.00, then the General Partner provided written notice to all Partners
thereof and informed all original Partners of any additional Capital
Contribution which they were required to make to the Partnership. Upon such
written request, all original Limited Partners made such additional Capital
Contributions to the Partnership no later than 15 days after the date of such
written notice from the General Partner.
	 
	 	(d)	 	The Hospital Limited Partner has made a capital contribution to
the Partnership by conversion of a portion of the Convertible Loans as
described on the Information Exhibit, in lieu of the procedures described in
the Convertible Note Purchase Agreement and the Convertible Notes issued in
connection therewith.
	 
	 	(e)	 	HMC Management has made a capital contribution to the
Partnership by assigning to the Partnership a portion of a loan owed by HMC
Realty, LLC (by assumption and assignment from the Partnership) to MedCath
Finance Co., LLC, an affiliate of HMC Management, as described on the
Information Exhibit. HMC Management has made a further capital contribution to
the Partnership by conversion of the unassigned portion of such loan as
described on the Information Exhibit.
	 
	 	(f)	 	The Partners may be liable to the Partnership for amounts
distributed to them as a return of capital as provided by the Act. Partners
shall not be required to contribute any additional capital to the Partnership
except as provided in Section 3.5.
	 
	 	(g)	 	The Capital Contributions shall also include any additional
Capital Contributions made by the Partners prior to the Effective Date.

     SECTION 3.2 Liability of Partners — For Capital.

     The liability of each Partner for capital shall be limited to the amount of its agreed Capital
Contribution as a Partner as provided in Section 3.1 and Section 3.5, except that the Partners may
be liable to the Partnership for amounts distributed to them as a return of capital as provided by
the Act. The Partners shall not be required to contribute any additional capital to the
Partnership except as provided in Section 3.5.

     SECTION 3.3 Maintenance of Capital Accounts; Withdrawals of Capital; Withdrawals from the
Partnership.

     An individual Capital Account shall be maintained for each Partner in accordance with
requirements of the Code and the Regulations promulgated thereunder. No Partner shall be entitled
to withdraw or to make demand for withdrawal of any part of its Capital Account or to receive any
distribution except as provided herein. Except as otherwise provided in this Agreement, each
Partner
shall look solely to the assets of the Partnership for the return of its Capital Contributions and
shall have no right or power to demand or receive property other than cash from the Partnership.
No Partner shall have priority over any other Partner as to the return of its Capital
Contributions, distributions or allocations, except as provided in this Agreement.

4

 

     Except as otherwise provided herein, a Partner may not withdraw from the Partnership without
the written consent of the General Partner and the Majority Vote of the Investor Limited Partners
and in no case shall a Partner have the right to have its Interest redeemed by the Partnership
unless approved by the General Partner and by the Majority Vote of the Investor Limited Partners.

     SECTION 3.4 Interest on Capital Contributions or Capital Accounts.

     No interest shall be paid to any Partner based solely on its Capital Contributions or Capital
Account. The preceding sentence shall not prevent the Partnership from earning interest on its
bank accounts and investments and distributing such earnings to the Partner in accordance with
Articles VI and VII.

     SECTION 3.5 Additional Funding.

     If from time to time, the General Partner reasonably determines that funds in addition to that
contemplated by Sections 3.1 and 3.2 are necessary or appropriate for the development or operation
of the Hospital, then:

     (a) First, the General Partner shall use commercially reasonable efforts to borrow such
funds from a bank or other lender on terms and conditions reasonably acceptable to the
General Partner. All loans obtained hereunder shall be subject to the approval of the
Investor Representatives, which approval shall not be unreasonably withheld or delayed;

     (b) Second, if loans as provided in (a) above are not available, the General Partner
may through written notice require that the Partners contribute additional capital to the
Partnership pro rata according to their respective Partnership Interests, provided however,
the maximum obligation for such additional Capital Contributions for HMC Management, HPHI
and the Investor Limited Partners shall be limited to an additional amount equal to such
Partners’ initial Capital Contribution pursuant to Section 3.1; provided further that the
Hospital Limited Partner may elect whether or not to contribute its pro rata portion of such
additional capital requirements but shall be diluted in the manner described in Section
3.5(c) if it elects not to contribute its pro rata portion of such additional capital
requirements.

     (c) Third, if additional funds are thereafter needed by the Partnership, the General
Partner shall request additional Capital Contributions from the Partners and each Partner
may elect whether or not to contribute its pro rata portion of such additional capital
requirements as optional Capital Contributions. The other Partners may elect to contribute
optional Capital Contributions not contributed by any Partner hereunder. Thereafter, the
General Partner shall reasonably adjust the percentage Partnership Interest of each Partner
(based on the aggregate of all Capital Contributions made by all of the Partners in
accordance with this Agreement) in the event any Partner (including the Hospital Limited
Partner) elected not to make optional Capital Contributions pursuant to this Section 3.5(c)
or in the event the Hospital Limited Partner elected not to make Capital Contributions
pursuant to Section 3.5(b);

     (d) At any stage of the process under this Section 3.5, if additional funds are needed
by the Partnership, the General Partner or one of its Affiliates may, but shall not be
required to, loan all or any portion of such funds to the Partnership at the Prime Rate plus
one percent (1%) per annum which loan shall be secured by the Partnership’s assets.
Interest shall be paid monthly in arrears and principal shall be repaid according to a
schedule to be agreed upon by the Investor Representatives and the General Partner or its
Affiliate; and

5

 

     (e) Finally, if funds are not available in accordance with (a) through (d) above, then
the General Partner may elect to dissolve the Partnership.

     SECTION 3.6 Enforcement of Commitments.

     In the event any Partner (a “Delinquent Partner”) fails to make a mandatory Capital
Contribution as provided in Section 3.1 or Section 3.5 or an optional Capital Contribution as
agreed to by the Partner under Section 3.5 (the “Commitment”), the General Partner shall give the
Delinquent Partner a Notice of the failure to meet the Commitment. If the Delinquent Partner fails
to perform the Commitment (including any costs associated with the failure to meet the Commitment
and interest on such obligation at the Default Interest Rate) within ten (10) business days of the
giving of Notice, the General Partner may take such action, including but not limited to enforcing
the Commitment in the court of appropriate jurisdiction in the state in which the principal office
of the Partnership is located or the state of the Delinquent Partner’s address as then reflected in
the Agreement. Each Partner expressly agrees to the jurisdiction of such courts but only for the
enforcement of Commitments. The other Partners may elect to contribute additional amounts equal to
any amount of the Commitment not contributed by such Delinquent Partner. The contributing Partner
shall be entitled at its election to treat the amounts contributed pursuant to this Section either
as a Capital Contribution or as a loan from the contributing Partner bearing interest at the
Default Rate secured by the Delinquent Partner’s Interest in the Partnership. If the contributing
Partner elects to contribute such amount as a Capital Contribution, the percentage Partnership
Interests of the Partners shall be adjusted proportionately. Until the contributing Partner is
fully repaid for such loan made as a result of the default by the Delinquent Partner and only if
the contributing Partner agrees to accept repayment of such amount, the contributing Partner shall
be entitled to all distributions to which the Delinquent Partner would have been entitled had such
Commitment been fulfilled thereby. Notwithstanding the foregoing, no Commitment or other
obligation to make an additional Capital Contribution may be enforced by a creditor of the
Partnership unless the Partner expressly consents to such enforcement or to the assignment of the
obligation to such creditor.

     SECTION 3.7 Tax Treatment of Conversion.

     Notwithstanding any provision herein to the contrary, the conversion, if any, of the
Convertible Loans shall be treated for US federal income tax purposes in a manner that (i) is
consistent with the proposed Regulations pertaining to noncompensatory partnership options
published by the Treasury Department and IRS in the Federal Register on January 22, 2003
(REG-103580-02), as amended, or (ii) complies with the requirements of any final Regulations and
associated guidance promulgated by the Treasury Department and IRS regarding the tax consequences
associated with the Partnership’s issuance of noncompensatory partnership options, including the
requirement to make any corrective allocations contemplated by proposed Regulations Section
1.704-1(b)(2)(iv)(s) (or the corresponding provision of any final Regulations and associated
guidance by the Treasury Department and IRS regarding the tax consequences pertaining to
noncompensatory partnership options), if and to the extent that any such final Regulations and
associated guidance are applicable to any conversion of the Convertible Loans; provided,
however, that (i) any elections required to be made by the Partnership or otherwise
contemplated in connection with the foregoing shall be made by the Partnership only with the
consent of the Hospital Limited Partner, which consent shall not be unreasonably withheld, and (ii)
the Partnership and Partners shall use the remedial allocation method provided under Regulation
Section 1.704-3(d) in connection with any corrective allocations contemplated by proposed
Regulations Section 1.704-1(b)(2)(iv)(s) (or the corresponding provision of any final Regulations
and associated guidance by the Treasury Department and IRS regarding the tax consequences
pertaining to noncompensatory partnership options). The Partners acknowledge and agree that Agreed
Values and Capital Accounts may be adjusted in connection with the foregoing.

6

 

     SECTION 3.8 Limitation on Hospital Limited Partner’s Contribution Right

     Notwithstanding any provision herein to the contrary, any right herein of the Hospital Limited
Partner’s to make a Capital Contribution shall be limited to the extent that a Capital Contribution
would result in the Hospital Limited Partner having a percentage Partnership Interest that exceeds
forty-nine percent (49%) at any time during the term of this Agreement.

ARTICLE IV

NAMES AND ADDRESSES OF PARTNERS

     The names and addresses of the Partners are as indicated on the Information Exhibit,
attached hereto and as amended from time to time.

ARTICLE V

MANAGEMENT OF THE PARTNERSHIP

     SECTION 5.1 General Authority and Powers of the General Partner.

     Except as set forth in those provisions of this Agreement that specifically require the vote,
consent, approval or ratification of the Partners, the General Partner shall have complete
authority and exclusive control over the management of the business and affairs of the Partnership.
Subject to the terms and conditions of this Agreement and except as otherwise provided herein, all
Material Agreements and Material Decisions with respect to the business and affairs of the
Partnership shall be approved or made by the General Partner with the consent of the Investor
Representatives in accordance with Section 5.16 hereof which in all cases shall not be unreasonably
withheld or delayed. No Limited Partner has the actual or apparent authority to cause the
Partnership to become bound in any contract, agreement or obligation, and no Limited Partner shall
take any action purporting to be on behalf of the Partnership. The General Partner shall not cause
the Partnership to become bound to any contract, agreement or obligation, and the General Partner
shall not take any other action on behalf of the Partnership, unless such matter has received the
vote, consent, approval or ratification if, and as, required pursuant to this Agreement with
respect to such matter or except as provided below with respect to the authority and actions of the
General Partner.

     The day-to-day management of the business and affairs of the Partnership shall be the
responsibility of the General Partner, provided, however, decisions relating to medical and
clinical practice at the Hospital shall be made exclusively by the qualified medical personnel of
the Hospital. Subject in all cases to the foregoing, the General Partner shall have the right and
the power, if, as, and when it, from time to time, deems necessary or appropriate on behalf of the
Partnership, subject only to the terms and conditions of this Agreement:

     (a) To negotiate and execute on behalf of the Partnership all documents, instruments
and agreements reasonably necessary or appropriate to lease, acquire and/or
construct the Hospital and/or the real property on which the Hospital is or will be located,
and to borrow funds to finance such lease, acquisition and/or construction (it being
acknowledged that the Hospital may be an existing building or may be a newly constructed
building);

     (b) To prepare a budget for the development of the Hospital and thereafter, annual
operating budgets;

7

 

     (c) To acquire the Equipment and enter into loans or other financing arrangements
therefor;

     (d) To handle the negotiation and execution of all other agreements regarding the
purchase of goods or services for the Hospital;

     (e) To establish and maintain procedures for quality assurance, peer review and
granting privileges to physicians with other specialties at the Hospital, subject to the
terms of the Hospital and medical staff bylaws adopted for the Hospital;

     (f) To expend all or portions of the Partnership’s capital and income in furtherance of
or relating to the Partnership’s business and purposes, including, but not limited to,
payment of all ongoing operational expenses, payment of commissions, organization expenses,
professional fees, rental fees, and management fees, and to invest in short-term debt
obligations (including, but not limited to, obligations of federal and state governments and
their agencies, commercial paper, and certificates of deposit of commercial banks, or
savings banks or savings and loan associations) such of the Partnership’s funds as are
temporarily not required for the development or operation of the Partnership and the payment
of Partnership obligations; provided, that the General Partner shall establish cash
management guidelines;

     (g) To employ or retain on such terms and for such compensation as the General Partner
may reasonably determine, such persons, firms, or corporations as the General Partner may
deem advisable, including without limitation qualified medical and other employees necessary
or appropriate to operate the Hospital, attorneys, accountants, financial and technical
consultants, supervisory managing agents, insurance brokers, brokers and loan brokers,
appraisers, architects and engineers, who may also provide such services to the General
Partner, provided that the selection of the senior administrator of the Hospital shall be a
Material Decision;

     (h) To execute leases, deeds, contracts, rental agreements, construction contracts,
sales agreements, and management contracts;

     (i) To exercise all rights, powers, and privileges of the Partnership as lessee with
respect to the Hospital or rights held by the Partnership;

     (j) To consent to the modification, renewal, or extension of any obligations to the
Partnership of any Person or of any agreement to which the Partnership is a party or of
which it is a beneficiary;

     (k) To execute in furtherance of any or all of the purposes of the Partnership, any
deed, lease, deed of trust, security interest, mortgage, promissory note, bill of sale,
assignment, contract, or other instrument purporting to purchase or convey or encumber in
whole or in part the Equipment or the Hospital or other real or personal property of the
Partnership;

     (l) To prepay in whole or in part, refinance, recast, increase, modify, or extend any
security interest, deed of trust, or mortgage affecting the Hospital and in connection
therewith to execute any extensions or renewals thereof on the Hospital and to grant
security interests in any of the Equipment or the Hospital;

     (m) To adjust, compromise, settle, or refer to arbitration any claim against or in
favor of the Partnership, and to institute, prosecute, and defend any actions or proceedings
relating to the Partnership, its business, and properties;

8

 

     (n) To acquire and enter into any contract of insurance which the General Partner deems
necessary or appropriate for the protection of the Partnership and the General Partner, for
the conservation of the Partnership or its assets, or for any purpose beneficial to the
Partnership; however, neither the General Partner nor its Affiliates shall be compensated
for providing insurance brokerage services relating to obtaining such insurance;

     (o) To prepare or cause to be prepared reports, statements, and other relevant
information for distribution to the Partners, including annual reports;

     (p) To open accounts and deposit and maintain funds in the name of the Partnership in
banks or savings and loan associations; provided, however, that the Partnership’s funds
shall not be commingled with the funds of any other Person;

     (q) To cause the Partnership to make or revoke any of the elections referred to in
Section 754 of the Internal Revenue Code of 1986 as amended or any similar provisions
enacted in lieu thereof;

     (r) To make all decisions related to generally accepted principles of accounting to be
applied on a consistent basis and federal income tax elections;

     (s) To possess and exercise, subject to the restrictions contained in this Agreement,
any and all of the rights, powers and privileges of a general partner under the Act;

     (t) To execute, acknowledge, and deliver any and all documents or instruments in
connection with any or all of the foregoing;

     (u) To modify or otherwise improve the Hospital, subject to the restrictions contained
in this Agreement;

     (v) To manage, direct, and guide the operation of the Hospital including all necessary
acts relating thereto, other than medical or clinical matters which shall be under the
direction of the Investor Representatives and other agreed upon qualified medical personnel;

     (w) To establish minimum insurance requirements for all physicians practicing at the
Hospital;

     (x) To admit as Partners additional investors who have been proposed for Partner status
by the General Partner and approved by the Investor Representatives, which approval shall be
given or withheld in the sole and absolute discretion of the Investor Representatives;

     (y) To sell assets of the Partnership, subject to the restrictions contained in this
Agreement; and

     (z) To prepare Medical Staff Bylaws (the approval of which shall constitute a Material
Decision) which shall provide that the medical staff of the Hospital will be open to
qualified physicians who meet the Hospital’s credentialing criteria, it being acknowledged
that exclusive contracts may be entered into upon the approval of the General Partner and
the Investor Representatives.

9

 

     SECTION 5.2 Restrictions on Authority of the General Partner.

     The General Partner shall not do any of the following:

     (a) Act in contravention of this Agreement;

     (b) Act in any manner which would make it impossible to carry on the express business
purposes of the Partnership;

     (c) Commingle the Partnership funds with those of any other Person;

     (d) Admit an additional General Partner, except as provided in this Agreement;

     (e) Admit an additional Partner, except as provided in this Agreement;

     (f) Alter the primary purposes of the Partnership as set forth in Section 2.3;

     (g) Possess any property or assign the rights of the Partnership in specific property
for other than a Partnership purpose;

     (h) Employ, or permit the employ of, the funds or assets of the Partnership in any
manner except for the exclusive benefit of the Partnership;

     (i) Make any payments of any type, directly or indirectly, to anyone for the referral
of patients to the Hospital in order to use the Hospital or to provide other services; or

     (j) Sell all or substantially all of the assets of the Partnership or merge the
Partnership with or into any other Entity without (i) the approval of a Majority Vote of the
Investor Limited Partners and (ii) complying with the requirements of the Right of First
Offer set forth on the Information Exhibit which incorporates the provisions of Article XVI
of the Convertible Note Purchase Agreement, if applicable.

     SECTION 5.3 Duties of the General Partner.

     The General Partner shall do the following:

     (a) Diligently and faithfully devote such of its time to the business of the
Partnership as may be necessary to properly conduct the affairs of the Partnership and,
perform the duties for which it will receive a Management Fee as provided in Section 5.6(b),
or otherwise, however, the General Partner shall not be required to devote its full time to
such duties;

     (b) Use its best efforts to cause the Partnership to comply with such conditions as may
be required from time to time to permit the Partnership to be classified for federal income
tax purposes as a partnership and not as an association taxable as a corporation;

     (c) File and publish all certificates, statements, or other instruments required by law
for the formation and operation of the Partnership as a limited partnership in all
appropriate jurisdictions;

     (d) Cause the Partnership to obtain and keep in force during the term of the
Partnership fire and extended coverage and public liability and professional liability
insurance with such issuers and in such amounts as the General Partner shall deem advisable,
but in

10

 

amounts not less (and deductible amounts not greater) than those customarily
maintained with respect to the business equipment and property comparable to the
Partnership’s;

     (e) Have a fiduciary duty to conduct the affairs of the Partnership in the best
interests of the Partnership and of the Partners, including the safekeeping and use of all
funds and assets, whether or not in its immediate possession and control, and it shall not
employ or permit others besides the General Partner to employ such funds or assets in any
manner except for the benefit of the Partnership; and

     (f) Deliver to the Secretary of State of North Carolina for filing an annual statement
in accordance with the Act and make any similar filings required under Texas law.

     SECTION 5.4 Delegation by the General Partner.

     Subject to restrictions otherwise provided herein, the General Partner may at any time employ
any other Person, including Persons and Entities employed by, affiliated with, or related to the
General Partner to perform services for the Partnership and its business, and may delegate all or
part of their authority or control to any such other Persons, provided that such employment or
delegation shall not relieve the General Partner of its responsibilities and obligations under this
Agreement or under the laws of the State of North Carolina nor will it make any such Person a
Partner or General Partner of the Partnership.

     SECTION 5.5 Right to Rely Upon the Authority of the General Partner.

     Persons dealing with the Partnership may rely upon the representation of the General Partner
that such General Partner is a general partner of the Partnership and that such General Partner has
the authority to make any commitment or undertaking on behalf of the Partnership. No Person
dealing with the General Partner shall be required to determine its authority to make any such
commitment or undertaking. In addition, no purchaser from the Partnership shall be required to
determine the sole and exclusive authority of the General Partner to sign and deliver on behalf of
the Partnership any instruments of transfer with respect thereto or to see to the application or
distribution of revenues or proceeds paid or credited in connection therewith, unless such
purchaser shall have received written notice from the Partnership affecting the same.

     SECTION 5.6 Partnership Expenses.

     (a) In general, the Partnership’s expenses shall be billed directly to and paid by the
Partnership. The Partnership shall reimburse the General Partner or its Affiliates for: (i)
all Organization Expenses incurred by the General Partner or its Affiliates in connection
with the formation of the Partnership; (ii) following consultation with the Investor
Representatives, the
costs to the General Partner or its Affiliates of goods, services, and materials used for
and by the Partnership; and (iii) all reasonable travel and other out-of-pocket expenses
incurred by the General Partner in the development and management of the Partnership and its
business provided that after the opening of the Hospital (i.e. the date upon which it
receives preliminary Medicare and Medicaid certification) employees of the General Partner
and MedCath Incorporated who are not employed full-time for the benefit of the Hospital
shall not be reimbursed for their travel and other similar expenses. The parties
specifically recognize that the General Partner and its Affiliates have incurred legal fees,
filing fees, and other out-of-pocket costs for the benefit of the Partnership, including
costs connected with the preparation of securities law and health care law compliance
documentation and filings, real estate acquisition matters and formation and registration of
the Partnership, and agree that the
General Partner shall be reimbursed for these amounts.
The reimbursement for expenses provided for in this Section 5.6(a) shall be made to the

11

 

General Partner or their Affiliates regardless of whether any distributions are made to the
Partners under Article VI and Article VII.

     (b) The Partnership shall also pay the following expenses of the Partnership:

     (i) All development and operational expenses of the Partnership, which may
include, but are not limited to: the salary and related expenses of employees and
staff of the Hospital, all costs of borrowed money, taxes, and assessments on the
Hospital, and other taxes applicable to the Partnership; expenses in connection with
the acquisition, maintenance, leasing, refinancing, operation, and disposition of
the Equipment, furniture and fixtures of the Hospital (including legal, accounting,
audit, commissions, engineering, appraisal, and the other fees); and the maintenance
of the Hospital and its Equipment, which may be performed by the General Partner or
one of its Affiliates as long as the charges to the Partnership for such service are
no greater than the charges for such service from a third party service provider;

     (ii) In addition to reimbursements and other amounts due hereunder, a
Management Fee shall be paid to the General Partner, which for periods prior to the
opening of the Hospital for business shall equal One Hundred Twenty Thousand Dollars
($120,000.00), which amount shall be paid in full on the date the Hospital is
opened, and for periods after the opening of the Hospital for business shall equal
one and one-half percent (11/2%) of the Hospital’s Net Revenues (defined below) for a
month and shall be payable monthly on or before the tenth (10th) day following the
end of each month. For purposes of this Agreement, “Net Revenues” shall mean all
revenues of the Hospital net of contract allowances and bad debt adjustments, all
determined on a monthly basis in accordance with GAAP on an accrual basis;

     (iii) A medical director’s fee in an amount approved by the General Partner and
the Investor Representatives to be paid to the medical director of the Hospital
which fee shall first accrue commencing as of the date on which the Hospital is
first ready to receive patients and shall be payable monthly on the last day of each
month based on actual time worked at an agreed upon rate and for an agreed upon
number of hours each month; and

     (iv) All fees and expenses paid to third parties for accounting, legal,
documentation, professional, and reporting services to the Partnership, which may
include, but are not limited to: preparation and documentation of Partnership
bookkeeping, accounting and audits; preparation and documentation of budgets, cash
flow projections, and working capital requirements; preparation and documentation of
Partnership state and federal tax returns; and taxes incurred in connection with the
issuance, distribution, transfer, registration, and recordation of documents
evidencing ownership of a Partnership Interest or Economic Interest in the
Partnership or in connection with the business of the Partnership; expenses in
connection with preparing and mailing reports required to be furnished to the
Partners or Economic Interest Owners for tax reporting or other purposes, including
reports, if any, that may be required to be filed with any federal or state
regulatory agencies, or expenses associated with furnishing reports to Partners
which the General Partner deems to be in the best interest of the Partnership;
expenses of revising, amending, converting, modifying, or terminating the
Partnership or this Agreement; costs incurred in connection with any litigation in
which the Partnership is involved as well as any examination, investigation, or
other proceedings conducted by any regulatory agency involving the Partnership;
costs of any computer equipment or services used for or by the Partnership; and the
costs of preparing

12

 

and disseminating informational material and documentation
relating to a potential sale, refinancing, or other disposition of the Hospital or
the Equipment.

     (c) Guarantee Fee. In the event that any Partner of the Partnership or its
Affiliates provide a guarantee of any indebtedness of the Partnership which is acceptable to
and required by the Partnership’s lenders (“Guarantor Partners”) and such guarantees
are not provided on a pro rata basis by all other Partners of the Partnership (the
“Nonguarantor Partners”), then the Guarantor Partners shall be paid an annual guarantee fee
equal to (a) the amount of such indebtedness which is guaranteed by the Guarantor Partners
or its Affiliates, multiplied by (b) .0075, multiplied by (c) the percentage Partnership
Interest in the Partnership owned by the Nonguarantor Partners (the “Guarantee Fee”). The
Guarantee Fee shall be paid quarterly and the expense thereof shall be allocated to the
Nonguarantor Partners as follows:

     (i) The Guarantee Fee shall be deducted from the Cash Distributions otherwise
distributable to the Nonguarantor Partners and shall be paid to the Guarantor
Partners;

     (ii) To the extent that at the time such Guarantee Fee is due to be paid
hereunder there are no anticipated Cash Distributions, then the Partnership shall
pay such Guarantee Fee to the Guarantor Partners and the amount of such payments
shall be charged to the Capital Accounts of the Nonguarantor Partners;

     (iii) When Cash Distributions (or, if necessary, liquidating distributions)
become available for distribution to the Partners in the future, the Cash
Distributions (or liquidating distributions) otherwise distributable to the
Nonguarantor Partners shall first be retained by the Partnership to the extent that
amounts were previously charged to the Capital Accounts of the Nonguarantor Partners
in accordance with (ii) above and any remaining Cash Distributions (or liquidating
distributions) shall be distributed to the Partners in accordance with Section 6.1
or 7.3, as appropriate.

     Loans made by MedCath Finance Company or its Affiliates to the Partnership shall be
considered the provision of a guarantee of indebtedness for purposes of calculating the
Guarantee Fee.

     SECTION 5.7 No Management by Limited Partners.

     The Limited Partners shall take no part in, or at any time interfere in any manner with, the
management, conduct, or control of the Partnership’s business and operations and shall have no
right or authority to act for or bind the Partnership except as set forth in this Agreement. The
rights and powers of such Limited Partners shall not extend beyond those set forth in this
Agreement and those granted under the Certificate of Limited Partnership and any attempt to
participate in the control of the Partnership in a manner contrary to the rights and powers granted
herein and under the Certificate of Limited Partnership shall be null and void and without force
and effect. Subject to the decisions and judgment with respect to all professional medical or
clinical matters of qualified medical personnel, the General Partner, in conjunction with the
Investor Representatives when applicable, shall have the right to determine when and how the
operations of the Partnership shall be conducted. The exercise by any Limited Partner of any of
the rights granted to the Limited Partner hereunder shall not be deemed to be taking part in the
control of the business of the Partnership and shall not constitute a violation of this Section.

13

 

     SECTION 5.8 Consent by Limited Partners to Exercise of Certain Rights and Powers by the
General Partner.

     By its execution hereof, each Limited Partner expressly consents to the exercise by the
General Partner of the rights, powers, and authority conferred on the General Partner by this
Agreement.

     SECTION 5.9 Other Business of Partners.

     (a) Subject to (b) below, any Partner, including the General Partner, may engage
independently or with others in other business ventures of every nature and description,
including without limitation the purchase of medical equipment, the rendering of medical
services of any kind, and the making or management of other investments and neither the
Partnership nor any Partner shall have any right by virtue of this Agreement or the
relationship created hereby in or to such other ventures or activities or to the income or
proceeds derived therefrom, and the pursuit of such ventures.

     (b) As long as any Partner owns a Partnership Interest in the Partnership, and for a
period of five (5) years after a Partner ceases for any reason to own a Partnership Interest
in the Partnership, other than with respect to investments made, equipment owned or services
provided on or prior to March 1, 1999, all of which the Partners will disclose in writing to
the General Partner upon request (a Partner may replace any such existing equipment after
March 1, 1999 as long as it does not constitute a new service or facility which is otherwise
restricted hereunder), neither a Partner nor any of its respective Affiliates, shall hold,
directly or indirectly, an investment, ownership or other beneficial interest in (i) any
hospital (ii) other Person (including a sole proprietorship) which provides any of the
services or facilities to be provided by the Hospital or (iii) any outpatient surgery
center, in any case within Cameron County, Texas (the “Territory”), provided that (i) no
Partner who is a physician shall be prohibited from maintaining his or her staff privileges
at any other hospital and (ii) nothing herein shall prohibit a Partner from owning up to
three percent (3%) of the outstanding capital stock of a company whose stock is publicly
traded and listed on a nationally recognized securities exchange or from investing in a
publicly traded mutual fund. In addition, the General Partner or its Affiliates may
separately operate a mobile catheterization laboratory within the Territory, but only if
either the General Partner or an Affiliate thereof is providing such service pursuant to a
lease of six (6) months or less to a provider who is already providing
cath lab services or if the Investor Representatives have elected not to have such service
provided by the Partnership.

     Notwithstanding the foregoing, the restrictions of this Section 5.9(b) shall not apply
to the Hospital Limited Partner.

     (c) In order to ensure that the Hospital has available to it at all times leading and
qualified physicians, the Partnership has entered into the Hospital Professional Services
Agreements (the “Professional Services Agreements”) with the Investor Limited Partners or
their medical practices (the “Practices”), which Agreements includes in paragraph 7 thereof
certain covenants by the Practices and its physicians which are designed to ensure that such
physicians will be available to the Hospital from time to time in order to enable it to meet
its objectives of being a quality provider of medical services on a cost efficient basis.
The parties acknowledge and agree that the Practices’ execution of the Professional Services
Agreements is further consideration for the execution by all of the Partners of this
Agreement.

     (d) The Partners, including the General Partner, have reviewed the terms, conditions
and geographical restrictions included in Sections 5.9(b) and (c) and in light of the
interests of the parties hereto, agree that such restrictions are fair and reasonable.

14

 

     (e) If there is a breach or threatened breach of the provisions of this Section 5.9 of
this Agreement, in addition to other remedies at law or equity, the non-breaching party
shall be entitled to injunctive relief. The parties desire and intend that the provisions
of this Section 5.9 shall be enforced to the fullest extent permissible under the law and
public policies applied, but the unenforceability or modification of any particular
paragraph, subparagraph, sentence, clause, phrase, word, or figure shall not be deemed to
render unenforceable the remainder of this Section 5.9. Should any such paragraph,
subparagraph, sentence, clause, phrase, word, or figure be adjudicated to be wholly invalid
or unenforceable, the balance of this Section 5.9 shall thereupon be modified in order to
render the same valid and enforceable and the unenforceable portion of this Section 5.9
shall be deemed to have been deleted from this Agreement.

     (f) The Partnership, the General Partner and the Limited Partners agree that the
benefits to any Limited Partner hereunder do not require, are not payment for, and are not
in any way contingent upon the referral, admission or any other arrangement for the
provision of any item or service offered by the General Partner or the Partnership to
patients of such Limited Partner in any facility, laboratory or other health care operation
controlled, managed or operated by the General Partner or the Partnership and nothing herein
is intended to prohibit any party from practicing medicine at any other facility.

     (g) If a Limited Partner is a legal entity and not an individual, such Limited Partner
shall cause each of its existing and future Affiliates to agree in writing to be personally
bound by the terms of this Section 5.9.

     SECTION 5.10 General Partner’s Standard of Care.

     The General Partner shall act in a manner it believes in good faith to be in the best interest
of the Partnership and with such care as an ordinarily prudent Person in a like position would use
under similar circumstances. In discharging its duties, the General Partner shall be fully
protected in relying in good faith upon the records required to be maintained under this Agreement
and upon such information, opinions, reports and statements by any Partners, or agents, or by any
other Person as to
matters the General Partner reasonably believes are within such other Person’s professional or
expert competence and who has been selected with reasonable care by or on behalf of the
Partnership, including information, opinions, reports or statements as to the value and amount of
the assets, liabilities, income or losses of the Partnership or any other facts pertinent to the
existence and amount of assets from which distributions to Partners might properly be paid.

     Notwithstanding anything herein to the contrary, the General Partner or Partner shall have the
right to vote or approve Partnership matters in accordance with the terms of this Agreement
regardless of the personal interest of any Partner or the General Partner in the outcome of any
vote, decision or matter.

     SECTION 5.11 Limitation of Liability.

     The General Partner shall not be liable to the Partnership, or its Partners, for any action
taken in managing the business or affairs of the Partnership if it performs the duty of its office
in compliance with the standard contained in Section 5.10. The General Partner has not guaranteed
nor shall have any obligation with respect to the return of a Partner’s Capital Contribution or
share of income from the operation of the Partnership. Furthermore, the General Partner, its
Affiliates or its employees (collectively, its “Agents”) shall not be liable to the Partnership or
to any Partner for any loss or damage sustained by the Partnership or any Partner except loss or
damage resulting from gross negligence or intentional misconduct or knowing violation of law or a
transaction for which such General Partner or Agent received a personal benefit in violation or
breach of the provisions of this Agreement.

15

 

     SECTION 5.12 Indemnification of the General Partner.

     (a) The General Partner and its Agents (as defined in Section 5.11) shall be
indemnified by the Partnership against any losses, judgments, liabilities, expenses,
including attorneys’ fees and amounts paid in settlement of any claims sustained by them
arising out of any action or inaction of the Partner or its Agents in its capacity as the
General Partner of the Partnership (or, in the case of an Agent, within the scope of the
General Partner’s authority) to the fullest extent allowed by law, provided that the same
were not the result of gross negligence or willful misconduct on the part of the General
Partner or an Agent and provided that the General Partner or an Agent, in good faith,
reasonably determined that such course of conduct was in the best interest of the
Partnership; provided, however, that such indemnification and agreement to hold harmless
shall be recoverable only out of Partnership assets. Subject to applicable law, the
Partnership shall advance expenses incurred with respect to matters for which the General
Partner may be indemnified hereunder.

     (b) If at any time, the Partnership has insufficient funds to furnish indemnification
as herein provided, it shall provide such indemnification if and as it generates sufficient
funds and prior to any cash distributions, pursuant to Article VI or Article VII hereof, to
the Partners.

     SECTION 5.13 Election and Replacement of Investor Representatives; Appointment of Hospital
Representative.

          (a) In accordance with the procedures outlined in Section 10.2 herein, the Investor Limited
Partners shall elect five (5) Investor Representatives by Majority Vote of the Investor Limited
Partners to serve for one year terms or until a successor is duly elected. At any time, in
accordance with Section 10.2, the Investor Limited Partners may replace individual Investor
Representatives and elect a new Investor Representative by Majority Vote of Investor Limited
Partners to replace such Investor Representative.

          (b) The Hospital Limited Partner shall be entitled to appoint an independent nonvoting
representative (the “Hospital Representative”) who shall be permitted to attend all meetings of the
General Partner and the Investor Representatives; provided that the Hospital Representative shall
not have access to competitive or proprietary information and shall not be permitted to attend any
portion of such meetings which relates to competitive or proprietary information, in each case as
determined collectively by the General Partner and the Investor Representatives in their reasonable
discretion. The Partnership shall reimburse the Hospital Representative for all reasonable travel
and other out-of-pocket expenses incurred by the Hospital Representative in attending meetings of
the Investor Limited Partners or Investor Representatives.

     SECTION 5.14 Role of and Decisions by Investor Representatives.

     Notwithstanding anything herein to the contrary, the Investor Representatives shall take no
action nor make any decision on behalf of the Partnership except to the extent they are expressly
authorized to do so under this Agreement in their capacity as Investor Representatives. Except as
otherwise expressly provided herein, all references to decisions to be made or objections given by
the Investor Representatives shall be deemed to be made upon the affirmative vote, consent, or
approval or objection of a majority of the Investor Representatives.

16

 

     SECTION 5.15 Purchase of Goods and Services from the General Partner.

     Goods and services may be purchased from the General Partner or its Affiliates as long as they
are of substantially the same quality and price as could be obtained from an unrelated third party.

     SECTION 5.16 Decisions by the General Partner.

     Except as provided in this Agreement, decisions and actions to be taken by the Partnership
shall be deemed to have been made only upon the affirmative approval or consent of the General
Partner and the Investor Representatives. In the event a decision, approval or consent is requested
of the Investor Representatives by the General Partner, it shall be deemed to have been
affirmatively made if the Investor Representatives fail to respond to any such written request
therefor within five (5) days of notice thereof by the General Partner. Notwithstanding anything
in this Agreement to the contrary, all decisions and actions to be made by the General Partner with
respect to any loan, lease or other similar financing of the development, construction or operation
of the Hospital or the Partnership’s affairs, including without limitation the decisions with
respect to incurring any indebtedness or the refinancing thereof, shall be made by the General
Partner and shall be subject to the consent of the Investor Representatives, which consent shall
not be unreasonably withheld; provided, the application of the Partnership’s funds toward
the repayment of all or a portion of any financing of the Partnership in excess of amounts then
required to be paid (i.e., voluntary prepayments) shall be made only with the consent of the
General Partner and the Investor Representatives. The Investor Representatives shall be deemed to
have specifically approved all expenditures proposed by the General Partner that are substantially
consistent with the Development Budget Exhibit or an approved operating budget when funded
from additional Capital Contributions made to the Partnership by the Partners pursuant to Section
3.5 above.

     The development and annual operating budgets to be proposed by the General Partner shall be
approved by the General Partner and the Investor Representatives as provided above subject to the
following:

     (a) The Investor Representatives shall be deemed to have approved a development budget
which is substantially consistent with the attached Development Budget Exhibit to
this Agreement;

     (b) The Investor Representatives shall not unreasonably withhold its approval of
budgets which are within the reasonable revenue expectations of the Hospital and which are
in compliance (both as to terms and availability of financing) with agreements with the
Partnership’s lenders and other parties providing financing to the Partnership; and

     (c) In the event that the General Partner and the Investor Representatives are unable
to approve an annual budget, the General Partner shall be authorized to operate the
Partnership under the previous year’s budget increased by the greater of 5% or the increase
during the previous year in the Consumer Price Index for Medical Items until a new budget is
approved.

17

 

ARTICLE VI

DISTRIBUTIONS AND ALLOCATIONS

     SECTION 6.1 Distributions of Cash Flow from Operations and Cash from Sales or
Refinancing.

     (a) Prior to the dissolution of the Partnership, Cash Flow from Operations and Cash
from Sales or Refinancing, if any, remaining after repayment of any amounts then due on
loans made by the Partners to the Partnership and after payment of any Cash Distributions
pursuant to Section 6.7, shall be distributed annually by the Partnership as Cash
Distributions following the end of such Fiscal Year. Such Cash Distributions shall be made
according to the relative percentage Partnership Interests of the Partners and Economic
Interest Owners.

     (b) To the extent possible, any Guarantee Fee shall be deducted from the Cash
Distributions otherwise distributable to the Nonguarantor Partners pursuant to paragraph (a)
of this Section 6.1 and paid to the Guarantor Partners as set forth in Section 5.6(c).
Notwithstanding anything herein to the contrary, no distributions shall be made to Partners
if prohibited by the Act.

     SECTION 6.2 Profits.

     Except as provided in the Regulatory Allocations Exhibit and subject to Section 6.6, Profits
shall be allocated as follows:

     (a) First, to the General Partner to the extent of the amount equal to the remainder,
if any, of (i) the cumulative Losses allocated to the General Partner pursuant to Section
6.3(e) for all prior Fiscal Years, less (ii) the cumulative Profits allocated to the General
Partner pursuant to this Section 6.2(a) for all prior Fiscal Years;

     (b) Second, to the Limited Partners pro rata in proportion to and to the extent of the
amount equal to the remainder, if any, of (i) the cumulative Losses allocated to the Limited
Partners pursuant to Section 6.3(e) for all prior Fiscal Years, less (ii) the cumulative
Profits allocated to the Limited Partners pursuant to this Section 6.2(b) for all prior
Fiscal Years;

     (c) Third, to the Partners pro rata in proportion to and to the extent of the amount
equal to the remainder, if any, of (i) the cumulative Losses allocated to the Partners
pursuant to Section 6.3(d) for all prior Fiscal Years, less (ii) the cumulative Profits
allocated to the Partners pursuant to this Section 6.2(c) for all prior Fiscal Years;

     (d) Fourth, to the Partners pro rata in proportion to and to the extent of the amount
equal to the remainder, if any, of (i) the cumulative Losses allocated to the Partners
pursuant to Section 6.3(c) for all prior Fiscal Years, less (ii) the cumulative Profits
allocated to the Partners pursuant to this Section 6.2(d) for all prior Fiscal Years;

     (e) Fifth, to the Partners until the cumulative Profits allocated pursuant to this
Section 6.2(e) (net of Losses allocated pursuant to Section 6.3(b)) equals the aggregate
Cash Distributions made for all years with respect to which any Partner’s Cash Distributions
were adjusted pursuant to Section 6.1(b), pro rata in accordance with the relative
difference, with respect to each Partner, between (i) such aggregate Cash Distributions and
(ii) the cumulative Profits previously allocated pursuant to this Section 6.2(e) (net of
Losses allocated pursuant to Section 6.3(b)); and

     (f) Finally, all remaining Profits shall be allocated to the Partners in accordance
with their percentage Partnership Interests.

18

 

     SECTION 6.3 Losses.

     Except as provided in the Regulatory Allocation Exhibit and subject to Section 6.6, Losses
shall be allocated as follows:

     (a) First, to the Partners that have been allocated Profits pursuant to Section 6.2(f)
until the cumulative Losses allocated pursuant to this Section 6.3(a) equals the cumulative
prior allocations of Profits pursuant to Section 6.2(f);

     (b) Second, to the Partners that have been allocated Profits pursuant to Section 6.2(e)
until the cumulative Losses allocated pursuant to this Section 6.3(b) equals the cumulative
prior allocations of Profits pursuant to Section 6.2(e);

     (c) Third, Losses shall be allocated to the Partners with positive Adjusted Capital
Account balances in proportion to those balances;

     (d) Finally, all remaining Losses shall be allocated to the Partners in accordance with
their percentage Partnership Interests.

     (e) Notwithstanding the foregoing, Losses allocated pursuant to this Section 6.3 shall
not exceed the maximum amount of Losses that can be so allocated without causing any Limited
Partner to have an Adjusted Capital Account deficit at the end of any Fiscal Year. In the
event some but not all of the Limited Partners would have Adjusted Capital Account deficits
as a consequence of an allocation of Losses pursuant to this Section 6.3, the limitation set
forth in this Section 6.3(e) shall be applied on a Limited Partner-by-Limited Partner basis
so as to allocate the maximum permissible Losses to each Limited Partner under Regulations
Section 1.704-1(b)(2)(ii)(d). All Losses in excess of the limitations set forth in this
Section 6.3(e) shall be allocated to the General Partner.

     SECTION 6.4 Code Section 704(c) Tax Allocations.

     Income, gain, loss, and deduction with respect to any property contributed to the capital of
the Partnership shall, solely for tax purposes, be allocated among the Partners so as to take
account of any variation between the adjusted basis of such property to the Partnership for federal
income tax purposes and its initial Agreed Value pursuant to any method allowable under Code
Section 704(c) and the Regulations promulgated thereunder.

     In the event the Agreed Value of any Partnership asset is adjusted after its contribution to
the Partnership, subsequent allocations of income, gain, loss and deduction with respect to such
asset shall take into account any variation between the adjusted basis of such asset for federal
income tax purposes and its Agreed Value pursuant to any method allowable under Code Section 704(c)
and the Regulations promulgated thereunder.

     Any elections or other decisions relating to allocations under this Section shall be
determined by the General Partner. Absent a determination by the General Partner, and subject to
the requirements of Section 3.7 hereof, the remedial allocation method under Regulation Section
1.704-3(d) shall be used. Allocations pursuant to this Section are solely for purposes of federal,
state, and local taxes and shall not be taken into account in computing any Partner’s Capital
Account or share of Profits, Losses, other items, or distributions pursuant to any provision of
this Agreement.

19

 

     SECTION 6.5 Miscellaneous.

     (a) Allocations Attributable to Particular Periods. For purposes of determining
Profits, Losses or any other items allocable to any period, such items shall be determined on a
daily, monthly, or other basis, as determined by the General Partner using any permissible method
under Code Section 706 and the Regulations thereunder.

     (b) Other Items. Except as otherwise provided in this Agreement, all items of
Partnership income, gain, loss, deduction, credit and any other allocations not otherwise provided
for shall be divided among the Partners in the same proportion as they share Profits or Losses, as
the case may be, for the year.

     (c) Tax Consequences; Consistent Reporting. The Partners are aware of the income tax
consequences of the allocations made by this Article and by the Regulatory Allocations and hereby
agree to be bound by those allocations as reflected on the information returns of the Partnership
in reporting their shares of Partnership income and loss for income tax purposes. Each Partner
agrees to report its distributive share of Partnership items of income, gain, loss, deduction and
credit on its separate return in a manner consistent with the reporting of such items to it by the
Partnership. Any Partner failing to report consistently, and who notifies the Internal Revenue
Service of the inconsistency as required by law, shall reimburse the Partnership for any legal and
accounting fees incurred by the Partnership in connection with any examination of the Partnership
by federal or state taxing authorities with respect to the year for which the Partner failed to
report consistently.

     (d) Economic Interest Owners. Each Economic Interest Owner shall be entitled to the
distributions and allocations to which its predecessor in interest would have been entitled under
this Article VI had it retained the Economic Interest acquired by the Economic Interest Owner.

     SECTION 6.6 Special Allocations of Guarantee Fees.

     Any and all deductions, losses or reductions to Capital Accounts attributable to the payment
by the Partnership of Guarantee Fees shall be allocated to the Nonguarantor Partners in accordance
with their relative percentage Partnership Interests.

     SECTION 6.7 Tax Distributions.

     The General Partner shall, to the extent permitted by applicable law, and subject to the
availability of Cash Flow from Operations or Cash from Sales or Refinancing, distribute cash
annually to the Partners, pro rata in accordance with the relative percentage Partnership Interests
of such Partners, in an amount which is sufficient to enable them to pay income taxes which arise
from allocations to them of the taxable income of the Partnership; provided, however, that the
foregoing shall not require the sale of any Partnership assets or any refinancing for the purpose
of making such distributions. In computing taxable income of each Partner, the taxable income of
each Partner for the current year shall be reduced by any cumulative tax losses incurred in prior
years (after reduction by taxable income in prior years). Such distributions shall assume for all
Partners the highest combined federal and state tax rates applicable to any Partner with respect to
his or its allocation of taxable income from the Partnership.

20

 

ARTICLE VII

DISSOLUTION, WINDING UP AND LIQUIDATING DISTRIBUTIONS

     SECTION 7.1 No Termination by Certain Acts of Partner.

     Neither the transfer of interest, withdrawal from the Partnership, bankruptcy, insolvency,
dissolution, liquidation or other disability, nor the legal incompetency of any Partner shall
result in the termination or dissolution of the Partnership or affect its continuance in any manner
whatsoever.

     SECTION 7.2 Dissolution.

     The Partnership shall be dissolved upon the happening of any of the following events,
whichever shall first occur:

     (a) The election by the General Partner to dissolve the Partnership in accordance with
the terms of Section 3.5(f) hereof;

     (b) If there is no longer a General Partner of the Partnership, unless the Partnership
is continued by the consent of not less than a majority in interest of the remaining
Partners within ninety (90) days after notice of such event, effective as of the date of
such event. If there is no remaining General Partner, the remaining Partners owning at
least 51% of the Partnership Interests which are owned by the remaining Partners shall, if
they desire to continue the Partnership, elect a Substitute General Partner who shall assume
all of the rights and duties of the General Partner under this Agreement (which Substitute
General Partner accepts such election);

     (c) Upon the written agreement of the General Partner and the Investor Representatives;

     (d) The expiration of the term of the Partnership as provided in Section 2.5 hereof;

     (e) The adjudication of bankruptcy of the Partnership;

     (f) In accordance with Section 12.11 hereof; and

     (g) The entry of a decree of judicial dissolution or the administrative dissolution of
the Partnership as provided in the Act.

     SECTION 7.3 Dissolution and Final Liquidation.

     (a) Upon any dissolution of the Partnership, the Partnership shall not terminate, but
shall cease to engage in further business except to the extent necessary to perform existing
contracts and preserve the value of its assets. Its assets shall be liquidated and its
affairs shall be wound up as soon as practical thereafter by the General Partner, or if for
any reason there is no General Partner, by another Person designated by HPHI and a Majority
Vote of the Investor Limited Partners. In winding up the Partnership and liquidating
assets, the General Partner, or other Person so designated for such purpose, may arrange,
either directly or through others, for the collection and disbursement to the Partners of
any future receipts from the Hospital or other sums to which the Partnership may be
entitled, and shall sell the Partnership’s interest in the Hospital and the Equipment to any
Person, including the General Partner or any Affiliate thereof, on such terms and for such
consideration as shall be consistent with obtaining the fair market

21

 

value thereof, as such fair market value is approved by HPHI and a Majority Vote of the
Investor Limited Partners.

     (b) Upon any such dissolution and liquidation of the Partnership, the net assets, if
any, of the Partnership available for distribution, including any cash proceeds from the
liquidation of Partnership assets, shall be applied and distributed in the following manner
or order, to the extent available:

     (i) To the payment of or creation of reserves for all debts, liabilities, and
obligations to all creditors of the Partnership (other than the Partners or their
Affiliates) and the expenses of liquidation;

     (ii) To the payment of all debts and liabilities (including interest), and
further including without limitation any accrued but unpaid Guarantee Fees, owed to
the Partners or their Affiliates as creditors; and

     (iii) The balance to the Partners with positive Capital Account balances after
taking into account all other adjustments during the Fiscal Year in which
liquidation occurs.

     (c) The Partners intend that the allocations provided under Article VI will produce
final Capital Account balances for the Partners that permit liquidating distributions
pursuant to Section 7.3(b)(iii) to be made in the order and priorities set forth in Section
6.1 (after taking into account all previous distributions made to the Partners pursuant to
Section 6.1). If the allocations otherwise made under Article VI would fail to produce such
final Capital Account balances, the General Partner shall cause the allocations made under
Article VI to be made in a manner that achieves the foregoing intent as close as possible.

     (d) The Partners shall look solely to the assets, if any, of the Partnership for any
return of their Capital Contributions and, if the assets of the Partnership remaining after
payment or discharge of the Partnership’s debts and liabilities, or provision therefor, are
insufficient to return all or any part of the Capital Contributions, no Partner shall have
any right of recourse against the General Partner or other Partners or to charge the General
Partner or other Partners for any amounts except as provided herein and except to the extent
otherwise provided by the Act and/or North Carolina law.

     (e) Upon such dissolution, reasonable time shall be allowed for the orderly liquidation
of the assets of the Partnership and the discharge of liabilities to creditors so as to
minimize the losses normally attendant to a liquidation.

     (f) The Capital Accounts of the Partners, as adjusted, shall be utilized by the
Partnership for the purpose of making distributions to those Partners with positive balances
in their respective Capital Accounts pursuant to Section 7.3(b). In making such
distributions, the General Partner or the Person winding up the affairs of the Partnership
shall distribute all funds available for distribution to the Partners and Economic Interest
Owners (after establishing any reserves that the General Partner deem or the Person winding
up the affairs of the Partnership deems reasonably necessary pursuant to Section 7.3(b))
prior to the later of (i) the end of the taxable year in which the event occurs which caused
the termination and dissolution of the Partnership, or (ii) ninety (90) days after the
occurrence of such event. The General Partner in its sole discretion, or the Person winding
up the affairs of the Partnership, in its discretion, may elect to have the Partnership
retain any installment obligations owed to the Partnership until collected in full so long
as any portion of the reserves which are later determined to be unnecessary, and all

22

 

collections on such installment obligations which are not deemed to be reasonably necessary
by the General Partner or the Person winding up the affairs of the Partnership to add to
such reserves are distributed as soon as practicable in accordance with the provisions of
Section 7.3(b) as modified by this Section.

     (g) Each Economic Interest Owner shall be entitled to the distributions to which its
predecessor in interest would have been entitled pursuant to this Article VII had it
retained the Economic Interest acquired by the Economic Interest Owner.

     SECTION 7.4 Termination.

     Upon completion of the dissolution, winding up, distribution of the liquidation proceeds and
any other Partnership assets, the Partnership shall terminate.

     SECTION 7.5 Payment in Cash.

     Any payments made to any Partner pursuant to this Article VII shall be made only in cash.

     SECTION 7.6 Goodwill and Trade Name.

     Upon the dissolution of the Partnership, the firm or trade name of the Partnership and any
goodwill associated therewith shall become the sole property of the General Partner, provided that
distributions and allocations otherwise due to the General Partner shall not be reduced as a result
of the General Partner becoming entitled to such assets.

     SECTION 7.7 Termination of Noncompetition Covenants.

     The Partners shall have no continuing liability, or obligation under Section 5.9(b) after the
second (2nd) anniversary of the dissolution of the Partnership; provided that if there is a
material breach of this Agreement by the General Partner which is not cured within thirty (30) days
thereafter and which results in a dissolution and termination of the Partnership, then the Investor
Limited Partners shall have no further liability under Section 5.9(b) after the dissolution and
termination of the Partnership.

ARTICLE VIII

REMOVAL OR WITHDRAWAL OF GENERAL PARTNER AND PARTNERS AND

TRANSFER OF PARTNERS’ PARTNERSHIP AND/OR ECONOMIC INTERESTS

     SECTION 8.1 General Partner — Transfers.

     (a) The General Partner and HPHI may sell or pledge their Partnership Interests or
transfer or assign any of HMC Management’s rights and duties as a General Partner to any
Person who assumes in writing HMC Management’s obligations and liabilities arising under
this Agreement, except that in no event shall they sell their Partnership Interests or
assign HMC Management’s rights and duties as a General Partner to any Person who owns a
hospital located within three (3) miles of the Hospital without the approval by a Majority
Vote of Investor Limited Partners.

     (b) No Investor Limited Partner may assign its rights to be an Investor Representative
herein. Upon the withdrawal or resignation of an Investor Representative, a

23

 

substitute therefore who must be an Investor Limited Partner, or an owner of a Limited
Partner that is an Entity, may be elected by a Majority Vote of the Investor Limited
Partners.

     (c) Any resignation or withdrawal by the General Partner as a general partner shall not
constitute the General Partner’s withdrawal as a Partner.

     SECTION 8.2 Partners’ Right to Continue When Partnership has no General Partner.

     If at any time there is no remaining General Partner, a meeting of the Partners shall be held
at the principal place of business of the Partnership within forty-five (45) days after the
happening of such event to consider whether to continue the Partnership on the same terms and
conditions as are contained in this Agreement (except that the General Partner may be different)
and to select a General Partner for the Partnership, or whether to wind up the affairs of the
Partnership, liquidate its assets and distribute the proceeds therefrom in accordance with Article
VII hereof. The Partnership may be continued and a new General Partner (who accepts such
appointment) selected by the Partners within ninety (90) days of the occurrence of the event
described in Section 7.2(b) with respect to the last General Partner. The new General Partner shall
execute, acknowledge, file or record (as appropriate) Certificate of Limited Partnership and a
Limited Partnership Agreement, or amendments to those documents, and such other documents as may be
required by the Act. The continuance of the Partnership pursuant to the terms of this Section 8.2
is conditioned upon (i) any amendment required by the Act of the Certificate of Limited Partnership
to reflect the foregoing change and, if applicable, compliance by the Partnership with any notice
provisions of the Act and (ii) delivery to the withdrawing General Partner of an indemnification
agreement by the Partnership, in form and substance reasonably satisfactory to the withdrawing
General Partner, indemnifying and holding the withdrawing General Partner harmless against all
future liabilities of the Partnership.

     SECTION 8.3 Relationship with Substitute General Partner.

     The relationship of the Partners to any Person that has either acquired the Partnership
Interest of the General Partner or has been elected as a successor General Partner as provided
herein shall be governed by this Agreement. If such Person was not previously a General Partner,
then such Person, as Substitute General Partner, shall have all the rights and powers of its
predecessor General Partner under this Agreement; provided, such Person assumes in writing the
obligations of such General Partner under this Agreement and any arising thereafter, and accepts
and adopts all the terms and provisions of this Agreement in writing. The withdrawing General
Partner shall be liable for all of its covenants and obligations under this Agreement for all
periods prior to its withdrawal until such liability is assumed by a Substitute General Partner.

     SECTION 8.4 Investor Limited Partners — Restriction on Transfer.

     Except as otherwise set forth in this Section or in this Agreement, no Economic Interest
and/or Partnership Interest of an Investor Limited Partner or any portion thereof, shall be validly
sold or assigned whether voluntarily, involuntarily or by operation of law, and no purported
assignee shall be recognized by the Partnership for any purpose, unless such Economic Interest
and/or Partnership Interest shall have been transferred in accordance with the provisions of this
Agreement and in compliance with such additional restrictions as may be imposed by the General
Partner to comply with requirements imposed by any federal or state securities regulatory authority
and unless the General Partner’s consent is obtained. In no event, however, shall an Investor
Limited Partner transfer or sell all or any of its Economic Interest and/or Partnership Interest to
(x) any Person who, if a Partner, would be in violation of Section 5.9(b) hereof or (y) any Person
who owns a hospital located within three (3) miles of the Hospital without the consent of the
General Partner and the Majority Vote of Investor Limited Partners. Except as otherwise set forth
in this Section or in this Agreement, an Investor Limited Partner may transfer, sell or assign its

24

 

entire Economic Interest and/or Partnership Interest if it has received the approval of the General
Partner, not to be unreasonably withheld, provided however: (a) other Investor Limited Partners
first for a period of fifteen (15) days, thereafter the General Partner for a period of fifteen
(15) days and thereafter the Partnership for a period of fifteen (15) days shall have the right,
but not the obligation, to purchase all, but not less than all, of the Economic Interest and/or
Partnership Interest proposed to be transferred, which right shall be exercisable on the terms and
for the purchase price set forth in writing in a bona fide offer made for the Interests by a
third-party, and (b) there shall have been filed with the Partnership a duly executed and
acknowledged counterpart of the instrument making such assignment signed by both the assignor and
assignee and such instrument evidences the written acceptance by the assignee of all of the terms
and provisions of the Agreement, represents that such assignment was made in accordance with all
applicable laws and regulations and the assignee shall have represented to the Partnership in
writing that it meets the investor suitability standards established by the appropriate state of
residence, or, in the absence thereof, the investor suitability standards established by the
Partnership. The General Partner shall use reasonable care to determine that transfers are in
accordance with applicable laws and regulations, including obtaining an opinion of counsel to that
effect. Any Investor Limited Partner that assigns all its Partnership Interest shall cease to be a
Partner of the Partnership. Any Partnership Interests acquired by the Partnership pursuant to
Section 8.4 shall, subject to applicable law, be re-offered by the Partnership to suitable
investors.

     Notwithstanding anything in this Section to the contrary, in the event that any Investor
Limited Partner wishes to sell his Partnership Interest to the Partnership or to another Person
whether or not currently an Investor Limited Partner, the right of first refusal procedure set
forth above shall not apply at the election and upon the approval of the General Partner, HPHI and
the Investor Representatives. In such event, either the General Partner, HPHI and the Investor
Representatives may agree on behalf of the Partnership to repurchase the Partnership Interest of
the divesting Investor Limited Partner or the Partnership Interest may be sold to another Person
who is otherwise a qualified investor in the Partnership and fulfills all of the obligations
required of each Investor Limited Partner. The purchase price for the Partnership Interest of the
divesting Investor Limited Partner shall be based upon the fair market value of the Partnership
Interest as reasonably agreed upon by the General Partner and the divesting Investor Limited
Partner and shall be payable according to the Payment Method, unless the General Partner, HPHI, and
the Investor Representatives approve payment of the purchase price in a lump sum.

     Any dissolution, liquidation, merger (unless Investor Limited Partners or their Affiliates
existing prior to such merger own at least fifty-one percent (51%) of the surviving entity after
the merger or unless both parties to such merger are majority owned by parties who are Investor
Limited Partners or their Affiliates prior to such merger) or sale of an Investor Limited Partner
which is an Entity (a sale shall include a transfer of fifty percent (50%) or more of its ownership
interests or of substantially all of its assets or any other transaction or series of related
transactions intended to accomplish, in substance, a sale of such Entity) shall constitute an offer
by such Investor Limited Partner to sell such Investor Limited Partner’s Interest pursuant to
Section 8.4 for the Formula Purchase Price (as defined in Section 8.10 below).

     SECTION 8.5 Hospital Limited Partner — Restriction on Transfer.

     Except as otherwise set forth in this Section or in this Agreement, no Economic Interest
and/or Partnership Interest of the Hospital Limited Partner or any portion thereof, shall be
validly sold or assigned whether voluntarily, involuntarily or by operation of law, and no
purported assignee shall be recognized by the Partnership for any purpose, unless such Economic
Interest and/or Partnership Interest shall have been transferred in accordance with the provisions
of this Agreement and in compliance with such additional restrictions as may be imposed by the
General Partner to comply with requirements imposed by any federal or state securities regulatory
authority and unless the General Partner’s consent is obtained. In no event, however, shall the
Hospital Limited Partner transfer or sell all or any of its

25

 

Economic Interest and/or Partnership Interest to any Person who, if a Partner, would be in
violation of Section 5.9(b) hereof. Except as otherwise set forth in this Section or in this
Agreement, the Hospital Limited Partner may transfer, sell or assign its entire Economic Interest
and/or Partnership Interest if it has received the approval of the General Partner and the Investor
Representatives, not to be unreasonably withheld, provided however: (a) the General Partner, HPHI
and the Investor Limited Partners, on a pro rata basis, first for a period of fifteen (15) days,
and thereafter the Partnership for a period of fifteen (15) days shall have the right, but not the
obligation, to purchase all, but not less than all, of the Economic Interest and/or Partnership
Interest proposed to be transferred, which right shall be exercisable on the terms and for the
purchase price set forth in writing in a bona fide offer made for the Interests by a third-party,
and (b) there shall have been filed with the Partnership a duly executed and acknowledged
counterpart of the instrument making such assignment signed by both the assignor and assignee and
such instrument evidences the written acceptance by the assignee of all of the terms and provisions
of the Agreement, represents that such assignment was made in accordance with all applicable laws
and regulations and the assignee shall have represented to the Partnership in writing that it meets
the investor suitability standards established by the appropriate state of residence, or, in the
absence thereof, the investor suitability standards established by the Partnership. The General
Partner shall use reasonable care to determine that transfers are in accordance with applicable
laws and regulations, including obtaining an opinion of counsel to that effect. Upon assigning all
its Partnership Interest, the Hospital Limited Partner shall cease to be a Partner of the
Partnership. Any Partnership Interests acquired by the Partnership pursuant this Section shall,
subject to applicable law, be re-offered by the Partnership to suitable investors.

     Notwithstanding anything in this Section to the contrary, in the event that the Hospital
Limited Partner wishes to sell its Partnership Interest to the Partnership or to another Person
whether or not currently a Investor Limited Partner, the right of first refusal procedure set forth
above shall not apply at the election and upon the approval of the General Partner, HPHI and the
Investor Representatives. In such event, either the General Partner, HPHI and the Investor
Representatives may agree on behalf of the Partnership to repurchase the Partnership Interest of
the divesting Hospital Limited Partner or the Partnership Interest may be sold to another Person
who is otherwise a qualified investor in the Partnership and fulfills all of the obligations
required of a Limited Partner. The purchase price for the Partnership Interest of the divesting
Hospital Limited Partner shall be based upon the fair market value of the Partnership Interest as
reasonably agreed upon by the General Partner and the divesting Hospital Limited Partner and shall
be payable according to the Payment Method, unless the General Partner, HPHI, and the Investor
Representatives approve payment of the purchase price in a lump sum.

     Any dissolution, liquidation, merger (unless the Hospital Limited Partner or its Affiliates
existing prior to such merger own at least fifty-one percent (51%) of the surviving entity after
the merger or unless both parties to such merger are majority owned by the Hospital Limited Partner
or its Affiliates prior to such merger) or sale of the Hospital Limited Partner (a sale shall
include a transfer of fifty percent (50%) or more of its ownership interests or of substantially
all of its assets or any other transaction or series of related transactions intended to
accomplish, in substance, a sale of the Hospital Limited Partner) or any transaction that results
in the ability of a third party to elect or designate a majority of the board of directors or
trustees of the Hospital Limited Partner shall constitute an offer by the Hospital Limited Partner
to sell its Interest pursuant to this Section 8.5 for the Formula Purchase Price (as defined in
Section 8.10 below); provided, however, that upon any such event, the Partnership may elect to
require the Hospital Limited Partner to require that any third party that purchases, merges with or
otherwise so controls the Hospital Limited Partner or its affiliates to assume as a condition to
the closing of such transaction, in writing and in a form reasonably satisfactory to the General
Partner, all of the Hospital Limited Partner’s rights and obligations under this Agreement.

26

 

     SECTION 8.6 Condition Precedent to Transfer of Economic Interest and/or Partnership
Interest.

     Notwithstanding anything herein to the contrary, no transfer of an Economic Interest and/or
Partnership Interest may be made if such transfer (a) constitutes a violation of the registration
provisions of the Securities Act of 1933, as amended, or the registration provisions of any
applicable state securities laws; (b) if after such transfer the Partnership will not be classified
as a partnership for federal income tax purposes; and (c) if when taken together with other prior
transfers, results in a “termination” of the Partnership for federal income tax purposes. The
Partnership may require, as a condition precedent to transfer of an Economic Interest and/or
Partnership Interest, delivery to the Partnership, at the proposed transferor’s expense, of an
opinion of counsel satisfactory (both as to the counsel and substance of the opinion) to the
General Partner that the transfer will not violate any of the foregoing restrictions.

     SECTION 8.7 Substitute Partner — Conditions to Fulfill.

     No assignee of a Partner’s Partnership Interest in the Partnership shall have the right to
become a Substitute Partner in place of its assignor unless, in addition to any other requirement
herein, all of the following conditions are satisfied:

     (a) The Partnership has waived its right pursuant to Section 8.4 to purchase the
Partnership Interest held by the assignee;

     (b) The duly executed and acknowledged written instrument of assignment which has been
filed with the Partnership sets forth that the assignee becomes a Substitute Partner in
place of the assignor;

     (c) The assignor and assignee execute and acknowledge such other instruments as the
General Partner may deem reasonably necessary or desirable to effect such admission,
including, but not limited to, the written acceptance and adoption by the assignee of the
provisions of this Agreement;

     (d) The written consent of the General Partner to such substitution is obtained, which
consent may be withheld in the General Partner’s sole and absolute discretion; and

     (e) The payment by the assignee of all costs to the Partnership associated with the
transaction, including but not limited to legal fees, transfer fees, and filing fees.

     SECTION 8.8 Allocations Between Transferor and Transferee.

     Upon the transfer of a Partner’s Economic Interest or Partnership Interest, all items of
income, gain, loss, deduction and credit attributable to the Economic Interest or Partnership
Interest so transferred shall be allocated between the transferor and the transferee in such manner
as the transferor and transferee agree at the time of transfer; provided such allocation does not
violate federal or state income tax law. If the General Partner, in its sole discretion, deems
such laws violated, then such allocation shall be made pro rata for the fiscal year based upon the
number of days during the applicable fiscal year of the Partnership that the Economic Interest or
Partnership Interest so transferred was held by the transferor and transferee, without regard to
the results of Partnership activities during the period in which each was the holder, or in such
other manner as the General Partner deems necessary to comply with federal or state income tax
laws. Distributions as called for by this Agreement shall be made to the holder of record of the
Economic Interest or Partnership Interest on the date of distribution. Notwithstanding anything
contained in this Agreement to the contrary, both the Partnership and the General Partner shall be
entitled to treat the assignor of any assigned Economic Interest or Partnership Interest as the
absolute owner

27

 

thereof in all respects, and shall incur no liability for distributions made in good faith to such
assignor in reliance on the Partnership records as they exist until such time as the written
assignment has been received by, and recorded on the books of the Partnership. For purposes of
this Article VIII, the effective date of an assignment of any Economic Interest or Partnership
Interest shall be the last day of the month specified in the written instrument of assignment.

     SECTION 8.9 Rights, Liabilities of, and Restrictions on Assignee.

     No assignee of a Partner’s Economic Interest or Partnership Interest shall have the right to
participate in the Partnership, inspect the books of account of the Partnership or exercise any
other right of a Partner unless and until admitted as a Substitute Partner. Notwithstanding the
General Partner’s failure or refusal to admit an assignee as a Substitute Partner, such assignee
shall be entitled to receive the share of income, credit, gain, expense, loss and deduction and
cash distributions provided hereunder that is assigned to it, and, upon demand, may receive copies
of all reports thereafter delivered pursuant to the requirements of this Agreement; provided, the
Partnership shall have first received notice of such assignment and all required consents thereto
shall have been obtained and other conditions precedent to transfer thereof shall have been
satisfied. The Partnership’s tax returns shall be prepared to reflect the interests of assignees
as well as Partners.

     SECTION 8.10 Death of a Partner.

     Heirs of Partners shall be entitled to inherit the Partnership Interests of a deceased
Investor Limited Partner or of an Investor Limited Partner owned by an individual who has deceased,
provided that upon such death such interests shall be automatically converted to an Economic
Interest only in the Partnership until such heir agrees in writing to all of the terms and
conditions of this Agreement and such other reasonable terms as may be established by the General
Partner as a condition to such heir becoming an Investor Limited Partner, in which event such
interest shall again become a Partnership Interest in the Partnership. Notwithstanding the
previous sentence at any time within nine (9) months of the death of an Investor Limited Partner
(or of an individual that owns such Investor Limited Partner) the other Investor Limited Partners
for a period of fifteen (15) days following written notice to them, thereafter the General Partner
for a period of fifteen (15) days and thereafter the Partnership for a period of fifteen (15) days
shall have the option to purchase the Partnership Interest of the deceased Investor Limited Partner
or of an Investor Limited Partner owned by an individual who has deceased, and the estate of the
deceased individual shall be obligated to sell such Partnership Interest to the other Partners or
the Partnership, in accordance with the terms of this Section 8.9. The other Partners or the
Partnership must exercise their option by giving written notice thereof to the estate of the
deceased Partner, or the appropriate representative thereof, within the time periods set forth
above and in all events within such nine (9) month period. The purchase price for such Partnership
Interest shall equal the greater of (i) five (5) multiplied by the net income (as reasonably
determined by the Partnership’s accountants) of the Partnership for the twelve (12) month period
ending as of the calendar quarter most recently ended prior to the death of such Partner multiplied
by the percentage Partnership Interest of such Partner in the Partnership (the “Formula Purchase
Price”); (ii) the Capital Contributions of the applicable Investor Limited Partner less all amounts
distributed to the applicable Investor Limited Partner by the Partnership and (iii) the fair market
value of such applicable Investor Limited Partner’s Partnership Interest determined by an
independent appraiser reasonably selected by the General Partner provided that the expenses thereof
shall be deducted from the proceeds of such sale. The purchase price shall be paid (the “Payment
Method”) in three (3) equal annual installments, the first third of which shall be paid upon the
determination of the purchase price and the remaining two (2) installments of which shall be paid
on the first and second anniversary of such date. The outstanding amounts due from the Partnership
to the estate of the deceased Partner shall bear interest at Prime Rate as of the date of such
Partner’s death. Accrued interest shall be paid as of the dates payments of principal are due as
provided above.

28

 

     SECTION 8.11 Repurchase of Interests in Certain Event.

     (a) In the discretion of the General Partner, the Partnership may, but is not obligated
to, repurchase a Partner’s Economic Interest or Partnership Interest upon such Partner’s
breach of the Partner’s obligations contained in Article III, Sections 5.9, 8.1(b), 8.4,
8.9, 12.1 and 12.11 of this Agreement.

     (b) Each Partner agrees to sell its Partnership Interest to the Partnership in the
event the General Partner elects to exercise the right of repurchase granted under Section
8.10(a) and the purchase price shall be the lower of (x) the Capital Contributions of the
Partner less all amounts distributed to such Partner by the Partnership and (y) the Formula
Purchase Price.

     SECTION 8.12 Permissible Transfers by Limited Partners.

     Notwithstanding anything in this Agreement to the contrary, one or more Limited Partners may
elect within ninety (90) days of the Effective Date or, if not Limited Partners on the Effective
Date, within thirty (30) days after acquiring a Partnership Interest in the Partnership, to assign
its or their Partnership Interests to a corporation, limited liability company or limited
partnership formed and maintained for the sole purpose of holding such Partnership Interests if
such assignee is owned by the assigning Limited Partner(s) or such assignee’s owners are
substantially identical to the owners of such Limited Partner(s) as long as such assignee and its
Affiliates agree in writing to be bound by all the terms and conditions of this Agreement and the
General Partner first approves in writing the terms of all documents creating and constituting such
Entity.

     SECTION 8.13 Sale of Partnership.

     For so long as the Hospital Limited Partner retains its Partnership Interest, the Hospital
Limited Partner shall have a right of first offer to purchase the Hospital or the controlling
equity interests of the Partnership if the Partnership or the Partners other than the Hospital
Limited Partner determine to market the Hospital or a controlling interest in the Partnership for
sale. The Partnership or the Partners other than the Hospital Limited Partner, as the case may be,
shall give written notice of their desire to sell the Hospital or a controlling interest in the
Partnership, as the case may be, and the Hospital Limited Partner and the Partnership or the
Partners other than the Hospital Limited Partner, as the case may be, shall negotiate in good faith
for up to forty-five (45) days after receipt of such notice regarding the terms of such purchase
and sale. If the Hospital Limited Partner and the Partnership (or the Partners other than the
Hospital Limited Partner) are unable to agree to terms of the purchase and sale within such
forty-five (45)-day period, the Partnership (or the Partners other than the Hospital Limited
Partner) shall be permitted to sell the Hospital or a controlling interest in the Partnership to a
third party on commercially reasonable terms.

ARTICLE IX

RECORDS, ACCOUNTINGS AND REPORTS

     SECTION 9.1 Books of Account.

     At all times during the continuance of the Partnership, the General Partner shall maintain or
cause to be maintained true and full financial records and books of account showing all receipts
and expenditures, assets and liabilities, income and losses, and all other records necessary for
recording the Partnership’s business and affairs including those sufficient to record the
allocations and distributions required by the provisions of this Agreement.

29

 

     SECTION 9.2 Access to Records.

     The books of account and all documents and other writings of the Partnership, including the
Certificate of Limited Partnership and any amendments thereto, shall at all times be kept and
maintained by the General Partner or, if required by law, at the registered office of the
Partnership. Each Partner or its designated representatives shall, upon reasonable notice to the
General Partner, be granted access to such financial and accounting books, records and other
documents and writings during reasonable business hours and shall have the right to inspect and
make copies of any of such books, records and other documents and writings, which information may
be used solely in connection with such Partner’s investment in the Partnership. In addition to the
foregoing rights, any one or more Limited Partners holding in the aggregate twenty percent (20%) of
the Partnership Interests shall have the right to retain, at their sole cost and expense and upon
reasonable notice to the General Partner, a firm of independent certified public accountants to
review and/or audit the financial and accounting books and records of the Partnership, the results
of which may be used solely in connection with such Limited Partners’ investment in the
Partnership.

     SECTION 9.3 Bank Accounts and Investment of Funds.

     (a) the General Partner shall open and maintain, on behalf of the Partnership, a bank
account or accounts in a federally insured bank or savings institution as it shall
determine, in which all monies received by or on behalf of the Partnership shall be
deposited. All withdrawals from such accounts shall be made upon the signature of such
Person or Persons as the General Partner may from time to time designate.

     (b) Any funds of the Partnership which the General Partner may determine are not
currently required for the conduct of the Partnership’s business may be deposited with a
federally insured bank or savings institution or invested in short-term debt obligations
(including obligations of federal or state governments and their agencies, commercial paper,
certificates of deposit of commercial banks, savings banks or savings and loan associations)
as shall be determined by the General Partner in its sole discretion.

SECTION 9.4 Fiscal Year.

The Fiscal Year and accounting period of the Partnership shall end on September 30 of each
year.

30

 

     SECTION 9.5 Accounting Reports.

     As soon as reasonably practicable after the end of each fiscal year but in no event later than
120 days after the end thereof, each Partner shall be furnished an annual accounting showing the
financial condition of the Partnership at the end of such fiscal year and the result of its
operations for the fiscal year then ended, which annual accounting shall be prepared on an accrual
basis in accordance with generally accepted accounting principles applied on a consistent basis and
shall be delivered to each of the Partners promptly after it has been prepared. It shall include a
balance sheet as of the end of such Fiscal Year and statements of income and expense, each
Partner’s equity, and cash flow for such Fiscal Year. At the General Partner’s election the
Partnership shall either be audited or such annual accountings shall be either reviewed or compiled
by a firm of independent certified public accountants engaged by the General Partner on behalf of
the Partnership. The report shall set forth the distributions to the Partners for such Fiscal Year
and shall separately identify distributions from (i) operating revenue during such Fiscal Year,
(ii) operating revenue from a prior period which had been held as reserves, (iii) proceeds from the
sale or refinancing of the Equipment, and (iv) unexpended proceeds received from the sale of
Partnership Interests. Following the opening of the Hospital, the General Partner shall also cause
to be prepared and distributed to the Partners quarterly financial statements following the General
Partner’s public announcement of its results for such quarter in a form and containing such
information as reasonably determined by the General Partner.

     SECTION 9.6 Tax Returns.

     The General Partner shall cause income tax returns for the Partnership to be prepared, at
Partnership expense, and timely filed with the appropriate authorities. As soon as is reasonably
practicable, and in any event on or before the expiration of 75 days following the end of each
Fiscal Year, each Partner shall be furnished with a statement to be used in the preparation of the
Partner’s tax returns, showing the amounts of any Profits or Losses allocated to the Partner, and
the amount of any distributions made to the Partner, pursuant to this Agreement, along with a
reconciliation of the annual report with information furnished to Partners for income tax purposes.

ARTICLE X

MEETINGS AND VOTING RIGHTS OF PARTNERS

     SECTION 10.1 Meetings.

     (a) Meetings of the Partners of the Partnership for any purpose may be called by the
General Partner, any Investor Representative or by Limited Partners holding in the aggregate
ten percent (10%) of the Partnership Interests. Such request shall state the purpose of the
proposed meeting and the matters proposed to be acted upon thereat. Such meetings shall be
held in the Harlingen, Texas area.

     (b) A notice of any such meeting shall be given by mail, not less than fifteen (15)
days nor more than sixty (60) days before the date of the meeting, to each Partner at its
address as specified in Section 12.7. Such notice shall be in writing, and shall state the
place, date and hour of the meeting, and shall indicate that it is being issued at or by the
direction of the General Partner or by the Limited Partners, as the case may be. The notice
shall state the purpose or purposes of the meeting. If a meeting is adjourned to another
time or place, and if any announcement of the adjournment of time or place is made at the
meeting, it shall not be necessary to give notice of the adjourned meeting.

31

 

     (c) Each Partner may authorize any Person or Persons to act for the Partner by proxy in
all matters in which a Partner is entitled to participate, whether by waiving notice of any
meeting, or voting or participating at a meeting. Every proxy must be signed by the Partner
or its attorney-in-fact. No proxy shall be valid after the expiration of eleven months from
the date thereof unless otherwise provided in the proxy. Every proxy shall be revocable at
the pleasure of the Partner executing it.

     SECTION 10.2 Voting Rights of Partners.

     (a) Each Partner shall take no part in or interfere in any manner with the control,
conduct or operation of the Partnership, and shall have no right or authority to act for or
bind the Partnership except as provided herein. Votes or decisions, to the extent taken or
to be made, of the Partners may be cast at any duly called meeting of the Partnership or in
writing within ten (10) days after written request therefor. Each Partner shall be entitled
to the number of votes equal to the percentage Partnership Interest of such Partner.

     (b) No Partner shall have the right or power to vote to: (i) withdraw or reduce the
Partner’s Capital Contributions except as a result of the dissolution and liquidation of the
Partnership or as otherwise provided by law or this Agreement; (ii) bring an action for
partition against the Partnership; (iii) cause the termination and dissolution of the
Partnership by court decree or otherwise, except as set forth in this Agreement; or (iv)
demand or receive property other than cash in return for its Capital Contributions.

     (c) The Hospital Limited Partner shall not be entitled to vote (i) on any matter if
counsel for the Partnership reasonably determines that the exercise of such voting rights
would be reasonably likely to violate any laws or regulations applicable to the ownership or
operation of hospitals in general and the Hospital, in particular; (ii) on any proposed
transaction, bid or other matter with respect to which the Hospital is (or is reasonably
likely to be) a competitor of the Hospital Limited Partner or any of its Affiliates; or
(iii) on any matter that relates to contracts or arrangements between the Partnership and
the Hospital Limited Partner or its affiliates.

ARTICLE XI

AMENDMENTS

     SECTION 11.1 Authority to Amend by General Partner.

     Except as otherwise provided by Section 11.2, this Agreement and the Certificate of Limited
Partnership of the Partnership may be amended by the General Partner with the approval of the
Investor Representatives which approval shall not be unreasonably withheld or delayed:

     (a) To admit additional Partners or Substitute Partners but only in accordance with and
if permitted by the other terms of this Agreement;

     (b) To preserve the legal status of the Partnership as a limited partnership under the
Act or other applicable state or federal laws if such does not change the substance hereof,
and the Partnership has obtained the written opinion of its counsel to that effect;

     (c) To cure any ambiguity, to correct or supplement any provision herein which may be
inconsistent with any other provision herein, to clarify any provision of this Agreement, or
to

32

 

make any other provisions with respect to matters or questions arising under this Agreement
which will not be inconsistent with the provisions of this Agreement;

     (d) To satisfy the requirements of the Code and Regulations with respect to limited
partnerships or of any federal or state securities laws or regulations, provided such
amendment does not adversely affect the Partnership Interests of Partners and is necessary
or appropriate in the written opinion of counsel and any amendment under this subsection (d)
shall be effective as of the date of this Agreement;

     (e) To the extent that it can do so without materially reducing the economic return on
investment in the Partnership to any Partner, to satisfy any requirements of federal or
state legislation or regulations, court order, or action of any governmental administrative
agency with respect the operation or ownership of the Hospital;

     (f) Subject to the terms of Section 2.5, to extend the term of the Partnership; and

     (g) Upon written notice to all Partners, the General Partner may elect to create a
governing body of up to nine (9) members to serve as the governing body of the Hospital. In
such event, the governing body members shall include, in addition to the General Partner or
its designee, the president or chief executive officer of the Hospital who shall be
designated by the General Partner and three (3) additional General Partners elected from
time to time by the Investor Limited Partners one of whom must be the medical director of
the hospital. The remaining members of the governing body shall be elected from time to
time by the General Partner. The General Partner may delegate to such governing body such
duties and responsibilities of the General Partner as the General Partner deems necessary or
appropriate. Notwithstanding the foregoing, in the event the governing body is so created,
the Investor Limited Partners shall continue to have the right to elect Investor
Representatives who shall be designated to make decisions which are specifically authorized
to be made by the Investor Representatives under this Agreement and the General Partner
shall continue to have the right to make decisions with respect to matters which are
reserved for the General Partner at the time the number of General Partners is so expanded.

     SECTION 11.2 Restrictions on General Partner’s Amendments: Amendments by Limited
Partners.

     Except as provided in Section 11.1, amendments to this Agreement shall be made only upon the
consent of the General Partner, HPHI and with a Majority Vote of Investor Limited Partners;
provided that any amendment to this Agreement that would amend the rights of the Hospital Limited
Partner expressly set forth in this Agreement in any material manner shall also require the consent
of the Hospital Limited Partner. Except as set forth in this Section 11.2, no amendment shall be
made pursuant to Section 11.1 which would materially and adversely affect the federal income tax
treatment to be afforded each Partner, materially and adversely affect the Partnership Interests
and liabilities of each Partner as provided herein, materially change the purposes of the
Partnership, extend or otherwise modify the term of the Partnership, or materially change the
method of allocations and distributions as provided in Article VI and Article VII.

     SECTION 11.3 Amendments to Certificate.

     In making any amendments to this Agreement, there shall be prepared, executed and filed for
recording by the General Partner such documents amending the Certificate of Limited Partnership as
required under the Act.

33

 

ARTICLE XII

MISCELLANEOUS

     SECTION 12.1 Revocable Limited Power of Attorney.

     Upon the execution hereof, each Limited Partner hereby revocably constitutes and appoints the
General Partner as its true and lawful attorney in the Limited Partner’s name and on the Limited
Partner’s behalf to take at any time all such action which the General Partner is expressly
authorized to perform, or which a Limited Partner is expressly required to perform, under this
Agreement.

     SECTION 12.2 Waiver of Provisions.

     The waiver of compliance at any time with respect to any of the provisions, terms or
conditions of this Agreement shall not be considered a waiver of such provision, term or condition
itself or of any of the other provisions, terms or conditions hereof.

     SECTION 12.3 Interpretation and Construction.

     This Agreement contains the entire agreement among the Partners and any modification or
amendment hereto must be accomplished in accordance with the provisions of Article XI and Article
XII. Where the context so requires, the masculine shall include the feminine and the neuter, and
the singular shall include the plural. The headings and captions in this Agreement are inserted
for convenience and identification only and are in no way intended to define, limit or expand the
scope and intent of this Agreement or any provision thereof. The references to Section and Article
in this Agreement are to the Sections and Articles of this Agreement.

     SECTION 12.4 Governing Law.

     This Agreement shall be governed by and construed in accordance with the laws of the State of
North Carolina, exclusive of its conflict of law rules.

     SECTION 12.5 Partial Invalidity.

     In the event that any part or provision of this Agreement shall be determined to be invalid or
unenforceable, the remaining parts and provisions of said Agreement which can be separated from the
invalid or unenforceable provision and shall continue in full force and effect.

     SECTION 12.6 Binding on Successors.

     The terms, conditions and provisions of this Agreement shall inure to the benefit of, and be
binding upon the parties hereto and their respective heirs, successors, distributees, legal
representatives, and assigns. However, none of the provisions of this Agreement shall be for the
benefit of or enforceable by any creditors of the Partnership.

     SECTION 12.7 Notices and Delivery.

     (a) To Partners. Any notice to be given hereunder at any time to any Partner
or any document reports or returns required by this Agreement to be delivered to any
Partner, may be delivered personally or mailed to such Partner, postage prepaid, addressed
to the Partner at such times as the Partner shall by notice to the Partnership have
designated as the Partner’s address for

34

 

the mailing of all notices hereunder or, in the absence of such notice, to the address set
forth in Article IV hereof. Any notice, or any document, report or return so delivered or
mailed shall be deemed to have been given or delivered to such Partner at the time it is
mailed, as the case may be.

     (b) To the Partnership. Any notice to be given to the Partnership hereunder
shall be delivered personally or mailed to the Partnership, by certified mail, postage
prepaid, addressed to the Partnership at its registered office. Any notice so delivered or
mailed shall be deemed to have been given to the Partnership at the time it is delivered or
mailed, as the case may be.

     SECTION 12.8 Counterpart Execution; Facsimile Execution.

     This Agreement may be executed in any number of counterparts with the same effect as if all of
the Partners had signed the same document. Such executions may be transmitted to the Partnership
and/or the other Partners by facsimile and such facsimile execution shall have the full force and
effect of an original signature. All fully executed counterparts, whether original executions or
facsimile executions or a combination, shall be construed together and constitute one and the same
agreement.

     SECTION 12.9 Statutory Provisions.

     Any statutory reference in this Agreement shall include a reference to any successor to such
statute and/or revision thereof.

     SECTION 12.10 Waiver of Partition.

     Each party does hereby waive any right to partition or the right to take any other action
which might otherwise be available to such party for the purpose of severing its relationship with
the Partnership or such party’s interest in the assets held by the Partnership from the interests
of other Partners until the end of the term of both this Partnership and any successor partnership
formed pursuant to the terms hereof.

     SECTION 12.11 Change In Law.

     If due to any new law, rule or regulation, or due to an interpretation or enforcement of any
existing law, rule or regulation, health care counsel reasonably selected by the General Partner
determines in writing that it is reasonably likely that the relationships established between any
of the parties to this Agreement including any of their Affiliates and/or successors or assigns
will not comply with any law, rule, regulation or interpretation thereof (“Applicable Law”), then
the parties hereto hereby agree first, to negotiate in good faith to restructure the
relationships established under this Agreement so as to bring them into compliance with such
applicable laws while at the same time preserving the material benefits of each of the parties
hereto. In the event that a specific proposal for the restructuring of this Agreement is approved
by the General Partner and a Majority Vote of Investor Limited Partners, such restructured
agreement shall become binding upon all Partners of the Partnership. Second, in the event
that within forty-five (45) days following the Partnership’s receipt of legal advice in writing
from such health care counsel regarding Applicable Law the parties hereto are unable to negotiate
an acceptable restructuring of their relationship, then the General Partner shall have the option,
within the following forty-five (45) day period, to purchase the Partnership Interests of some or
all of the Limited Partners whose ownership is involved with such noncompliance with Applicable Law
for a purchase price equal to the greater of: (a) the Formula Purchase Price or (b) the amount of
the Capital Contributions made by each such Partner to the Partnership together with interest
thereon computed at the Prime Rate as of the date of this Agreement from the date of such
contribution through the date upon which the General Partner pays all amounts due under the terms
of this Section 12.11. For these purposes, distributions to the Partners by the Partnership

35

 

after the effective date of this Agreement (and whether before or after health care counsel
determined there was a problem under an Applicable Law or before or after the exercise of the
purchase option) shall be treated as payments by the General Partner. Such purchase price shall be
paid in accordance with the Payment Method. Third, in the event that the General Partner
does not exercise its option to purchase Partnership Interests of a Partner whose ownership causes
the Partnership not to be in compliance with Applicable Law, such Partners may elect in writing
within the following forty-five (45) day period, to require that the Partnership be dissolved, in
which event the Partnership shall be dissolved in accordance with the terms of this Agreement.

     SECTION 12.12 Investment Representations of the Partners.

     (a) Each Partner or individual executing this Agreement on behalf of an Entity which is
a Partner hereby represents and warrants to the Partnership and to the Partners that such
Partner has acquired such Partner’s Partnership Interest in the Partnership for investment
solely for such Partner’s own account with the intention of holding such Partnership
Interest for investment, without any intention of participating directly or indirectly in
any distribution of any portion of such Partnership Interest, including an Economic
Interest, and without the financial participation of any other Person in acquiring such
Partnership Interest in the Partnership.

     (b) Each Partner or individual executing this Agreement on behalf of an entity which is
a Partner hereby acknowledges that such Partner is aware that such Partner’s Partnership
Interest in the Partnership has not been registered (i) under the Securities Act of 1933, as
amended (the “Federal Act”), (ii) under applicable Texas securities laws, or (iii) under any
other state securities laws. Each Partner or individual executing this Agreement on behalf
of an Entity which is a Partner further understands and acknowledges that his
representations and warranties contained in this Section are being relied upon by the
Partnership and by the Partners as the basis for the exemption of the Partners’ Partnership
Interest in the Partnership from the registration requirements of the Federal Act and from
the registration requirements of applicable Texas securities laws and all other state
securities laws. Each Partner or individual executing this Agreement on behalf of an Entity
which is a Partner further acknowledges that the Partnership will not and has no obligation
to recognize any sale, transfer, or assignment of all or any part of such Partner’s
Partnership Interest, including an Economic Interest in the Partnership to any Person unless
and until the provisions of this Agreement hereof have been fully satisfied.

     (c) Each Partner or individual executing this Agreement on behalf of an Entity which is
a Partner hereby acknowledges that prior to his execution of this Agreement, such Partner
received a copy of this Agreement and that such Partner has examined this Agreement or
caused this Agreement to be examined by such Partner’s representative or attorney. Each
Partner or individual executing this Agreement on behalf of an Entity which is a Partner
hereby further acknowledges that such Partner or such Partner’s representative or attorney
is familiar with this Agreement and with the Partnership’s business plans. Each Partner or
individual executing this Agreement on behalf of an Entity which is a Partner acknowledges
that such Partner or such Partner’s representative or attorney has made such inquiries and
requested, received, and reviewed any additional documents necessary for such Partner to
make an informed investment decision and that such Partner does not desire any further
information or data relating to the Partnership or to the Partners. Each Partner or
individual executing this Agreement on behalf of an Entity which is a Partner hereby
acknowledges that such Partner understands that the purchase of such Partner’s Partnership
Interest in the Partnership is a speculative investment involving a high degree of risk and
hereby represents that such Partner has a net worth sufficient to bear the economic risk of
such Partner’s investment in the Partnership and to justify such Partner’s investing in a
highly speculative venture of this type.

36

 

     SECTION 12.13 Authorization and Release of Investor Representatives.

     Each of the Investor Limited Partners hereby authorizes the Investor Representatives to make
the decisions to be made by the Investor Representatives hereunder and hereby release and hold
harmless the Investor Representatives from any and all claims, liabilities, losses or damages which
any of them may have now or in the future resulting from any decision made by the Investor
Representatives hereunder unless due to the gross negligence or willful misconduct of such Investor
Representative.

     SECTION 12.14 Referrals to Hospital and Ownership of Shares of Common Stock of MedCath
Holdings, Inc. and/or MedCath Incorporated.

     Each Limited Partner agrees that if in the reasonable opinion of health care counsel to the
General Partner or its Affiliates, referrals of patients to the Hospital by the Limited Partner or
ownership of shares of common stock in MedCath Holdings, Inc. and/or MedCath Incorporated by the
Limited Partner would cause or constitute a violation of any federal or state law, rule or
regulation, then, as applicable,

     (a) the Limited Partner shall not refer patients to the Hospital; and

     (b) the Limited Partner shall not acquire, nor continue to own any of shares of common stock
of MedCath Holdings, Inc. and/or MedCath Incorporated.

     SECTION 12.15 Acknowledgments Regarding Legal Representation.

     Each of the Partners hereunder acknowledge and agree that Moore & Van Allen, PLLC is counsel
for the General Partner and its Affiliates, and may also serve as counsel for the Partnership from
time to time. Each of the Partners hereby acknowledges and consents to such representation. Each
Partner other than the General Partner further acknowledges and agrees that it shall have no
attorney-client relationship with Moore & Van Allen, PLLC as a result of Moore & Van Allen, PLLC’s
representation of the Partnership from time to time. Each Partner further consents to Moore & Van
Allen’s representation of the Partnership to the extent such firm is requested to do so by the
General Partner.

     SECTION 12.16 Exhibits.

     The Exhibits to this Agreement, each of which is incorporated by reference, are:

	 	 	 	 
	 	EXHIBIT A:

	 	Certificate of Limited Partnership.
	 	EXHIBIT B:

	 	Information Exhibit.
	 	EXHIBIT C:

	 	Glossary of Terms.
	 	EXHIBIT D:

	 	Development Budget Exhibit.
	 	EXHIBIT E:

	 	Regulatory Allocations.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the following execution
page(s), to be effective as of the date hereof.

[EXECUTIONS APPEAR ON THE FOLLOWING PAGES]

37

 

EXECUTION PAGE

TO THE

AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

	 	 	 	 	 	 	 
	 	 	GENERAL PARTNER:	 	 
	 
	 	 	 	 	 	 
	 	 	HMC MANAGEMENT COMPANY, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 

	 	 
	 	 	LIMITED PARTNERS:	 	 
	 
	 	 	 	 	 	 
	 	 	HARLINGEN PARTNERSHIP HOLDINGS, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	VALLEY BAPTIST MANAGEMENT SERVICES CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 

38

 

For the purpose of acknowledging and agreeing to be bound by the terms of Section 5.9 hereof, the
undersigned Affiliates of the Partners other than the General Partner and HPHI hereby execute this
Amended and Restated Limited Partnership Agreement.

	 	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

39

 

EXHIBIT A

TO THE

AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

[SEE ATTACHED]

 

 

Certificate of Domestic Limited Partnership

 

 

EXHIBIT B

TO THE

AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

INFORMATION EXHIBIT

	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Additional	 	 
	 	 	Initial Capital*	 	Capital	 	Percentage
	Name, Address & TIN	 	Contribution	 	Contributions 	 	Partnership Interest
	GENERAL PARTNER:
	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	HMC Management Company, LLC.

7621 Little Avenue, Suite 106

Charlotte, NC 28226

	 	$	80,000	 	$	1,472,304

(Note 1)
	 	 	3.42	%
	 
	 	 	 	 	 	 	 	 	 	 
	LIMITED PARTNERS:
	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Harlingen Partnership Holdings, Inc.

7621 Little Avenue, Suite 106

Charlotte, NC 28226

	 	$	 4,000,000	 	 	 	 	 	32.58	%
	 
	 	 	 	 	 	 	 	 	 	 
	Investor Limited Partners

	 	$	3,920,000	 	 	 	 	 	31.90	%
	 
	 	 	 	 	 	 	 	 	 	 
	Valley Baptist Management Services Corporation

	 	 	 	 	$	17,055,400

(Note 2)
	 	 	32.10	%

 

Notes:

			
	(1)	 	HMC Management has made or caused to be made a capital contribution of a portion of an
obligation payable by HMC Realty, LLC, in the principal amount of $317,696, and has agreed to
convert a portion of a loan obligation in the principal amount of $1,154,607 owed by the
Partnership to HMC Management or an affiliate to general partnership interest in the
Partnership.
	 
	(2)	 	The Hospital Limited Partner has agreed to convert a portion of a loan obligation in
the principal amount of $17,055,393 owed by the Partnership to an affiliate of the Hospital
Limited Partner to limited partnership interest in the Partnership.

 

 

Sale of Hospital; Right of First Offer

(formerly Article XVI of the Convertible Note Purchase Agreement)

     The Partnership hereby agrees it will not pursue the sale of the Hospital or a controlling
interest in the Partnership during the period from December 27, 2005 to December 27, 2008 unless
approved by the partners of the Partnership and Hospital Limited Partner; provided, however, that
nothing herein will prohibit a sale of a controlling interest in HPH or its parent, MedCath or its
Affiliates (other than the Partnership) or a sale of substantially all of the assets of HPH or
MedCath or its Affiliates (other than the Partnership). After December 27, 2008, for so long as
Hospital Limited Partner owns the Partnership Interest, Hospital Limited Partner shall have a right
of first offer to purchase the Hospital or the equity interests of the Partnership if the partners
of the Partnership determine to market the Hospital or a controlling interest in the Partnership
for sale. The Partnership or the partners of the Partnership, as the case may be, shall give
written notice of their desire to sell the Hospital or a controlling interest in the Partnership,
as the case may be, and Hospital Limited Partner and the Partnership or the partners of the
Partnership, as the case may be, shall negotiate in good faith for up to forty-five (45) days after
receipt of such notice regarding the terms of such purchase and sale. If Hospital Limited Partner
and the Partnership (or the partners) are unable to agree to terms of the purchase and sale within
such forty-five (45)-day period, the Partnership (or the partners) shall be permitted to sell the
Hospital or a controlling interest in the Partnership to a third party on commercially reasonable
terms.

 

 

EXHIBIT C

TO THE

AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

GLOSSARY OF TERMS

     As used in this Agreement, the following terms shall have the following definitions (unless
otherwise expressly provided herein).

     “Act” means the North Carolina Revised Uniform Limited Partnership Act, as in effect
in North Carolina and set forth at N.C. Gen. Stat. §§ 59-101 through 59-1106 (or any corresponding
provisions of succeeding law).

     “Adjusted Capital Account” means, with respect to any Partner or Economic Interest
Owner, such Person’s Capital Account (as defined below) as of the end of the relevant Fiscal Year
increased by any amounts which such Person is obligated to restore, or is deemed to be obligated to
restore pursuant to the next to last sentences of Regulations Section 1.704-2(g)(1) (share of
minimum gain) and Regulations Section 1.704-2(i)(5) (share of partner nonrecourse debt minimum
gain) and decreased by the items described in Regulations Section
1.704-1(b)(2)(ii)(d)(4), (5) and (6).

     “Affiliate” means with respect to a Person, (i) any relative of such Person; (ii) any
officer, director, trustee, partner, manager, employee or holder of ten percent (10%) or more of
any class of the outstanding voting securities or of an equity interest of such Person; or (iii)
Entity or holder of ten percent (10%) or more of the outstanding voting securities or of an equity
interest of any Entity, controlling, controlled by, or under common control with such Person.

     “Agreed Value” means with respect to any noncash asset of the Partnership an amount
determined and adjusted in accordance with the following provisions:

     (a) The initial Agreed Value of any noncash asset contributed to the capital of the
Partnership by any Partner shall be its gross fair market value, as agreed to by the contributing
Partner and the Partnership.

     (b) The initial Agreed Value of any noncash asset acquired by the Partnership other than by
contribution by a Partner shall be its adjusted basis for federal income tax purposes.

     (c) The initial Agreed Values of all the Partnership’s noncash assets, regardless of how those
assets were acquired, shall be reduced by depreciation or amortization, as the case may be,
determined in accordance with the rules set forth in Regulations Section
1.704-1(b)(2)(iv)(f) and (g).

     (d) The Agreed Values, as reduced by depreciation or amortization, of all noncash assets of
the Partnership, regardless of how those assets were acquired, shall be adjusted from time to time
to equal their gross fair market values, as agreed to by the Partners in writing, as of the
following times:

	 	(i)	 	the acquisition of a Partnership Interest or an additional
Partnership Interest in the Partnership by any new or existing Partner in
exchange for more than a de minimis Capital Contribution;

 

 

	 	(ii)	 	the distribution by the Partnership of more than a de minimis
amount of money or other property as consideration for all or part of a
Partnership Interest in the Partnership; and
	 
	 	(iii)	 	the termination of the Partnership for federal income tax
purposes pursuant to Code Section 708(b)(1)(B).

     If, upon the occurrence of one of the events described in (i), (ii) or (iii) above the
Partners do not agree in writing on the gross fair market values of the Partnership’s assets, it
shall be deemed that the fair market values of all the Partnership’s assets equal their respective
Agreed Values immediately prior to the occurrence of the event and thus no adjustment to those
values shall be made as a result of such event.

     “Agreement” means this Limited Partnership Agreement, as amended from time to time.

     “Certificate of Limited Partnership” means the Certificate of Limited Partnership of
the Partnership, as filed with the Secretary of State of North Carolina as the same may be amended
from time to time.

     “Capital Account” means with respect to each Partner or assignee an account maintained
and adjusted in accordance with the following provisions:

     (a) Each Person’s Capital Account shall be increased by Person’s Capital Contributions, such
Person’s distributive share of Profits, any items in the nature of income or gain that are
allocated pursuant to the Regulatory Allocations and the amount of any Partnership liabilities that
are assumed by such Person or that are secured by Partnership property distributed to such Person.

     (b) Each Person’s Capital Account shall be decreased by the amount of cash and the Agreed
Value of any Partnership property distributed to such Person pursuant to any provision of this
Agreement, such Person’s distributive share of Losses, any items in the nature of loss or deduction
that are allocated pursuant to the Regulatory Allocations, and the amount of any liabilities of
such Person that are assumed by the Partnership or that are secured by any property contributed by
such Person to the Partnership.

     In the event any Partnership Interest is transferred in accordance with the terms of this
Agreement, the transferee shall succeed to the Capital Account of the transferor to the extent it
relates to the transferred Partnership Interest.

     In the event the Agreed Values of the Partnership assets are adjusted pursuant to the
definition of Agreed Value contained in this Agreement, the Capital Accounts of all Partners shall
be adjusted simultaneously to reflect the aggregate adjustments as if the Partnership recognized
gain or loss equal to the amount of such aggregate adjustment.

     The foregoing provisions and the other provisions of this Agreement relating to the
maintenance of Capital Accounts are intended to comply with Regulations Section 1.704-1(b), and
shall be interpreted and applied in a manner consistent with such regulations. In the event the
General Partner shall determine that it is prudent to modify the manner in which the Capital
Accounts, or any debits or credits thereto, are computed to comply with such Regulation, the
General Partner may make such modification, provided that it is not likely to have a material
effect on the amounts distributable to any Partner pursuant to Articles VI or VII hereof upon the
dissolution of the Partnership. In the event the General Partner shall determine such adjustments
are necessary or appropriate to comply with Regulations Section 1.704-1(b)(2)(iv), the General
Partner shall adjust the amounts debited or credited to Capital Accounts with

C-5 

 

respect to (i) any property contributed by the Partners or distributed to the Partners and (ii) any liabilities
secured by such contributed or distributed property or assumed by the Partners. The General
Partner shall also make any other appropriate modifications in the event unanticipated events might
otherwise cause this Agreement not to comply with Regulations Section 1.704-1(b). In the event any
Partnership Interest in the Partnership is transferred in accordance with the terms of this
Agreement, the transferee shall succeed to the Capital Account of the transferor to the extent it
relates to the transferred Partnership Interest.

     “Capital Contribution” means with respect to any Partner, the amount of money and the
initial Agreed Value of any property (other than money) contributed to the Partnership with respect
to the Partnership Interest of such Partner.

     “Cash Distributions” means net cash distributed to Partners resulting from Cash Flow
from Operations or Cash from Sales or Refinancing, but shall not include cash payments made to the
General Partner as its Management Fee for services or any amount in repayment of loans made by the
Partners to the Partnership.

     “Cash Flow from Operations” means net cash funds provided from operations, exclusive
of Cash from Sales or Refinancing, of the Partnership or investment of any Partnership funds,
without deduction for depreciation, but after deducting cash funds used to pay or establish a
reserve for expenses, debt payments, capital improvements, and replacements and for such other
items as the General Partner reasonably determines to be necessary or appropriate; provided,
however, that such amount shall be reduced to the extent required to comply with written
requirements of the Partnership’s lenders; provided further, that without the consent of the
Investor Representatives, the General Partner shall not use such net cash funds for the early
repayment of Partnership debt.

     “Cash from Sales or Refinancing” means the net cash proceeds received by the
Partnership from or as a result of any Sale or Refinancing of property after deducting (i) all
expenses incurred in connection therewith, (ii) any amounts applied by the General Partner in its
sole and absolute discretion toward the payment of any indebtedness and other obligations of the
Partnership then due and payable, including payments of principal and interest on mortgages, (iii)
the payment of any other expenses or amounts owed by the Partnership to other parties to the extent
then due and payable, and (iv) the establishment of any reserves deemed necessary by the General
Partner in its sole and absolute discretion; provided, however, that such amount shall be reduced
to the extent required to comply with written requirements of the Partnership’s lenders. If the
proceeds of any sale or refinancing are paid in more than one installment, each such installment
shall be treated as a separate Sale or Refinancing for the purposes of this definition.

     “Code” means the Internal Revenue Code of 1986, as amended from time to time. Any
reference herein to a specific section(s) of the Code shall be deemed to include a reference to any
corresponding provision of future law.

     “Convertible Loans” is defined in Recital D hereto.

     “Convertible Note Purchase Agreement” is defined in Recital D hereto.

     “Default Rate” means a per annum rate of return on a specified principal sum,
compounded monthly, equal to the greater of (a) the Prime Rate plus 500 basis points, or (b) 18%,
but in no event greater than the highest rate allowed by law.

C-6 

 

     “Economic Interest” means and shall refer to that portion of the Partnership Interest
of a Partner in the economic rights and benefits of the Partnership, including but not limited to
all Profits, Losses and Cash Distributions. Such an Economic Interest will be measured by an amount equal to the Partner’s
percentage Partnership Interest in the Partnership as the same may be adjusted from time to time.

     “Economic Interest Owner” means a Person who has validly acquired a Partner’s Economic
Interest as permitted under this Agreement but who has not become a Partner. Such Person shall be
entitled to the allocations of Profits and Losses and Cash Distributions under Article VI and VII
to which the previous owner of the Economic Interest would have been entitled had such previous
owner retained the Economic Interest. Unless and until such Economic Interest Holder is admitted
as a Substitute Partner, it shall be a mere assignee of a Partner.

     “Entity” means any general partnership, limited partnership, limited liability
company, corporation, joint venture, trust, business trust, cooperative or association or any
foreign trust or foreign business organization.

     “Equipment” means the appropriate equipment and supplies required from time to time in
connection with the development and operation of the Hospital.

     “Fiscal Year” means, with respect to the first year of the Partnership, the period
beginning upon the formation of the Partnership and ending on the next September 30, with respect
to subsequent years of the Partnership, the twelve month period beginning October 1 and ending
September 30, and, with respect to the last year of the Partnership, the portion of the period
beginning October 1 and ending with the date of the final liquidating distributions.

     “General Partner” means and shall refer to HMC Management. The powers, rights and
duties of the General Partner to manage the affairs of the Partnership are specified or designated
in this Agreement.

     “HHM” means and shall refer to Harlingen Hospital Management, Inc., which served as
the initial General Partner of the Partnership.

     “HMC Management” means and shall refer to HMC Management Company, LLC, a North
Carolina limited liability company, assignee of all of HHM’s rights and obligations as General
Partner of the Partnership.

     “Hospital” means an acute care general hospital providing medical care and surgery in
Harlingen, Texas as further described in Section 2.3 of the Agreement.

     “Hospital Limited Partner” means Valley Baptist Management Services Corporation.

     “HPHI” means Harlingen Partnership Holdings, Inc., which shall be a Limited Partner of
the Partnership.

     “Investor Limited Partners” means the Limited Partners other than (a) HPHI and (b) the
Hospital Limited Partner.

     “Investor Representatives” means five (5) individuals elected by the Investor Limited
Partners in accordance with Section 5.13.

     “Limited Partners” means the Limited Partners listed on the Information
Exhibit attached hereto.

C-7

 

     “Majority Vote of Investor Limited Partners” means and shall refer to the affirmative
vote, approval or consent of Investor Limited Partners holding a majority of the percentage
Partnership Interests held by the Investor Limited Partners in the aggregate.

     “Management Fee” means the amounts payable to the General Partner pursuant to Section
5.6(b)(ii) for services rendered in managing the operations of the Partnership.

     “Material Agreement” means any binding agreement which may not be canceled upon less
than ninety (90) days notice and which calls for the expenditure of funds, or involves an
obligation for financing, in excess of $100,000.00 exclusive of agreements or obligations
contemplated by any budget, development plan, financing or construction contract approved by the
General Partner or agreements incurred in the ordinary course of business such as employment
agreements, purchases of supplies and routine services and the like.

     “Material Decision” means any decisions regarding approvals of the development and
operating budgets for the Hospital, the selection of the site for the Hospital, the design of the
Hospital, the selection of the Hospital’s senior administrator, strategic planning, the execution
of managed care contracts and the execution of exclusive contracts to provide physician services to
the Hospital.

     “Organization Expenses” means those expenses incurred, either by the Partnership, on
behalf of the Partnership or for which the Partnership has agreed to make reimbursement, in
connection with the formation of the Partnership including such expenses as: (i) registration fees,
filing fees, and taxes; and (ii) legal fees incurred in connection with any of the foregoing.

     “Partner” means and shall refer to the organizers of the Partnership (unless or until
any such organizer has withdrawn) and each of the Persons identified as “Partners” in the then
applying Information Exhibit attached hereto and incorporated herein by this reference. If
a Person is already a Partner immediately prior to the purchase or other acquisition by such Person
of an Economic Interest or Partnership Interest, such Person shall have all the rights of a Partner
with respect to such purchased or otherwise acquired Partnership Interest or Economic Interest, as
the case may be.

     “Partnership” means and shall refer to Harlingen Medical Center, Limited Partnership,
which was created upon the filing of the Certificate of Limited Partnership with the Office of the
Secretary of State of North Carolina, to be operated under the name Harlingen Medical Center,
Limited Partnership, a North Carolina limited partnership, and to continue under this Agreement, as
amended from time to time.

     “Partnership Interest” means all of a Partner’s rights in the Partnership, including
without limitation the Partner’s share of Profits, Losses, Cash Distributions and other benefits of
the Partnership, any right to vote, any right to participate in the management of the business and
affairs of the Partnership, including the right to vote on, consent to, or otherwise participate in
any decision or action of or by the Partners granted pursuant to this Limited Partnership Agreement
or the Act. The percentage Partnership Interest of each Partner, their Capital Contributions and
other related information shall be listed on the Information Exhibit. The percentage
Partnership Interests generally shall be based upon the pro rata Capital Contribution of each
Partner.

     “Person” means any individual or Entity, and the heirs, executors, administrators,
legal representatives, successors, and assigns of such individual or Entity where the context so
permits.

     “Prime Rate” means the rate of interest as of the relevant day or time period as
announced by the Bank of America, N.A. or its successor in interest from time to time as its prime
or reference rate.

C-8

 

     “Profits and Losses” means, for each Fiscal Year or other period, an amount equal to
the Partnership’s taxable income or loss for such year or period, determined in accordance with
Code Section 703(a) (for this purpose, all items of income, gain, loss, or deduction required to be
stated separately pursuant to Code Section 703(a)(l) shall be included in taxable income or loss), with the following
adjustments:

     (a) Any income of the Partnership that is exempt from federal income tax and not otherwise
taken into account in computing Profits or Losses shall be added to such taxable income or loss;

     (b) Any expenditures of the Partnership described in Code Section 705(a)(2)(B) or treated as
Code Section 705(a)(2)(B) expenditures pursuant to Regulations Section
1.704-1(b)(2)(iv)(i), and not otherwise taken into account in computing Profits or Losses,
shall be subtracted from such taxable income or loss;

     (c) Gain or loss resulting from dispositions of Partnership assets shall be computed by
reference to the Agreed Value of the property disposed of, notwithstanding that the adjusted tax
basis of such property differs from its Agreed Value.

     “Project Costs” shall include, without limitation, all costs incurred by the
Partnership in connection with the development and construction of the Hospital, including without
limitation, land acquisition costs, equipment costs, architectural, design and engineering costs,
legal and accounting costs, construction costs, construction period interest, pre-opening expenses,
fees payable to the General Partner or its Affiliates, and other construction and development costs
incurred in connection with the construction and development of the Hospital, which total amount
shall finally be determined by the General Partner following the opening of the Hospital.

     “Refinancing” means any borrowing incurred or made to recapitalize the Partnership or
the equity investment in, or to refinance any loan used to finance the acquisition of property.

     “Regulations” means rules, orders, and regulations issued pursuant to or under the
authority of the Code and shall include revisions to and succeeding provisions as appropriate.

     “Regulatory Allocations” means those allocations of items of Partnership income, gain,
loss or deduction set forth on the Regulatory Allocations Exhibit and designed to enable the
Partnership to comply with the alternate test for economic effect prescribed in Regulations Section
1.704-1(b)(2)(ii)(d), and the safe-harbor rules for allocations attributable to nonrecourse
liabilities prescribed in Regulations Section 1.704-2.

     “Sale” means the sale, exchange, involuntary conversion (other than a casualty
followed by reconstruction), condemnation, or other disposition of property by the Partnership,
except for dispositions of inventory items and personal property in the ordinary course of business
and in connection with the replacement of such property.

     “Substitute General Partner” means a General Partner who succeeds the General Partner
with all of the specific rights and powers of such General Partner under this Agreement.

     “Substitute Investor Representative” means an Investor Representative who succeeds an
Investor Representative with all of the specific rights and powers of such Investor Representative
under this Agreement.

C-9

 

     “Substitute Partner” means an assignee of a Partner who has been admitted to the
Partnership and granted all the rights of a Partner in place of its assignor pursuant to the
provisions of this Agreement. A Substitute Partner, upon its admission as such, shall replace and
succeed to the rights, privileges, and liabilities of the Partner from whom it acquired its
interest in the Partnership, to the extent of the Economic Interest assigned.

C-10

 

EXHIBIT D

TO THE

AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

A North Carolina Limited Partnership

DEVELOPMENT BUDGET EXHIBIT

[INTENTIONALLY OMITTED]

C-11

 

EXHIBIT E

TO THE

AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT

OF

HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP

a North Carolina limited partnership

REGULATORY ALLOCATIONS

     This Exhibit contains special rules for the allocation of items of Partnership income, gain,
loss and deduction that override the basic allocations of Profits and Losses in the Agreement to
the extent necessary to cause the overall allocations of items of Partnership income, gain, loss
and deduction to have substantial economic effect pursuant to Regulations Section 1.704-1(b) and
shall be interpreted in light of that purpose. Subsection (a) below contains special technical
definitions. Subsections (b) through (h) contain the Regulatory Allocations themselves.
Subsections (i), (j) and (k) are special rules applicable in applying the Regulatory Allocations.

     (a) Definitions Applicable to Regulatory Allocations. For purposes of the Agreement,
the following terms shall have the meanings indicated:

	 	(i)	 	“Partnership Minimum Gain” means the same as the
meaning of “partnership minimum gain” set forth in Regulations Section
1.704-2(d), and is generally the aggregate gain the Partnership would realize
if it disposed of its property subject to Nonrecourse Liabilities in full
satisfaction of each such liability, with such other modifications as provided
in Regulations Section 1.704-2(d). In the case of Nonrecourse Liabilities for
which the creditor’s recourse is not limited to particular assets of the
Partnership, until such time as there is regulatory guidance on the
determination of minimum gain with respect to such liabilities, all such
liabilities of the Partnership shall be treated as a single liability and
allocated to the Partnership’s assets using any reasonable basis selected by
the General Partner.
	 
	 	(ii)	 	“Partner Nonrecourse Deductions” means losses,
deductions or Code Section 705(a)(2)(B) expenditures attributable to Partner
Nonrecourse Debt under the general principles applicable to “partner
nonrecourse deductions” set forth in Regulations Section 1.704-2(i)(2).
	 
	 	(iii)	 	“Partner Nonrecourse Debt” means any Partnership
liability with respect to which one or more but not all of the Partners or
related Persons to one or more but not all of the Partners bears the economic
risk of loss within the meaning of Regulations Section 1.752-2 as a guarantor,
lender or otherwise.
	 
	 	(iv)	 	“Partner Nonrecourse Debt Minimum Gain” means the
minimum gain attributable to Partner Nonrecourse Debt as determined pursuant to
Regulations Section 1.704-2(i)(3). In the case of Partner Nonrecourse Debt for
which the creditor’s recourse against the Partnership is not limited to
particular assets of the Partnership, until such time as there is regulatory
guidance on the determination of minimum gain with respect to such liabilities,
all such liabilities of the Partnership shall be treated as a single liability
and allocated to the Partnership’s assets using any reasonable basis selected
by the General Partner.

 

 

	 	(v)	 	“Nonrecourse Deductions” means losses, deductions, or
Code Section 705(a)(2)(B) expenditures attributable to Nonrecourse Liabilities
(see Regulations Section 1.704-2(b)(1)). The amount of Nonrecourse Deductions
for a Fiscal Year shall be determined pursuant to Regulations Section
1.704-2(c), and shall generally equal the net increase, if any, in the amount
of Partnership Minimum Gain for that taxable year, determined generally
according to the provisions of Regulations Section 1.704-2(d), reduced (but not
below zero) by the aggregate distributions during the year of proceeds of
Nonrecourse Liabilities that are allocable to an increase in Partnership
Minimum Gain, with such other modifications as provided in Regulations Section
1.704-2(c).
	 
	 	(vi)	 	“Nonrecourse Liability” means any Partnership liability
(or portion thereof) for which no Partner bears the economic risk of loss under
Regulations Section 1.752-2.
	 
	 	(vii)	 	“Regulatory Allocations” means allocations of
Nonrecourse Deductions provided in Paragraph (b) below, allocations of Partner
Nonrecourse Deductions provided in Paragraph (c) below, the minimum gain
chargeback provided in Paragraph (d) below, the Partner nonrecourse debt
minimum gain chargeback provided in Paragraph (e) below, the qualified income
offset provided in Paragraph (f) below, the gross income allocation provided in
Paragraph (g) below, and the curative allocations provided in Paragraph (h)
below.

     (b) Nonrecourse Deductions. All Nonrecourse Deductions for any Fiscal Year shall be
allocated to the Partners in accordance with their percentage Partnership Interests.

     (c) Partner Nonrecourse Deductions. All Partner Nonrecourse Deductions for any Fiscal
Year shall be allocated to the Partner who bears the economic risk of loss under Regulations
Section 1.752-2 with respect to the Partner Nonrecourse Debt to which such Partner Nonrecourse
Deductions are attributable.

     (d) Minimum Gain Chargeback. If there is a net decrease in Partnership Minimum Gain
for a Fiscal Year, each Partner shall be allocated items of Partnership income and gain for such
year (and, if necessary, subsequent years) in an amount equal to such Partner’s share of such net
decrease in Partnership Minimum Gain, determined in accordance with Regulations Section
1.704-2(g)(2) and the definition of Partnership Minimum Gain set forth above. This provision is
intended to comply with the minimum gain chargeback requirement in Regulations Section 1.704-2(f)
and shall be interpreted consistently therewith.

     (e) Partner Nonrecourse Debt Minimum Gain Chargeback. If there is a net decrease in
Partner Nonrecourse Debt Minimum Gain attributable to a Partner Nonrecourse Debt for any Fiscal
Year, each Partner who has a share of the Partner Nonrecourse Debt Minimum Gain attributable to
such Partner Nonrecourse Debt as of the beginning of the Fiscal Year, determined in accordance with
Regulations Section 1.704-2(i)(5), shall be allocated items of Partnership income and gain for such
year (and, if necessary, subsequent years) in an amount equal to such Partner’s share of the net
decrease in Partner Nonrecourse Debt Minimum Gain attributable to such Partner Nonrecourse Debt,
determined in accordance with Regulations Sections 1.704-2(i)(4) and (5) and the definition of
Partner Nonrecourse Debt Minimum Gain set forth above. This Paragraph is intended to comply with
the Partner nonrecourse debt minimum gain chargeback requirement in Regulations Section
1.704-2(i)(4) and shall be interpreted consistently therewith.

 

 

     (f) Qualified Income Offset. In the event any Partner unexpectedly receives any
adjustments, allocations, or distributions described in Regulations Sections
1.704-1(b)(2)(ii)(d)(4), (5), or (6), items of Partnership income
and gain (consisting of a pro rata portion of each item of Partnership income, including gross
income, and gain for such year) shall be allocated to such Partner in an amount and manner
sufficient to eliminate, to the extent required by the Regulations, any deficit in such Partner’s
Adjusted Capital Account created by such adjustments, allocations or distributions as quickly as
possible.

     (g) Gross Income Allocation. In the event any Partner has a deficit in its Adjusted
Capital Account at the end of any Fiscal Year, each such Partner shall be allocated items of
Partnership gross income and gain, in the amount of such Adjusted Capital Account deficit, as
quickly as possible.

     (h) Curative Allocations. When allocating Profits and Losses under Article VI, such
allocations shall be made so as to offset any prior allocations of gross income under Paragraph (g)
above to the greatest extent possible so that overall allocations of Profits and Losses shall be
made as if no such allocations of gross income occurred.

     (i) Ordering. The allocations in this Exhibit to the extent they apply shall be made
before the allocations of Profits and Losses under Article VI and in the order in which they appear
above.

     (j) Waiver of Minimum Gain Chargeback Provisions. If the General Partner determines
that (i) either of the two minimum gain chargeback provisions contained in this Exhibit would cause
a distortion in the economic arrangement among the Partners, (ii) it is not expected that the
Partnership will have sufficient other items of income and gain to correct that distortion, and
(iii) the Partners have made Capital Contributions or received net income allocations that have
restored any previous Nonrecourse Deductions or Partner Nonrecourse Deductions, then the General
Partner shall have the authority, but not the obligation, after giving notice to the Partners, to
request on behalf of the Partnership the Internal Revenue Service to waive the minimum gain
chargeback or Partner nonrecourse debt minimum gain chargeback requirements pursuant to Regulations
Sections 1.704-2(f)(4) and 1.704-2(i)(4). The Partnership shall pay the expenses (including
attorneys’ fees) incurred to apply for the waiver. The General Partner shall promptly copy all
Partners on all correspondence to and from the Internal Revenue Service concerning the requested
waiver.

     (k) Code Section 754 Adjustments. To the extent an adjustment to the adjusted tax
basis of any Partnership asset pursuant to Code Section 734(b) or Code Section 743(b) is required,
pursuant to Regulations Section 1.704-1(b)(2)(iv)(m), to be taken into account in
determining Capital Accounts, the amount of such adjustment to the Capital Accounts shall be
treated as an item of gain (if the adjustment increases the basis of the asset) or loss (if the
adjustment decreases such basis), and such gain or loss shall be specially allocated to the
Partners in a manner consistent with the manner in which their Capital Accounts are required to be
adjusted pursuant to such Section of the Regulations.

[THE REMAINDER OF THIS PAGE INTENTIONALLY HAS BEEN LEFT BLANK.]Exhibit 10.70

 

Exhibit 10.70

HMC REALTY, LLC

A Texas Limited Liability Company

AMENDED AND RESTATED OPERATING AGREEMENT

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	ARTICLE I DEFINITIONS AND GLOSSARY OF TERMS
	 	 	5	 
	 
	 	 	 	 
	ARTICLE II FORMATION; NAME; PURPOSES; OFFICE; TERM
	 	 	7	 
	SECTION 2.1. Company Formation
	 	 	7	 
	SECTION 2.2. Name of Company
	 	 	7	 
	SECTION 2.3. Purposes
	 	 	7	 
	SECTION 2.4. Registered Office and Principal Place of Business
	 	 	8	 
	SECTION 2.5. Commencement and Term
	 	 	8	 
	SECTION 2.6. Representations and Warranties
	 	 	8	 
	 
	 	 	 	 
	ARTICLE III CAPITAL CONTRIBUTIONS, LIABILITY OF MEMBERS, CAPITAL ACCOUNTS, RETURN OF
CAPITAL AND INTEREST ON CAPITAL
	 	 	9	 
	SECTION 3.1. Initial Contributions
	 	 	9	 
	SECTION 3.2. Additional Capital Contributions
	 	 	10	 
	SECTION 3.3. Limited Liability of Members and Managers
	 	 	10	 
	SECTION 3.4. Maintenance of Capital Accounts; Withdrawals
	 	 	10	 
	SECTION 3.5. Percentage Interests
	 	 	10	 
	SECTION 3.6. Additional Members
	 	 	10	 
	SECTION 3.7. Member Loans
	 	 	11	 
	SECTION 3.8. Credit Support
	 	 	11	 
	 
	 	 	 	 
	ARTICLE IV MANAGEMENT OF THE COMPANY
	 	 	11	 
	SECTION 4.1. Management; Execution of Company Contracts
	 	 	11	 
	SECTION 4.2. Number, Tenure and Qualifications of Managers; Decisions by Managers
	 	 	12	 
	SECTION 4.3. Powers and Authority of Managers
	 	 	12	 
	SECTION 4.4. Managers to Act in Best Interests of Company
	 	 	14	 
	SECTION 4.5. Other Business of Members
	 	 	14	 
	SECTION 4.6. Maintenance of Tax Status
	 	 	15	 
	SECTION 4.7. Liability and Indemnification of the Managers; Expense
Advancement
	 	 	15	 
	 
	 	 	 	 
	ARTICLE V ALLOCATIONS
	 	 	17	 
	SECTION 5.1. Allocation of Income and Losses
	 	 	17	 
	SECTION 5.2. Miscellaneous
	 	 	18	 
	 
	 	 	 	 
	ARTICLE VI DISTRIBUTIONS
	 	 	18	 
	SECTION 6.1. Distributions
	 	 	18	 

 

 

	 	 	 	 	 
	 	 	Page	 
	SECTION 6.2. Tax Distributions
	 	 	19	 
	SECTION 6.3. Distributions In Kind
	 	 	19	 
	SECTION 6.4. Withholding
	 	 	19	 
	SECTION 6.5. Right of Offset
	 	 	20	 
	 
	 	 	 	 
	ARTICLE VII WINDING UP AND TERMINATION OF THE COMPANY
	 	 	20	 
	SECTION 7.1. Winding Up and Termination of the Company
	 	 	20	 
	SECTION 7.2. Winding-Up and Liquidation
	 	 	21	 
	 
	 	 	 	 
	ARTICLE VIII WITHDRAWAL OF MEMBERS AND TRANSFER OF MEMBERS’ INTERESTS
	 	 	22	 
	SECTION 8.1. Restriction on Transfer and Withdrawal
	 	 	22	 
	SECTION 8.2. Conditions Precedent to Transfer of Member’s Interest
	 	 	22	 
	SECTION 8.3. Substitute or Additional Member — Conditions to Fulfill
	 	 	23	 
	SECTION 8.4. Further Assignment by Assignee
	 	 	23	 
	SECTION 8.5. Rights and Liabilities of and Restrictions on Assignee
	 	 	23	 
	SECTION 8.6. Involuntary Transfers; Transfer of Interests in Members
	 	 	24	 
	 
	 	 	 	 
	ARTICLE IX BOOKS; DEPOSITORY ACCOUNTS; ACCOUNTING REPORTS; ELECTIONS
	 	 	24	 
	SECTION 9.1. Books of Account
	 	 	24	 
	SECTION 9.2. Access to Records; Audit
	 	 	24	 
	SECTION 9.3. Depository Accounts and Investment of Funds
	 	 	24	 
	SECTION 9.4. Reports
	 	 	25	 
	SECTION 9.5. Tax Accounting Methods; Periods; Elections
	 	 	25	 
	 
	 	 	 	 
	ARTICLE X MEETINGS OF MEMBERS
	 	 	25	 
	SECTION 10.1. Meetings of Members
	 	 	25	 
	SECTION 10.2. Notice of Meetings of Members
	 	 	26	 
	SECTION 10.3. Record Date
	 	 	26	 
	SECTION 10.4. Quorum
	 	 	26	 
	SECTION 10.5. Organization
	 	 	27	 
	SECTION 10.6. Actions by Members
	 	 	27	 
	SECTION 10.7. Proxies
	 	 	27	 
	SECTION 10.8. Action Without Meeting
	 	 	27	 
	SECTION 10.9. Meeting by Conference Telephone
	 	 	27	 
	SECTION 10.10. Registered Members
	 	 	28	 
	 
	 	 	 	 
	ARTICLE XI MISCELLANEOUS PROVISIONS
	 	 	28	 
	SECTION 11.1. Waiver of Provisions
	 	 	28	 
	SECTION 11.2. Amendment
	 	 	28	 

ii 

 

	 	 	 	 	 
	 	 	Page	 
	SECTION 11.3. Interpretation and Construction
	 	 	28	 
	SECTION 11.4. Governing Law; Jurisdiction
	 	 	28	 
	SECTION 11.5. Partial Invalidity
	 	 	28	 
	SECTION 11.6. Binding on Successors
	 	 	28	 
	SECTION 11.7. Notices and Delivery
	 	 	28	 
	SECTION 11.8. Counterparts
	 	 	29	 
	SECTION 11.9. Statutory Provisions
	 	 	29	 
	SECTION 11.10. Waiver of Partition
	 	 	29	 
	SECTION 11.11. Tax Matters Member
	 	 	29	 
	SECTION 11.12. Determination of Matters Not Provided For In This Agreement
	 	 	29	 
	SECTION 11.13. Further Assurances
	 	 	29	 
	SECTION 11.14. Arbitration
	 	 	29	 

iii 

 

AMENDED AND RESTATED OPERATING AGREEMENT

OF

HMC REALTY, LLC

a Texas Limited Liability Company

     THIS AMENDED AND RESTATED OPERATING AGREEMENT, is made and entered into as of the ___day of
                    , 2007, by and among VALLEY BAPTIST REALTY CORPORATION, a Texas corporation
(“VB”), HARLINGEN HOSPITAL MANAGEMENT, INC., a North Carolina corporation
(“MedCath”), and HMC PHYSICIANS, LTD., a Texas limited partnership (the “Physician
Investor”) (VB, MedCath and the Physician Investor are referred to herein collectively as the
“Members”), and HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP, a North Carolina limited
partnership (the “Hospital”), as the original member of the Company.

RECITALS

	 	A.	 	The Company has been formed by the Hospital by filing a Certificate of
Formation of HMC Realty, LLC with the Secretary of State of Texas. The Hospital has
executed an Operating Agreement of the Company effective as of the date of formation
(the “Original Agreement”).
	 
	 	B.	 	The Hospital contributed the Property (as defined herein) to the capital of the
Company, subject to an existing mortgage to HCPI Mortgage Corp. In connection with the
contribution of the Property, the Company also assumed $11,345,393 in obligations owed
by the Hospital to MedCath Finance Co., LLC, an affiliate of MedCath, and $2,944,607 in
principal amount of obligations owned by the Hospital to Valley Baptist Health System,
an affiliate of VB.
	 
	 	C.	 	The parties to this Amended and Restated Agreement wish to amend and restate
the Original Agreement in its entirety to provide for: (i) the admission of the
Physician Investor for a cash capital contribution as described herein; (ii) the
admission of VB as a Member in return for a cash capital contribution and the
conversion of certain obligations to equity as described herein; (iii) the admission of
MedCath as a Member in return for the conversion of a portion of the obligations to
equity as described herein; (iv) the withdrawal of the Hospital from membership in the
Company; and (v) such other provisions regarding the Company and its affairs as are set
forth herein.

     NOW, THEREFORE, the parties hereto hereby amend and restate the Original Agreement in its
entirety as follows:

 

 

ARTICLE I

DEFINITIONS AND GLOSSARY OF TERMS

     “Acquisition Loan” means a loan from Citicorp Vendor Finance, Inc. or other lender
selected by the Managers in the approximate principal amount of $39,000,000.

     “Adjusted Capital Account Deficit” means with respect to any Member, the deficit
balance, if any, in such Member’s Capital Account as of the end of the relevant fiscal year, after
giving effect to the following adjustments:

     (i) Credit to such Capital Account any amounts which the Member is obligated to
restore or is deemed to be obligated to restore pursuant to the penultimate sentences of
Regulations Sections 1.704-2(g)(1) and 1.704-2(i)(5); and

     (ii) Debit to such Capital Account the items described in Sections
1.704-1(b)(2)(ii)(d)(4), 1.704-1(b)(2)(ii)(d)(5), and 1.704-2(b)(2)(ii)(d)(6) of the
Regulations.

The foregoing definition of Adjusted Capital Account Deficit is intended to comply with the
provisions of Section 1.704-1(b)(2)(ii)(d) of the Regulations and shall be interpreted consistently
therewith.

     “Affiliate” with respect to a Member shall mean any person or entity controlling,
controlled by, or under common control with such Member.

     “Agreement” shall mean this Amended and Restated Operating Agreement as amended from
time to time, which is intended to constitute the “company agreement” of the Company as set forth
in the TLLCL.

     “Assigned MedCath Loan” means a portion of the obligation owed to MedCath or its
affiliates by the Hospital which has been assigned to and assumed by the Company in the principal
amount of $11,345,393.

     “Assigned VB Loan” means a portion of the obligation owed to VB or its affiliates by
the Hospital which has been assigned to and assumed by the Company in the principal amount of
$2,944,607.

     “Capital Account” shall mean with respect to each Member a financial and tax
accounting account maintained and adjusted in accordance with the Treasury Regulations promulgated
under Section 704 of the Code.

     “Cash Flow” shall mean cash available to the Company as a result of the operations of
the Company and the sale or refinancing of Company property after (i) payment of all expenses,
costs, amortization of indebtedness of the Company, (ii) acquisition of investments or other
capital assets and (iii) the establishment by the Managers of reasonable reserves for working
capital, debt service, contingencies, investments, and replacements, subject however to
restrictions upon distribution which the Company agrees upon with its third party lenders.

5

 

     “Certificate of Formation” shall mean the certificate of formation, together with any
amendments thereto, required to be filed by the Company pursuant to the TLLCL and the TBOC.

     “Closing” shall mean the closing of the transaction pursuant to which the Company will
acquire the Property.

     “Closing Date” shall mean July 2, 2007, unless the Closing is extended by mutual
agreement of the Members.

     “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time, or
any successor federal revenue law and any final treasury regulations, revenue rulings, and revenue
procedures thereunder or under any predecessor federal revenue law.

     “Company” shall refer to the limited liability company created under this Agreement
and the Certificate of Formation.

     “Credit Support” shall mean any letters of credit, guarantees or other forms of
collateral or credit that any Member provides to any lender to the Company.

     “Distributions” shall mean distributions of cash or other property made by the Company
to the Members from any source.

     “GAAP” shall mean generally accepted accounting principles, consistently applied.

     “Hospital” shall mean Harlingen Medical Center, Limited Partnership, a North Carolina
limited partnership.

     “Income” shall mean the net income (including tax exempt income) of the Company or any
separately allocable item thereof as determined in accordance with GAAP.

     “Interest” shall mean all of the rights created under this Agreement or under the
TLLCL of each Member with respect to the Company and the Company property.

     “Lease” shall mean the agreement to be entered into between the Company and the
Hospital pursuant to which the Hospital will lease the Property from the Company.

     “Loan Closing” shall mean the closing of the transaction pursuant to which the
Company, acting through the Managers, will incur the Acquisition Loan.

     “Losses” shall mean the net loss of the Company as determined in accordance with GAAP
or any separately allocable deduction of the Company, including expenditures of the Company not
deductible in computing its taxable income and not properly chargeable to a capital account.

6

 

     “Managers” shall refer to the persons appointed as Managers pursuant to Section 4.2
herein and any other persons or entities who may become Managers pursuant to the terms of this
Agreement.

     “Members” shall refer collectively to the entities the names of which are listed in
the preamble to this Agreement and, in accordance with this Agreement, their successors and
assigns.

     “Percentage Interest” shall refer to the entire ownership Interest of a Member,
expressed as a percentage.

     “Prime Rate” shall mean the prime rate then in effect at CitiBank, N.A.

     “Property” shall mean the real property and improvements thereon located in Harlingen,
Cameron County, Texas, and more particularly described on Exhibit D attached hereto.

     “TLLCL” shall mean the Texas Limited Liability Company Law set forth in the Texas
Business Organizations (“TBOC”).

     Certain other capitalized terms not defined above shall have the meanings given such terms in
the Agreement.

ARTICLE II

FORMATION; NAME; PURPOSES; OFFICE; TERM

     SECTION 2.1. Company Formation. The Company has been formed as a limited liability
company under and pursuant to the TLLCL. The Members shall cause to be executed and filed all such
instruments or documents and shall do or cause to be done all filing, recording, or other acts, as
may be necessary or appropriate from time to time to comply with the requirements of law for the
formation of a limited liability company in the State of Texas.

     SECTION 2.2. Name of Company. The name of the Company shall be HMC Realty, LLC.

     SECTION 2.3. Purposes. The purposes of the Company are as follows:

     (a) To own, operate, finance, improve, maintain, lease to the Hospital or other
tenants, and sell or otherwise dispose of the Property;

     (b) To do all things reasonably incidental to the purposes described in subsection (a);
and

     (c) All such other lawful purposes to which the Members may consent.

7

 

     The Company may execute, deliver and perform all contracts and other undertakings and engage
in all activities and transactions as may be necessary or advisable to carry out the foregoing
objects and purposes.

     SECTION 2.4. Registered Office and Principal Place of Business. The registered office
of the Company in Texas shall be maintained at Harlingen Medical Center, 5501 South Expressway 77,
Harlingen, TX  78550, or at such other place as the Managers may determine, and the initial
registered agent at such address shall be                     . The principal place of business of the
Company shall be maintained at the above referenced registered office or at such other place as the
Managers may determine.

     SECTION 2.5. Commencement and Term. The Company commenced upon the filing of the
Certificate of Formation in the office of the Secretary of State of the State of Texas, as required
by Section 2.1 hereof, and shall continue indefinitely until terminated as provided herein and the
TLLCL.

     SECTION 2.6 Representations and Warranties. Each member represents and warrants to
the other Members as follows:

	 	(a)	 	MedCath represents, warrants and covenants that (i) it is a corporation duly
formed and validly existing under the laws of the State of North Carolina and is duly
qualified to transact business in the State of Texas; (ii) the execution, delivery and
performance of this Agreement is within its company power and all requisite action has
been taken to authorize the execution, delivery and performance of this Agreement;
(iii) the execution, delivery and performance of this Agreement will not contravene any
provision of its articles of organization, operating agreement, or any contract or
agreement to which it is a party; (iv) it has consulted with its own tax and legal
advisors regarding its participation in the Company, including without limitation
specialists in health care law and regulation; and (v) it is in compliance and will
remain in compliance with all laws and regulations applicable to it in connection with
its participation in the Company, including without limitation health care laws and
regulations.
	 
	 	(b)	 	VB represents, warrants and covenants that (i) it is a corporation duly formed
and validly existing under the laws of the State of Texas; (ii) the execution, delivery
and performance of this Agreement is within its corporate power and all requisite
corporate action has been taken to authorize the execution, delivery and performance of
this Agreement; (iii) the execution, delivery and performance of this Agreement will
not contravene any provision of its articles of incorporation, bylaws, or any contract
or agreement to which it is a party; (iv) it has consulted
with its own tax and legal advisors regarding its participation in the Company,
including without limitation specialists in health care law and regulation; and (v)
it is in compliance and will remain in compliance with all laws and regulations
applicable to it in connection with its participation in the Company, including
without limitation health care laws and regulations.

8

 

	 	(c)	 	Physician Investor represents, warrants and covenants that (i) it is a limited
partnership duly formed and validly existing under the laws of the State of Texas; (ii)
the execution, delivery and performance of this Agreement is within its company power
and all requisite action has been taken to authorize the execution, delivery and
performance of this Agreement; (iii) the execution, delivery and performance of this
Agreement will not contravene any provision of its certificate of formation, agreement
of limited partnership, or any contract or agreement to which it is a party; (iv) it
has consulted with its own tax and legal advisors regarding its participation in the
Company, including without limitation specialists in health care law and regulation;
and (v) it is in compliance and will remain in compliance with all laws and regulations
applicable to it in connection with its participation in the Company, including without
limitation health care laws and regulations.
	 
	 	 	 	Physician Investor further covenants that it will give the Managers the right to
review all offering memoranda, prospectuses, subscription documents and other
materials which will be used in connection with the offering of interests in
Physician Investor to investors, and that it will incorporate the Managers’
reasonable comments into any such materials.
	 
	 	(d)	 	Each of the Members acknowledges and agrees that (i) MedCath, VB and certain
members of Physician Investor, including without limitation Dr. Hugo Blake, are also
direct or indirect owners of the Hospital and as such may be subject to certain
conflicts of interest; (ii) such Member has consulted its own counsel in connection
with its participation in the Company and has made its own evaluation of the risks
related thereto, including without limitation such potential conflicts of interest; and
(iii) the representatives of the Members shall be entitled to take all actions and vote
on all matters relating to the Lease and other agreements and arrangements relating to
the relationship between the Company and the Hospital, and the Company and its lenders,
and all other matters involving the Company, regardless of any such potential conflicts
of interest.

ARTICLE III

CAPITAL CONTRIBUTIONS, LIABILITY OF MEMBERS,

CAPITAL ACCOUNTS, RETURN OF CAPITAL AND INTEREST ON CAPITAL

     SECTION 3.1. Initial Contributions. The Hospital formed the Company and made an
initial capital contribution to the Company of the Property, subject to certain obligations as
described on Exhibit A attached hereto. Upon the execution and effectiveness of this
Agreement, the Hospital will withdraw from the Company. The other Members shall make the initial
capital contributions to the Company set forth on Exhibit A, including without limitation
the conversions of the VB Assigned Loan and a portion of the MedCath Assigned Loan to equity as
described on Exhibit A, and shall receive therefor the Interest in the Company set forth on
Exhibit A.

9

 

     SECTION 3.2. Additional Capital Contributions. If the Managers determine that
additional capital is required for Company purposes (and no Manager shall fail to vote to approve a
capital call which is necessary to fund payments of any type or nature due from the Company with
respect to the Acquisition Loan or any refinancing or replacement financing thereof, or other
indebtedness for borrowed money, or to enable the Company to fulfill its obligations under the
Lease), the existing Members shall make additional contributions to the Company pro rata based on
their respective Percentage Interests in an aggregate amount equal to the additional capital
required. In the event any Member fails to make the required additional contributions, the other
Members may, but shall not be obligated to, make the contribution of the defaulting Member, and in
any event if any Member fails to make such additional capital contributions, the Percentage
Interests of all of the Members will be adjusted so that each Member’s Percentage Interest shall
equal the Percentage determined by dividing the amount of all capital contributions made to the
Company by such Member by the total of all capital contributions made to the Company by all
Members.

     SECTION 3.3. Limited Liability of Members and Managers. No Member shall have any
personal liability for any debts or losses of the Company beyond its Interest, except as provided
by law. No Member or Manager shall be liable, responsible or accountable in damages or otherwise
to the Company or any other Member for any acts performed in good faith and reasonably believed by
the Member or Manager to be within the scope of this Agreement, unless such act or failure to act
is attributable to gross negligence, malfeasance, fraud or breach of a provision of this Agreement.
No Member shall be personally liable to restore any Adjusted Capital Account Deficit. Other than
as provided in Section 3.2 and as may be required under the TLLCL, no Member or Manager shall be
liable for any debts or losses of capital or profits of the Company or be required to contribute or
lend funds to the Company.

     SECTION 3.4. Maintenance of Capital Accounts; Withdrawals; Individual Capital
Accounts shall be maintained for each of the Members. No Member shall be entitled to withdraw any
part of his Capital Account or to receive any Distribution or to make any capital contribution
except as expressly provided herein. No Member shall be entitled to receive any interest on his
contributions to the capital of the Company or with respect to his Capital Account.

     SECTION 3.5. Percentage Interests. Whenever it shall be necessary for voting or other
purposes herein specified to determine the Interest of one or more Members in the Company relative
to a group of Members or to all Members, that interest shall be determined based on the Percentage
Interests of the Members as set forth on Exhibit A attached hereto. Percentage Interests
shall be adjusted and Exhibit A shall be amended by the Managers from time to time as may
be required to reflect any purchases, sales, withdrawals, additional capital contributions,
transfers or other events resulting in a change in Company Interests, including the application of
Section 3.2, provided that such events may occur only in accordance with the terms of this
Agreement.

     SECTION 3.6. Additional Members. Additional Members may be admitted from time to time
upon terms approved by the Managers.

10

 

     SECTION 3.7. Member Loans. If and only if all Members agree to make such a loan
proportionate to their respective Percentage Interests in the Company, and such loans are permitted
under the terms of loans to the Company, then all Members together may, but shall not be obligated
to, make loans to the Company (individually, an “Optional Loan,” and collectively, the “Optional
Loans”), from time to time, to cover Company obligations and operating cash deficits, but only with
the consent of all of the Managers. Such Optional Loans shall be evidenced by promissory notes
executed by the Company, which shall bear interest at a variable annual rate equal to the Prime
Rate or such other rate as the Managers and such lending Member may otherwise agree, which in all
events shall be at no less than a fair market rate (the “FMV Rate”). Such Optional Loans
shall be repaid by the Company in accordance with Sections 6.1 and 7.2.

     SECTION 3.8. Credit Support. The Members acknowledge and agree that each of the
Members or their respective Affiliates (individually, a “Guarantor,” and collectively, the
“Guarantors”), shall provide a letter of credit as of the date hereof in the amount set forth on
Exhibit A. In the event that any Guarantor is ever required to fund under any such letter
of credit described in this Section 3.8, or any collateral pledged by such Guarantor as additional
security for any loan is liquidated and applied in repayment of such loan, such funding or
application of collateral shall, as the sole and exclusive remedy of such Guarantor, be treated as
a loan to the Company made by such Guarantor (individually, a “Guarantor Loan,” and collectively,
the “Guarantor Loans”). The Guarantor Loans shall bear interest at the Prime Rate plus two percent
(2%), beginning as of the date that the Lender receives the loan funds from the Guarantor or
applies such Guarantor’s collateral to payment of the Loan, and shall be payable as provided in
Sections 6.1 and 7.2.

ARTICLE IV

MANAGEMENT OF THE COMPANY

     SECTION 4.1. Management; Execution of Company Contracts. The management of the
Company shall be vested in the Managers subject to the other terms hereof. All contracts and
agreements undertaken by the Company, and any other documents, instruments, certificates and
filings shall be executed by one or more of the Managers or such person or entity as may be
empowered by this Agreement or designated in writing by the Managers to execute any contract,
agreement, document, instrument, certificate or filing, and in such contracts the Company shall be
identified as a limited liability company.

     The Managers hereby delegate to and agree that MedCath shall have the duty and responsibility
to prepare and maintain the books and records of the Company in accordance with GAAP, to provide
all accounting and reporting services and obligations to of the Company to either the Members,
Managers or to third parties and to provide or to obtain from a qualified accounting firm tax
return preparation and other tax services. MedCath shall be paid annually a fee equal to $75,000
for such services, which fee shall be increased annually as of January 1 of each year by the
Consumer Price Index. MedCath may relinquish such duty and responsibility at any time by written
notice to the Company, and in such event MedCath will no longer be entitled to such fee and the
Managers will appoint another Member or representative of a Member to

11

 

undertake such functions. The Company also shall pay for any needed services from third party accounting firms approved by
the Managers.

     SECTION 4.2. Number, Tenure and Qualifications of Managers; Decisions by
Managers. The Company shall have three (3) Managers. Each Member shall have the right to
appoint one (1) Manager, and shall have the right to remove and replace its appointed Manager at
any time and from time to time. Each Manager shall serve until his or her (i) removal by the
Member that appointed such Manager, (ii) resignation as Manager, or (iii) death or total
disability. In such case the Member which appointed such Manager shall promptly appoint a
replacement Manager. Managers need not be residents of the State of Texas or Members of the
Company.

     The initial Managers of the Company shall be as follows:

	 	 	 
	MedCath appointment

	 	James A. Parker
	VB appointment

	 	James G. Springfield
	Physician Investor appointment

	 	Hugo Blake, M.D.

     Subject to the other terms of this Agreement, the Managers may take action only upon unanimous
consent of all Managers. The Managers may participate in any meeting of such Managers by means of
conference telephone or similar communications equipment by means of which all persons
participating in the meeting can hear each other and such participation in a meeting shall
constitute presence in person at such meeting.

     SECTION 4.3. Powers and Authority of Managers. Subject to the terms and conditions of
this Agreement, the Managers shall have exclusive management and control of the affairs of the
Company and shall have the power and authority to do all things necessary or appropriate, and to
take all steps and to execute all documents and agreements as are necessary or appropriate, to
carry out the purposes of the Company, including without limitation the power:

     (a) To cause the Company to acquire the Property at Closing, to incur the Acquisition
Loan at the Loan Closing and such indebtedness as may be necessary or desirable for the
maintenance, repair, reconstruction, upgrade or improvement of the Property or structures
from time to time located thereon, and to acquire the Property, and in connection therewith
to repay the remaining outstanding balance of the Assigned MedCath Loan to the holders
thereof, and to take all steps and to execute all documents and agreements as are necessary
or appropriate to complete all of such transactions;

     (b) To cause the Company to enter into and perform the Lease in such form and substance
as may be approved by the Managers, and to take all steps and to execute all documents and
agreements as are necessary or appropriate to complete all of such transactions;

     (c) To cause the Company to enter into agreements with respect to the management of the
Property upon terms approved by the Managers, and to take all steps and to execute all
documents and agreements as are necessary or appropriate to complete all of such
transactions;

12

 

     (d) To do such acts and incur such expenses on behalf of the Company as may be
reasonably necessary or advisable in connection with the conduct of the Company affairs,
specifically including doing acts and incurring expenses necessary to (i) acquire any
properties or assets necessary or appropriate for the conduct of the Company’s business,
including borrowing money for the acquisition of such properties (subject to the terms
hereof) and executing pledges, evidences of liens, mortgages and/or deeds of trust in
connection therewith; (ii) do such other acts and incur such costs and expenses as are
consistent with the purposes of the Company; and (iii) sell, transfer, exchange or otherwise
dispose of the Property or other Company properties or assets;

     (e) To engage such agents, attorneys, accountants, custodians and other advisers and
consultants as may be necessary or advisable for the affairs of the Company;

     (f) To open, maintain and close bank accounts and custodial accounts for the Company
and to draw checks and other orders for the payment of money;

     (g) To file on behalf of the Company, all required local, state and federal tax returns
and other documents relating to the Company, and if in the best interests of the Company,
cause the Company to make or revoke if permissible, any of the elections referred to in
Sections 108, 709, 754 and 1017 of the Code or any similar provisions enacted in lieu
thereof, or make or revoke other elections permitted by the Code.

     (h) To cause the Company to purchase or bear the cost of any insurance covering the
potential liabilities of any person indemnified under Section 4.7;

     (i) To commence or defend litigation that pertains to the Company or any Company
assets, provided that the Company shall not bear the expenses of any litigation which arose
as a result of the bad faith, gross negligence or willful misconduct of any party
indemnified under this Agreement;

     (j) To prepare and file on behalf of the Company any statement, report, return or
document required by any state or federal agency or other governmental agency;

     (k) Subject to the other provisions of this Agreement, to enter into, make and perform
such contracts, agreements and other undertakings, and to do such other acts, as it may deem
necessary or advisable for, or as may be incidental to, the conduct to the business
contemplated by Section 2.3, including, without in any manner limiting the generality of the
foregoing, contracts, agreements, undertakings and transactions with any Member or with any
other person, firm or corporation having any business, financial or other relationship with
any Member or Members; provided, however, such transactions with such persons and entities
shall be on terms no less favorable to the Company than are generally afforded to unrelated
third parties in comparable transactions;

13

 

     (l) To sign or endorse on behalf of the Company any contracts, deeds, mortgages, deeds
of trust, notes, stock or other security certificates or other documents or instruments;

     (n) To reimburse any Member, affiliate or related person for any reasonable cost or
expense incurred on behalf of the Company in a manner authorized by this Agreement;

     (o) To delegate authority to act for the Company and other duties and responsibilities
to officers or other agents as may be designated by the Managers;

     (p) To cause the Company to enter into any merger, consolidation or reorganization; and

     (q) To take such other acts as are incidental to the foregoing matters.

     SECTION 4.4. Managers to Act in Best Interests of Company. In exercising any powers
hereunder or otherwise acting for the Company, each of the Managers shall exercise reasonable skill
and care and use his best judgment and shall act at all times in what he deems to be the best
interests of the Company. The Managers shall not be liable, responsible or accountable in damages
or otherwise to the Company or any Member for any acts performed or omitted by him in good faith
and within the scope of this Agreement. More specifically, but without limiting the generality of
the preceding sentence, the Managers shall not be liable for good faith mistakes of
judgment or for losses due to such mistakes or the good faith mistakes of judgment or losses due to
such mistakes of any employee, broker or other agent of the Company. Each Manager shall, however,
be liable for his actions to the extent they are attributable to gross negligence, willful
misconduct and/or fraud.

     Notwithstanding anything herein to the contrary, each Member acknowledges and agrees that (x)
each other Member is directly or indirectly also an owner of Harlingen Medical Center Limited
Partnership, the Tenant under the Lease, and (y) each Member and its designated Manager may vote on
any issue with respect to the business and affairs of the Company and the Tenant based upon its own
self-interest, subject to the express obligations set forth herein or in the Tenant’s agreement of
limited partnership.

     SECTION 4.5. Other Business of Members. Except as specifically provided to the
contrary in any separate written agreement with the Company, any Member may engage independently or
with others in other business ventures of any kind, render advice or services of any kind to other
investors or ventures, or make or manage other investments or ventures. Neither the Company nor
any Member shall have any right by virtue of this Agreement or the relationship created hereby in
or to such other ventures or activities or to the income or proceeds derived therefrom, and the
pursuit of such ventures, even if competitive with the business of the Company, shall not be deemed
wrongful or improper. Nothing herein shall be deemed to negate or modify any separate agreement
among the Members and the Company, or their respective Affiliates, or any of them, with respect to
restrictions on competition.

14

 

     SECTION 4.6. Maintenance of Tax Status. The Managers shall use their best efforts and
take all appropriate action to cause the Company to be classified, for federal income tax purposes,
as a partnership and to maintain the Company’s valid existence as a partnership for tax purposes.

     SECTION 4.7. Liability and Indemnification of the Managers; Expense Advancement.

     (a) Exculpation. No Covered Person (as defined in Section 4.7(h)) shall be
liable, responsible or accountable in damages or otherwise to the Company or any Member for
any acts or omissions performed or omitted by such Covered Person in good faith and
reasonably believed by such Covered Person to be in the best interest of the Company. More
specifically, but without limiting the generality of the preceding sentence, no Covered
Person shall be liable for (i) good faith mistakes of judgment, for any mistakes in fact or
law or for damages, claims or losses due to such mistakes or (ii) good faith mistakes of
judgment, for any mistakes in fact or law or for damages, claims or losses due to such
mistakes of any employee or agent of the Company. Notwithstanding the foregoing, each
Covered Person shall be liable for its actions to the extent they are attributable to such
Covered Person’s breach of fiduciary duty, gross negligence, willful misconduct and/or
fraud.

     (b) Indemnification. To the fullest extent permitted by applicable law, the
Company, its receiver or trustee shall indemnify and hold harmless each Covered Person from
any and all loss, damage, liability, or expense incurred by such Covered Person at any time
by reason of or arising out of any act or omission by such Covered Person for or on behalf
of the Company or in furtherance of the interest of the Company, except to the extent such
loss, damage, liability, or expense is attributable to such Covered Person’s breach of
fiduciary duty, gross negligence, willful misconduct and/or fraud; provided that the
satisfaction of any indemnification and any holding harmless shall be from and limited to
the Company’s assets and no Member shall have any personal liability on account thereof.

     (c) Advancement of Expenses. Unless otherwise restricted by the Certificate of
Formation or the TLLCL, expenses (including legal fees) incurred by a Covered Person in
defending any claim, demand, action, suit or proceeding shall, from time to time, be
advanced by the Company prior to the final disposition of such claim, demand, action, suit
or proceeding upon receipt by the Company of an undertaking by or on behalf of such Covered
Person to repay such amount if it shall be determined that such Covered Person is not
entitled to be indemnified as authorized in Section 4.7(b). Notwithstanding the foregoing,
no advance shall be made by the Company to a Covered Person (other than a Covered Person who
is or was a Manager, in which event this sentence shall not apply to such Covered Person) in
any action, suit or proceeding, whether civil, criminal, administrative or investigative, if
a determination is reasonably and promptly made by the Managers (or if there is no Manager,
or Managers to direct, by independent legal counsel (chosen by a majority in Percentage
Interest of the disinterested Members), as the case may be, the “Decision-Making
Party”) in a written opinion that the facts known to

15

 

the Decision-Making Party at the time such determination is made demonstrate clearly and convincingly that such Covered
Person acted in bad faith or in a manner that (i) was outside the scope of authority
conferred on such Covered Person, and (ii) was not in the best interests of the Company.

     (d) Enforcement Without the necessity of entering into an express contract,
all rights to indemnification and advances to Covered Persons under this Section 4.7 shall
be deemed, unless otherwise restricted by the Certificate of Formation or the TLLCL, to be
contractual rights and be effective to the same extent and as if provided for in a contract
between the Company and such Covered Person. Unless otherwise restricted by the Certificate
of Formation or the TLLCL, (i) any right to indemnification or advances granted by this
Section 4.7 to a Covered Person shall be enforceable by or on behalf of the person holding
such right in any court of competent jurisdiction if (A) the claim for indemnification or
advances is denied, in whole or in part, by the Company, or (B) no disposition of such claim
is made within ninety (90) days of request therefore, and (ii) the claimant in such
enforcement action, if successful in whole or in part, shall be entitled to be paid also the
reasonable expense of prosecuting the claim. In connection with any claim for
indemnification, the Company shall be entitled to raise as a defense to any such action that
the claimant has not met the standards of conduct that make it permissible under this
Agreement or any applicable law for the Company to indemnify the claimant for the amount
claimed. Neither the failure of the Company (including the Decision-
Making Party) to have made a determination prior to the commencement of such action
that indemnification of the claimant is proper in the circumstances because he/she/it has
met the applicable standard of conduct set forth in this Agreement or any applicable law,
nor an actual determination by the Company (including the Decision-Making Party) that the
claimant has not met such applicable standard of conduct, shall be a defense to the action
or create a presumption that claimant has not met the applicable standard of conduct. In
any suit brought by a Covered Person to enforce a right to indemnification or to an
advancement of expenses hereunder, the burden of proving that the Covered Person is not
entitled to be indemnified, or to such advancement of expenses, under this Section 4.7 or
otherwise shall be on the Company.

     (e) Insurance. Unless otherwise restricted by the Certificate of Formation or
the TLLCL, the Company may purchase and maintain insurance on behalf of Covered Persons and
such other persons as the Managers shall determine against any liability that may be
asserted against or expenses that may be incurred by any such Covered Person in connection
with the activities of the Company or such other indemnitees, regardless of whether the
Company would have the power to indemnify any such Covered Person or such other indemnitees
against such liability under the terms of this Agreement. The Company may enter into
indemnity contracts with Covered Persons and such other legal entities and persons as the
Managers shall determine and may adopt written procedures pursuant to which arrangements are
made for the advancement of expenses and the funding of obligations hereunder and containing
such other procedures regarding indemnification as are appropriate.

16

 

     (f) Survival of Rights. The rights conferred on any Covered Person by this
Section 4.7 shall continue as to a Covered Person who has ceased to be a Member, Manager or
other agent of the Company and shall inure to the benefit of the successors, assigns, heirs,
executors and administrators of such Covered Person.

     (g) Amendments . Unless otherwise restricted by the Certificate of Formation
or the TLLCL, any repeal or modification of this Section 4.7 shall only be prospective and
shall not affect the rights under this Section 4.7 in effect at the time of the alleged
occurrence of any action or omission to act that is the cause of any proceeding against any
Covered Person.

     (h) Covered Person. For purposes of this Agreement, a “Covered Person”
means each Manager and any other entity or person to whom the Managers have delegated
management responsibilities.

ARTICLE V

ALLOCATIONS

     SECTION 5.1. Allocation of Income and Losses. After giving effect to the special
allocations set forth in Exhibit B hereto, Income and Losses for each calendar year, or fraction
thereof, as the case may be, shall be allocated to the Members (and for purposes of Articles V and
VI hereof, the term “Member” shall include a transferee of an Interest whether or not such
transferee has been admitted to membership in the Company) as follows:

     (a) Income shall be allocated in the following priorities:

          (i) First, to the Members in the amounts and proportions necessary to offset
any Losses previously allocated pursuant to Section 5.1(b);

          (ii) Second, to the Members in accordance with their relative Percentage
Interests.

     (b) Losses shall be allocated in the following priorities:

          (i) Except as provided in Section 5.1(b)(ii), Losses shall be allocated to the
Members in accordance with their relative Percentage Interests.

          (ii) Any Losses allocated pursuant to Section 5.1(b)(i) hereof shall not exceed
the maximum amount of Losses that can be so allocated without causing any Member to
have an Adjusted Capital Account Deficit at the end of any fiscal year. In the
event some but not all of the Members would have Adjusted Capital Account Deficits
as a consequence of an allocation of Losses pursuant to Section 5.1(b)(i), the
limitation set forth in this Section 5.1(b)(ii) shall be applied on a Member by
Member basis so as to allocate the maximum permissible Loss to each Member under
Section 1.704-1(b)(2)(ii)(d) of the Regulations. All Losses in

17

 

excess of the limitation set forth in this Section 5.1(b)(ii) shall be allocated to the Members in
accordance with their relative Percentage Interests.

     SECTION 5.2. Miscellaneous.

     (a) For purposes of determining Income, Losses, or any other items allocable to any
period, such items shall be determined on a daily, monthly, or other basis, as determined by
the Managers using any permissible method under Code Section 706 and the Treasury
Regulations thereunder.

     (b) Except as otherwise provided in this Agreement, all items of Company Income, gain,
Loss, deduction and any other allocations for any tax period not otherwise provided for,
shall be allocated among the Members in the same proportion as they share Income or Losses,
as the case may be, for such tax period.

     (c) Except as otherwise provided in Section B.4 of Exhibit B for income tax
purposes under the Code and the Regulations, each Company item of income, gain, loss, and
deduction shall be allocated among the Members in the same manner as its correlative item of
“book” income, gain, loss, or deduction is allocated pursuant to Section 5.1.

     (d) The Members are aware of the income tax consequences of the allocations made by
this Article V and hereby agree to be bound by this Article V as reflected on the income tax
returns of the Company in reporting their shares of Income and Losses for federal income tax
purposes.

ARTICLE VI

DISTRIBUTIONS

     SECTION 6.1. Distributions. Cash Flow shall be paid to the Members on a monthly basis
by the Managers as follows:

     (a) First, to any Guarantors, an amount equal to the amount of their respective
Guarantor Loans made pursuant to Section 4.7, if any, with such distributions to be applied
first to the Guarantor Loans of the most distant date and origin and then applied to the
Guarantor Loans of the second most distant date and origin, and so on, until the principal
and interest of all Guarantor Loans have been paid in full, and made pro rata among the
Guarantors based upon the total amount of Guarantor Loans of even date made by each, to be
applied first against interest, then against principal;

     (b) Second, to the Members, respectively, an amount equal to the amount of their
respective Optional Loans made pursuant to Section 4.5, if any, with such distributions to
be applied first to the Optional Loans of the most distant date and origin and then applied
to the Optional Loans of the second most distant date and origin, and so on, until the
principal and interest of all Optional Loans have been paid in full, and made

18

 

pro rata among the Members based upon the total amount of Optional Loans of even date made by each, to be
applied first against interest, then against principal; and

     c) Thereafter, to the Members in accordance with their respective Percentage Interests.

     Except as otherwise provided herein or unless otherwise agreed to by all of the Members, all
Distributions shall be paid to the Members in accordance with their respective Percentage
Interests. No Distribution shall be declared and paid if payment of such Distribution would cause
the Company to violate any limitation on distributions set forth in the TLLCL or the terms of any
financing.

     SECTION 6.2. Tax Distributions. Absent distributions pursuant to Section 6.1 above,
the Managers shall, to the extent permitted by the Company’s agreements with third party lenders
and subject to the availability of Cash Flow and using commercially reasonable efforts, distribute
cash annually to the Members in accordance with their respective Percentage Interests in an amount
which is sufficient to enable them to pay income taxes which arise from the taxable income of the
Company. In computing the taxable income of each Member for purposes of this Section 6.2, the
taxable income of each Member for the current year shall be reduced by any cumulative tax losses
incurred in prior years (after reduction by taxable income in prior years). Such distributions
shall assume for all Members the highest combined federal and state tax rates applicable to any
Member with respect to its taxable income from the Company.

     SECTION 6.3. Distributions In Kind. Distributions in kind of the Company’s assets, in
liquidation or otherwise, may be made by the Managers in their sole discretion, and any
distributions in kind shall be valued at their then current fair market values, as determined in
good faith by the Managers. Prior to any such distribution in kind, the difference between such
fair market value of the property to be distributed and the value on the Company’s books for such
property shall be credited or charged, as is appropriate, to the Members’ Capital Accounts. Upon
the distribution of such property, such fair market value shall be charged to the Capital Account
of the Member or Members receiving such distribution.

     SECTION 6.4. Withholding. Each Member hereby authorizes the Company to withhold from
or pay on behalf of or with respect to such Member any amount of federal, state, local or foreign
taxes that the Managers determine that the Company is required to withhold or pay with respect to
any amount distributable or allocable to such Member pursuant to this Agreement, including, without
limitation, any taxes required to be withheld or paid by the Company pursuant to Code
Sections 1441, 1442, 1445 or 1446. Any amount paid on behalf of or with respect to a Member shall
constitute a loan by the Company to such Member, which loan shall be repaid by such Member within
15 days after notice from the Managers that such payment must be made unless (a) the Company
withholds such payment from a distribution that would otherwise be made to the Member or (b) the
Managers determine, in their sole and absolute discretion, that such payment may be satisfied out
of the Distributions of the Company that would, but for such payment, be distributed to the Member.
Each Member hereby unconditionally and irrevocably grants to the Company a security interest in
such Member’s Interest to secure such Member’s obligation to pay to the Company any amounts
required to be

19

 

paid pursuant to this Section 6.2. In the event that a Member fails to pay any
amounts owed to the Company pursuant to this Section 6.2 when due, the Managers may, in their sole
and absolute discretion, elect to make the payment to the Company on behalf of such defaulting
Member and shall succeed to all rights and remedies of the Company as against such defaulting
Member (including, without limitation, the right to receive Distributions otherwise distributable
to such defaulting Member). Any amounts payable by a Member hereunder shall bear interest at the
Prime Rate plus two percent (2%) (but not higher than the maximum lawful rate) from the date such
amount is due (i.e., fifteen (15) days after demand) until such amount is paid in full. Each
defaulting Member shall take such actions as the Company or the Manger shall request in order to
perfect or enforce the security interest created hereunder.

     SECTION 6.5. Right of Offset. Notwithstanding anything contained in this Agreement to
the contrary, unless expressly waived by the Managers, the Company shall retain and have a right of
offset against any and all Distributions or payments of cash (including all returns of capital)
related to the Interest of each Member respecting all obligations of such Member (and its
Affiliates or partners, members or shareholders or any entity owned by it or them) to the Company
or its Affiliates, including without limitation obligations to make Capital Contributions and other
payments required hereunder and any obligations of the Member (or its Affiliates or partners, members or
shareholders or any entity owned by it or them), whether as an obligor, guarantor or otherwise.
Such right of offset is exercisable by the Company without regard to any assignment, transfer or
other disposition of the Interest.

ARTICLE VII

WINDING UP AND TERMINATION OF THE COMPANY

     SECTION 7.1. Winding Up and Termination of the Company. The Company shall be wound up
upon the happening of any of the following events:

     (a) The written consent of the Members to terminate the Company;

     (b) The occurrence of any event which, under the TLLCL or any other applicable law,
causes the termination of the Company, except as expressly modified herein;

     (c) The sale of all or a substantial portion of the Company Property, unless the
Managers agree in writing at the time of such sale that the sale will not cause the
termination of the Company; or

     (d) The bankruptcy, death, termination, winding up, adjudication of incompetence, or
withdrawal of the last remaining Member or the transfer or conversion of the entire
Interests of the last remaining Member.

     Except as specifically set forth herein, the Company shall not be terminated by the death,
incapacity or other event of withdrawal of a Member.

20

 

     SECTION 7.2. Winding-Up and Liquidation.

     (a) Upon the termination of the Company, its assets shall be sold and liquidated, and
its affairs shall be wound up as soon as practicable thereafter by the Managers;
provided that a reasonable time shall be allowed for the orderly liquidation of the
assets of the Company and the discharge of liabilities to creditors so as to minimize the
losses normally attendant to a liquidation. In winding up the Company and liquidating the
assets thereof, the Managers, or other Person so designated for such purpose, may arrange
for the collection and disbursement to the Members of any future receipts from the Company’s
assets or other sums to which the Company may be entitled, or may sell the Company’s
interest in the Company’s assets to any person, including Affiliates of the Members , on
such terms and for such consideration as shall be consistent with obtaining the fair market
value thereof.

     (b) Upon the termination of the Company and after the Capital Accounts of the Members
have been adjusted to reflect the allocations described in Article V and Exhibit B
with respect to all Company transactions and operations occurring prior to final liquidating
Distributions, the assets, if any, of the Company available for distribution and any net
proceeds from the liquidation of any such assets, shall be applied and distributed in the
following manner or order, to the extent available:

          (i) First, to the discharge of debts and obligations of the Company,
including Guarantor Loans and Optional Loans from Members;

          (ii) Second, to fund reserves for contingent liabilities;

          (iii) Third, to the Members in accordance with their positive Capital
Accounts; and

          (iv) Fourth, to the Members in accordance with their Percentage
Interests.

     (c) Upon the termination and commencement of the winding-up of the Company, the
Managers or the remaining Members shall cause a certificate of termination to be executed on
behalf of the Company and filed with the Secretary of State of the State of Texas, and the
Managers and, at the request of the Managers or their designee, each Member shall execute,
acknowledge and file any and all other instruments necessary or appropriate to reflect the
termination of the Company. The termination of the Company shall be effective as of the day
in which the event occurs giving rise to the termination, but the Company shall not
terminate until there has been a winding-up the Company’s business and affairs, and the
assets of the Company have been distributed as provided in this Section 7.2.

21

 

ARTICLE VIII

WITHDRAWAL OF MEMBERS AND TRANSFER

OF MEMBERS’ INTERESTS

     SECTION 8.1. Restriction on Transfer and Withdrawal. Except as provided in this
Agreement, no Member shall transfer or assign its Interest at any time prior to the Company’s
winding-up and liquidation without the written consent of the other Members, nor shall any Member
voluntarily withdraw from the Company.

     Notwithstanding the foregoing, the following types of transfers (each, a “Permitted
Transfer”) shall be permitted and shall not be subject to the restrictions set forth in this
Section 8.1 (but shall be subject to the requirements of Sections 8.2 and 8.3):

     (a) Transfers to Affiliates. Each of MedCath and VB shall have the right to
assign or transfer all or a portion of its Interest to an Affiliate, provided however that
no such assignment or transfer shall relieve the assigning or transferring Member from its
obligations and responsibilities herein.

     (b) Transfers Approved by Managers. Any Member may transfer all or a portion
of its Interest pursuant to the prior written approval of all of the Managers, which may be
withheld or conditioned in the sole discretion of the Managers.

     (c) Transfers of Interests in Physician Investor. The owners and members of
the Physician Investor may transfer or assign the interests therein only with the prior
written approval of the Managers of the Company. The owners and members of the Physician
Investor may pledge or assign their interests in the Physician Investor to third-party
lenders, which lenders, upon foreclosure of any such interest, shall be subject to the terms
and conditions of the limited partnership agreement of the Physician Investor. The operating
agreement or limited partnership agreement of the Physician Investor shall be presented to
the Managers for approval and once so approved shall not be amended without the prior
written consent of the Managers.

     (d) Transfers as Collateral for Lenders. The Members of the Company are each
entitled to pledge or assign their interests in the Company to their third-party lenders,
which lenders, upon foreclosure of any such Interest, shall be subject to the terms and
conditions of this Agreement.

     SECTION 8.2. Conditions Precedent to Transfer of Member’s Interest. No transfer may
be made of all or a portion of any Member’s Interest (i) if such transfer constitutes a violation
of the registration provisions of the Securities Act of 1933, as amended, or the registration
provisions of any applicable state’s securities provisions; (ii) unless approved by all of the
Managers, if after such transfer the Company will be classified other than as a partnership for
federal income tax purposes; or (iii) unless approved by all of the Managers, if such transfer,
when taken together with other prior transfers, results in a “termination” of the Company for
federal income tax purposes. The Company may require, as a condition precedent to any transfer of
a Company Interest, delivery to the Company at the proposed transferor’s expense, an opinion

22

 

of counsel satisfactory (both as to the counsel and substance of the opinion) to the Managers that the
transfer will not result in the occurrence of any of the foregoing restrictions recited in clauses
(i), (ii) or (iii) above.

     SECTION 8.3. Substitute or Additional Member — Conditions to Fulfill. No assignee of
a Member’s Interest in the Company or additional Member shall have the right to become a Member in
place of his assignor or otherwise unless all of the following conditions are satisfied:

     (a) In the event of an assignment, a duly executed and acknowledged written instrument
of assignment has been filed with the Company and sets forth that the assignee becomes a
substitute Member in place of the assignor.

     (b) The assignor and assignee or additional Members execute and acknowledge such other
instruments as the existing Members may deem necessary or desirable to effect such
admission, including, but not limited to, the written acceptance and adoption by the
assignee or additional Members of the provisions of this Agreement.

     (c) The written consent of all of the Managers to such substitution or admission of a
Member shall be obtained.

     (d) The assignee shall have provided the Company with any notice that may be required
by Section 6050K of the Code or other applicable law.

     (e) Payment has been made to the Company of all costs and expenses of admitting any
such assignee or additional Members to the Company.

     SECTION 8.4. Further Assignment by Assignee. An assignee of any Interest who does not
become a Member and who desires to make a further assignment of such Interest shall be subject to
all the provisions of this Article VIII to the same extent and in the same manner as any Member
desiring to make an assignment of his Interest.

     SECTION 8.5. Rights and Liabilities of and Restrictions on Assignee. No person shall
be recognized as an assignee of an Interest if such Interest was transferred in violation of this
Article VII. No assignee of an Interest in the Company shall have the right to participate in the
Company, inspect the books of account of the Company, or exercise any other right of a Member until
admitted as a Member. Notwithstanding the failure of such assignee to be admitted as a Member,
such assignee shall be entitled to receive, with respect to the Interest validly assigned to it,
the allocations and distributive shares of Income, Losses, tax credits, and Distributions otherwise
pertaining thereto under this Agreement, and, upon demand, may receive copies of all reports
thereafter delivered pursuant to the requirements of this Agreement; provided, the Company shall
have first received notice of such assignment and all required consents thereto shall have been
obtained and other conditions precedent to transfer thereof, as set forth herein or otherwise
required by applicable law, shall have been satisfied. The Company’s tax returns shall be prepared
to reflect assignees as Members for tax purposes.

23

 

     SECTION 8.6. Involuntary Transfers; Transfer of Interests in Members. The prohibition
on transfers of Interests in the Company set forth in Section 8.1(a) shall include and apply to:
(i) involuntary transfers of Interests, including without limitation any purported transfer by or
pursuant to bankruptcy, attachment, divorce, equitable distribution, or operation of law, and (ii)
transfers of shares, membership interests, partnership interests, or other equity ownership
interests in the Members, provided however that such prohibition shall apply to a transfer by an
equity owner of MedCath or VB only to the extent that such transfer results in a change of
ultimate control of such Member. In addition to any other remedy available at law or in equity,
the Managers shall not be required to take any purported transfer in violation of this Agreement
into account for purposes of this Agreement, or to recognize any purported transferee as a Member
or an assignee of a Member.

ARTICLE IX

BOOKS; DEPOSITORY ACCOUNTS; ACCOUNTING REPORTS; ELECTIONS

     SECTION 9.1. Books of Account. At all times during the continuance of the Company,
the Company shall maintain or cause to be maintained true and full financial records and books of
account showing all receipts and expenditures, assets and liabilities, profits and losses, and all
other records necessary for recording the Company’s business and affairs, including those
sufficient to record the allocations and Distributions required by the provisions of this
Agreement. MedCath shall have the administrative responsibility for maintaining the books of
account on behalf of the Company. MedCath may relinquish such responsibility at any time by
written notice to the Company, and in such event the Managers will appoint another Member or
representative of a Member to maintain the books of account on behalf of the Company.

     SECTION 9.2. Access to Records; Audit. The books of account, tax returns, reports,
records, this Agreement, and all documents and other writings of the Company, including the
Certificate of Formation, shall at all times be kept and maintained at the principal office of the
Company, or at such other place or places as the Managers may determine. Each Member or the
Member’s designated representatives shall, upon reasonable notice to the Company, have access to
such financial books, tax returns, reports, records, and documents during reasonable business hours
and may inspect and make copies of any of them.

     SECTION 9.3. Depository Accounts and Investment of Funds. The Managers may open and
maintain on behalf of the Company one or more depository or investment accounts at such times and
in such depositories or institutions as they shall determine, in which all monies received by or on
behalf of the Company shall be deposited. All withdrawals from such accounts shall be made upon
the signature of such person or persons as the Managers may from time to time designate in writing.
MedCath shall have the responsibility for maintaining such accounts and investments on behalf of
the Company. MedCath may relinquish such responsibility at any time by written notice to the
Company, and in such event the Managers will appoint another Member or representative of a Member
to maintain such accounts and investments.

24

 

     SECTION 9.4. Reports.

     (a) The Company shall prepare or cause to be prepared, at the end of each fiscal year
of the Company, annual financial statements showing the financial condition of the Company
at the end of such fiscal year and the results of its operations for the fiscal year then
ended, which annual financial statements shall be prepared in accordance with GAAP.

     (b) In addition to the financial statements provided for in Section 9.4(a), the Company
shall prepare or cause to be prepared:

     (i) income tax returns for the Company and shall timely file them with the
appropriate authorities; and

     (ii) a notice of each Member’s share of the Company
Income, Losses and tax credits for federal income tax purposes for each
year and any other information necessary or desirable for preparation
by each Member of such Member’s federal and state income tax return.

     MedCath shall have the administrative responsibility for preparing and distributing such
reports on behalf of the Company. MedCath may relinquish this responsibility at any time by
written notice to the Company, and in such event the Managers will appoint another Member or
representative of a Member to prepare and distribute such reports.

     SECTION 9.5. Tax Accounting Methods; Periods; Elections. The Company’s annual
financial accounting and tax accounting period shall be based upon a fiscal year ending December 31
of each year, unless another accounting period is required by the Code. The Managers may cause the
Company to make or refrain from making any election allowable to the Company under the Code,
including elections under Section 754 of the Code with respect to Company distributions described
in Section 734 of the Code and with respect to transfers of Interests described in Section 743 of
the Code. MedCath shall have the administrative responsibility for handling such tax matters on
behalf of the Company and pursuant to Section 11.11 herein, shall serve as the “Tax Matters
Partner” of the Company. MedCath may relinquish such responsibility upon written notice to the
Company and in such event the Managers shall appoint another “Tax Matters Partner.”

ARTICLE X

MEETINGS OF MEMBERS

     SECTION 10.1. Meetings of Members. Meetings of the Members (a) may be called by the
Managers and (b) shall be called by the Managers at the request, in writing, of the holders of not
less than fifteen percent (15%) in Percentage Interest of the Members, which request shall state
the purpose or purposes of the proposed meeting. Business transacted at all

25

 

meetings held pursuant to this Section 10.1 shall be confined to the purpose or purposes stated in the related notice as set
forth in Section 101.352(b) of the TLLCL.

     SECTION 10.2. Notice of Meetings of Members. Written notice stating the location, day
and hour of the meeting and, if required by Section 101.352 of the TLLCL, stating the business to
be transacted at the meeting, shall be delivered not less than ten (10) nor more than sixty (60)
days before the date of the meeting, to each Member of record entitled to vote at such meeting. If
mailed, such notice shall be deemed to be given when deposited in the mail, postage prepaid,
directed to the Member at its address as it appears on the records of the Company. Any duly
convened meeting may be adjourned by the Members to a later time without further notice other than
announcement at the meeting. Any Member may waive notice of any meeting before, during or after
the duly convened meeting. The waiver must be signed in writing by the Member entitled to notice
and delivered to the Company for inclusion in the Company’s records. A Member’s attendance at or
participation in a meeting, whether present in person or represented by proxy, shall constitute a
waiver of notice of such meeting, except when such Member or its proxy attends a meeting for the
sole and express purpose of objecting, at the beginning of the meeting, to the transaction of any
business because the meeting is not lawfully called or convened. Neither the business to be
transacted at, nor the purpose of, a meeting need be specified in any written waiver of notice.

     SECTION 10.3. Record Date. In order that the Company may determine the Members
entitled to notice of or to vote at any meeting of the Members or any adjournment thereof, or to
express consent to corporate action in writing without a meeting, or entitled to receive payment of
any distribution or allotment of any rights, or entitled to exercise any rights in respect of any
change, conversion or exchange of an Interest in the Company or for the purpose of any other lawful
action, the Managers may fix, in advance, a record date, which shall not be more than sixty (60)
nor less than ten (10) days before the date of such meeting, nor more than sixty (60) days prior to
any other action. If no record date is fixed: (a) the record date for determining the Members
entitled to notice of or to vote at a meeting of such Members shall be at the close of business on
the day next preceding the day on which notice is given, or, if notice is waived, at the close of
business on the day next preceding the day on which the meeting is held; and (b) the record date
for determining Members for any other purpose shall be at the close of business on the day on which
the Members adopt the resolution relating thereto. A determination of the Members of record
entitled to notice of or to vote at a meeting of the Members shall apply to any adjournment of the
meeting; provided, however, that the Managers may fix a new record date for the
adjourned meeting.

     SECTION 10.4. Quorum. The attendance in person or by proxy of all of the Managers and
all of the Members shall constitute a quorum at all meetings of the Members. Once a quorum is
present at the meeting of the Members, the subsequent withdrawal from the meeting by any Member
prior to adjournment or the refusal of any Member to vote shall not affect any business that is
transacted at such meeting prior to such withdrawal. If, however, such quorum shall not be present
at the opening of any meeting of the Members, the Members entitled to vote at such meeting, whether
present in person or represented by proxy, shall have the power to adjourn the meeting from time to time,
without notice other than announcement at the meeting, until the holders of the requisite amount of
Interests shall be present or represented. At

26

 

such adjourned meeting at which a quorum shall be present or represented, any business may be
transacted which might have been transacted at the meeting as originally notified. If the
adjournment is for more than thirty (30) days or if, after the adjournment, a new record date is
fixed for the adjourned meeting by the Managers, a notice of the adjourned meeting shall be given
to each Member of record entitled to vote at the meeting.

     SECTION 10.5. Organization. Meetings of the Members shall be presided over by the
Managers, or their designee, and the Managers or their designee shall act as secretary of each
meeting.

     SECTION 10.6. Actions by Members. Except for a matter for which the affirmative vote
of Members is required by applicable law, the Certificate of Formation or this Agreement, the
Managers shall act for the Company in all respects. With respect to a matter for which the
affirmative vote of the Members is required by applicable law, the Certificate of Formation or this
Agreement, the unanimous vote of the Members shall be required for any act of the Members, whether
present in person or represented by proxy. Voting at meetings of the Members need not be by
written ballot and need not be conducted by inspectors unless the Managers shall so determine.

     SECTION 10.7. Proxies. Each Member entitled to vote at a meeting of the Members may
authorize another person or persons to act for such Member by proxy; provided,
however, that no proxy will be effective and recognized by the Managers unless such proxy:
(a) is in writing, (b) is signed by the Member authorizing another Person to act on his, her or its
behalf, (c) specifies the purpose for which the proxy is being given, and (d) indicates a specific
meeting for which the proxy has been authorized. A proxy shall only be effective for the specific
meeting (and any adjournments thereof) for which such proxy has been executed. A duly executed
proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is
coupled with an interest sufficient in law to support an irrevocable power. A Member may revoke
any proxy which is not irrevocable by attending the meeting and voting in person or by filing an
instrument in writing revoking the proxy or another duly executed proxy bearing a later date with
the Managers.

     SECTION 10.8. Action Without Meeting. Any action required or permitted to be taken at
any meeting of the Members may be taken without a meeting, if a written consent thereto is signed
by the holders of an aggregate Percentage Interest sufficient to approve or consent to such action,
before or after such action, describing the action taken, and included in the minutes of the
meetings of the Members or filed with the Company’s records. A consent transmitted by electronic
transmission by a Member or by a person or persons authorized to act for a Member shall be deemed
to be written and signed for purposes of this Section 10.8.

     SECTION 10.9. Meeting by Conference Telephone. The Members may participate in any
meeting of such Members by means of conference telephone or similar communications equipment by
means of which all persons participating in the meeting can hear each other and such participation
in a meeting shall constitute presence in person at such meeting.

27

 

     SECTION 10.10. Registered Members. The Company shall be entitled to treat the holder
of record of any Interest as the holder in fact of such Interest for all purposes, and accordingly
shall not be bound to recognize any equitable or other claim to or interest in such Interest on the
part of any other person, whether or not it shall have express or other notice of such claim or
interest, except as expressly provided by this Agreement or the laws of the State.

ARTICLE XI

MISCELLANEOUS PROVISIONS

     SECTION 11.1. Waiver of Provisions. The waiver of compliance at any time with respect
to any of the provisions, terms, or conditions of this Agreement shall not be considered a waiver
of such provision, term, or condition itself or of any of the other provisions, terms, or
conditions hereof or bar its enforcement at any time thereafter.

     SECTION 11.2. Amendment. This Agreement contains the entire agreement among the
Members and any modification or amendment thereto must be in writing signed by each of the Members.

     SECTION 11.3. Interpretation and Construction. Where the context so requires, the
masculine shall include the feminine and the neuter and the singular shall include the plural. The
headings and captions in this Agreement are inserted for convenience and identification only and
are in no way intended to define, limit, or expand the scope or intent of this Agreement or any
provision hereof. Unless otherwise specified, the references to Section and Article in this
Agreement are to the Sections and Articles of this Agreement.

     SECTION 11.4. Governing Law; Jurisdiction. This Agreement shall be governed by and
construed in accordance with the laws of the State of Texas. The parties hereto hereby submit to
the jurisdiction of the courts of the State of Texas for the adjudication of any matter arising
with respect to this Agreement.

     SECTION 11.5. Partial Invalidity. In the event that any part or provision of this
Agreement shall be determined to be invalid or unenforceable, the remaining parts and provisions of
this Agreement which can be separated from the invalid, unenforceable provision or provisions shall
continue in full force and effect.

     SECTION 11.6. Binding on Successors. The terms, conditions, and provisions of this
Agreement shall inure to the benefit of, and be binding upon the parties hereto and their
respective permitted successors and assigns. However, none of the provisions of this Agreement
shall be for the benefit of or enforceable by any creditors of the Company (other than a Member who
is also a creditor).

     SECTION 11.7. Notices and Delivery.

     (a) To Members. Any notice to be given hereunder at any time to any Member, or
any documents, reports, or returns required by this Agreement to be

28

 

delivered to any Member,
may be delivered personally or mailed to such Member, postage prepaid, addressed to him at
the address set forth on Exhibit A or such other address as such Member shall by
notice to the Company have designated as his or her address for the mailing of all notices
hereunder. Any notice, or any document, report, or return so delivered or mailed shall be
deemed to have been given or delivered to such Member at the time it is delivered or mailed,
as the case may be.

     (b) To the Company. Any notice to be given to the Company hereunder may either
be delivered personally or mailed to the Company, by registered or certified mail, postage
prepaid, addressed to the Company at its principal office, and shall be copied to each other
Member. Any notice so delivered or mailed shall be deemed to have been given to the Company
at the time it is delivered or mailed, as the case may be.

     SECTION 11.8. Counterparts. This Agreement may be executed in any number of separate
counterparts, each of which shall be deemed an original document, and all counterparts taken
together shall constitute but one instrument.

     SECTION 11.9. Statutory Provisions. Any statutory or regulatory reference in this
Agreement shall include a reference to any successor to such statute or regulation and/or revision
thereof.

     SECTION 11.10. Waiver of Partition. Each party does hereby waive any right to
partition or the right to take any other action which might otherwise be available to such party
for the purpose of severing its relationship with the Company or its interest in the property held
by the Company from the interests of other Members.

     SECTION 11.11. Tax Matters Member. The Managers hereby elect MedCath to act as the
“Tax Matters Partner”” as that term is defined in Section 6231 of the Code.

     SECTION 11.12. Determination of Matters Not Provided For In This Agreement. The
Managers shall decide any questions arising with respect to the Company and this Agreement which
are not specifically or expressly provided for in this Agreement.

     SECTION 11.13. Further Assurances. The Members each agree to cooperate, and to execute
and deliver in a timely fashion
any and all additional documents necessary to effectuate the purposes of the Company and this
Agreement.

     SECTION 11.14. Arbitration. Any dispute, controversy or difference arising out of or
in connection with this Agreement or any transaction hereunder shall be finally settled under the
Commercial Arbitration Rules of the American Arbitration Association then in effect by three
arbitrators selected in accordance with such rules (provided, however, that if the amount in
controversy is less than $500,000, then such dispute, controversy or difference shall be finally
settled by one arbitrator selected in accordance with such Rules). The arbitrators’ award shall be
final and binding on the parties. The arbitration shall be administered by the American
Arbitration Association in English and shall take place in Houston, Texas.

29

 

     (a) Procedure. Once the arbitrators have been selected, a hearing date shall
be set within forty-five (45) days thereafter. Written submittals shall be presented and
exchanged by the parties no less than fifteen (15) days before the hearing date, including
reports prepared by experts upon whom either party intends to rely. At such time the
parties shall also exchange copies of all documentary evidence upon which they will rely at
the arbitration hearing and a list of the witnesses whom they intend to call to testify at
the hearing. Each party shall also make its respective experts available for deposition by
the other party prior to the hearing date. The arbitrators shall make their award as
promptly as practical after conclusion of the hearing.

     The arbitrators shall not be bound by any rules of evidence or civil procedure, but
rather may consider such writings and oral presentations as reasonable businessmen would use
in the conduct of their day-to-day affairs, and may require the parties to submit some or
all of their presentation orally or in written form as the arbitrator may deem appropriate.
It is the intention of the parties to limit live testimony and cross examination to the
extent necessary to insure a fair hearing to the parties on the matters submitted to
arbitration, and to provide neither party more than two complete business days to present
its position. The parties have included the foregoing provisions limiting the scope and
extent of the arbitration with the intention of providing for prompt, economic and fair
resolution of any dispute submitted to arbitration.

     (b) Award. The arbitrators shall have the discretion to award the costs of
arbitration, arbitrators’ fees and the respective attorneys’ fees of each party between the
parties as they see fit. Judgment upon the award entered by the arbitrators may be entered
in any court having jurisdiction thereof. The arbitrators shall make their award in
accordance with applicable law and based on the evidence presented by the parties, and shall
include in their written award findings of fact and conclusions of law. The arbitrators
shall have the power to award relief both in law and equity, which would be available in a
court having jurisdiction over the parties and over the subject matter of the dispute. Such
powers shall include, but not be limited to, the power to grant injunctions and require
specific performance.

     (c) Statute of Limitations. Any such dispute, controversy or difference
settled in arbitration shall be subject to the statute of limitations which would be
applicable to an action at law.

30

 

     IN WITNESS WHEREOF, the undersigned have executed this Amended and Restated Operating
Agreement as of the day and year first above written.

	 	 	 	 	 	 	 
	 	 	MEMBERS:	 	 
	 
	 	 	 	 	 	 
	 	 	VALLEY BAPTIST REALTY CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	James G. Springfield,	 	 
	 

	 	 	 	Chairman and President	 	 
	 
	 	 	 	 	 	 
	 	 	HARLINGEN HOSPITAL MANAGEMENT, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	HMC PHYSICIANS, LTD.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	HOSPITAL:	 	 
	 
	 	 	 	 	 	 
	 	 	The Hospital, as sole initial Member, hereby
withdraws from the Company and relinquishes all
right, title and interest in and to its interest in
the Company:	 	 
	 
	 	 	 	 	 	 
	 	 	HARLINGEN MEDICAL CENTER, LIMITED PARTNERSHIP	 	 
	 
	 	 	 	 	 	 
	 	 	By: HMC Management Company, LLC, its General Partner	 	 
	 
	 	 	 	 	 	 
	 	 	By: Harlingen Hospital Management, Inc., its sole
Member	 	 

31

 

	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	MANAGERS:	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	                    James G. Springfield	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	                    James A. Parker	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	                    Hugo Blake	 	 

32

 

EXHIBIT A

TO

AMENDED AND RESTATED OPERATING AGREEMENT

OF

HMC REALTY, LLC

	 	 	 	 	 	 	 	 	 	 	 	 	 
	Name, Address	 	 	 	 	 	Initial	 	 	 	 
	and Taxpayer	 	Percentage	 	 	Capital	 	 	Letter of Credit	 
	Identification Number	 	Interest	 	 	Contribution	 	 	Amount	 
	Harlingen Medical Center, Limited Partnership
	 	 	N/A	 	 	(Note 1)	 	 	N/A	 
	Valley Baptist Realty Corporation

	 	 	18.66	%	 	$	4,944,607	 	 	$	558,000	 
	P.O. Drawer 2588

	 	 	 	 	 	(Note 2)	 	 	 	 
	2101 Pease Street

Harlingen, Texas 78551

Attn: James G. Springfield, Chairman and President

#                                    
	 	 	 	 	 	 	 	 	 	 	 	 
	Harlingen Hospital Management, Inc.

	 	 	36.06	%	 	$	9,555,393	 	 	$	1,083,000	 
	10720 Sikes Place, Suite 300

	 	 	 	 	 	(Note 3)	 	 	 	 
	Charlotte, NC 28277

#56-2141739
	 	 	 	 	 	 	 	 	 	 	 
	HMC Physicians, Ltd. 
801 E. Fern #144

McAllen, TX 78501

Attn: Hugo G. Blake, M.D.

#26-0144229
	 	 	45.28	%	 	$	12,000,000	 	 	$	1,359,000
	 
	 	 	 	 	 	 	 	 	 
	Total
	 	 	100	%	 	$	26,500,000	 	 	$	3,000,000	 
	 
	 	 	 	 	 	 	 	 	 

 

			
	Notes:
	 
	(1)	 	The Hospital formed the Company and immediately prior to the effectiveness of this
Agreement contributed fee simple title to the Property to the Company, with an agreed gross
fair market value of approximately $57,790,000, and subject to certain mortgages and debts
in an aggregate principal amount of approximately $57,790,000, and assigned all of its
interest in the Company to Harlingen Hospital Management, Inc.. Upon the execution and
effectiveness of this Agreement, the Hospital shall have no further interest in the Company
or any items of income, loss, deduction, credit or distributions therefrom, and shall have
no further rights or obligations pursuant to this Agreement.

33

 

			
	(2)	 	Represents $2,000,000 cash contribution and conversion of $2,944,607 of debt
represented by the Assigned VB Loan.
	 
	(3)	 	Represents conversion of $9,555,393 of debt represented by a portion of the Assigned
MedCath Loan. The remaining principal balance of the Assigned MedCath Loan of $1,790,000
will be repaid in cash upon closing of the Acquisition Loan to the holders thereof (it
being acknowledged by the parties that $1,472,303 of such debt is held by Harlingen
Hospital Management Inc., by assignment from MedCath Finance Co., LLC and $317,696 of such
debt is held by the Hospital)

34

 

EXHIBIT B

TO

AMENDED AND RESTATED OPERATING AGREEMENT

OF

HMC REALTY, LLC

Special Tax Provisions

For purposes of this Exhibit B, references in the Code or the Regulations to “partner” and
“partnership” shall be deemed to refer to “Member” and “Company,” respectively.

     SECTION B.1. Definitions.

     “Company Minimum Gain” shall mean “partnership minimum gain” as defined in Regulations
Sections 1.704-2(b)(2) and 1.704-2(d).

     “Member Minimum Gain” means an amount, with respect to each Member Nonrecourse Debt,
equal to the Company Minimum Gain that would result if such Member Nonrecourse Debt were treated as
a Nonrecourse Liability, determined in accordance with Section 1.704-2(i) of the Regulations.

     “Member Nonrecourse Debt” has the meaning set forth in Section 1.704-2(b)(4) of the
Regulations.

     “Member Nonrecourse Deductions” has the meaning set forth in Section 1.704-2(i)(2) of
the Regulations. The amount of Member Nonrecourse Deductions with respect to a Member Nonrecourse
Debt for a Company fiscal year equals the excess, if any, of the net increase, if any, in the
amount of Member Minimum Gain attributable to such Member Nonrecourse Debt during that fiscal year
over the aggregate amount of any distributions during that fiscal year to the Member that bears the
economic risk of loss for such Member Nonrecourse Debt to the extent such distributions are from
the proceeds of such Member Nonrecourse Debt and are allocable to an increase in Member Minimum
Gain attributable to such Member Nonrecourse Debt, determined in accordance with Section
1.704-2(i)(2) of the Regulations.

     “Nonrecourse Deductions” has the meaning set forth in Section 1.704-2(b) and 2(c) of
the Regulations. The amount of Nonrecourse Deductions for a Company fiscal year equals the excess,
if any, of the net increase, if any, in the amount of Company Minimum Gain during that fiscal year
over the aggregate amount of any distributions during that fiscal year of proceeds of a Nonrecourse
Liability that are allocable to an increase in Company Minimum Gain, determined according to the
provisions of Section 1.704-2(c) of the Regulations.

     “Nonrecourse Liability” has the meaning set forth in Section 1.704-2(b)(3) of the
Regulations.

35

 

     SECTION B.2 Special Allocations. The following special allocations shall be made in
the following order:

     (a) Minimum Gain Chargeback. Notwithstanding any other provision of this
Exhibit B, if there is a net decrease in Company Minimum Gain during any Company
fiscal year, each Member shall be specially allocated items of Company income and gain for
such year (and, if necessary, subsequent years) in an amount equal to the portion of such
Member’s share of the net decrease in Company Minimum Gain, determined in accordance with
Regulations Section 1.704-2(g). Allocations pursuant to the previous sentence shall be made
in proportion to the respective amounts required to be allocated to each Member pursuant
thereto. The items to be so allocated shall be determined in accordance with Sections
1.704-2(f)(6) and 1.704-2(j)(2) of the Regulations. This Section B.2(a) is intended to
comply with the minimum gain chargeback requirement in Section 1.704-2(f) of the Regulations
and shall be interpreted consistently therewith.

     (b) Member Minimum Gain Chargeback. Notwithstanding any other provision of
this Exhibit B except Section B.2(a), if there is a net decrease in Member Minimum
Gain attributable to a Member Nonrecourse Debt during any Company fiscal year, each Member
who has a share of the Member Minimum Gain attributable to such Member Nonrecourse Debt,
determined in accordance with Section 1.704-2(i)(5), shall be specially allocated items of
Company income and gain for such year (and, if necessary, subsequent years) in an amount
equal to the portion of such Member’s share of the net decrease in Member Minimum Gain
attributable to such Member Nonrecourse Debt, determined in accordance with Regulations
Section 1.704-2(i)(4). Allocations pursuant to the previous sentence shall be made in
proportion to the respective amounts required to be allocated to each Member pursuant
thereto. The items to be so allocated shall be determined in accordance with Sections
1.704-2(i)(4) and 1.704-2(j)(2) of the Regulations. This Section B.2(b) is intended to
comply with the minimum gain chargeback requirement in such Section of the Regulations and
shall be interpreted consistently therewith.

     (c) Qualified Income Offset. In the event any Member unexpectedly receives any
adjustments, allocations, or distributions described in Regulations Section
1.704-1(b)(2)(ii)(d)(4), 1.704-1(b)(2)(ii)(d)(5), or 1.704-1(b)(2)(ii)(d)(6), items of
Company income and gain shall be specially allocated to each such Member in an amount and
manner sufficient to eliminate, to the extent required by the Regulations, the Adjusted
Capital Account Deficit of such Member as quickly as possible; provided that an
allocation pursuant to this Section B.2(c) shall be made if and only to the extent that such
Member would have an Adjusted Capital Account Deficit after all other allocations provided
for in this Exhibit B have been tentatively made as if this Section B.2(c) were not
in the Agreement.

     (d) Nonrecourse Deductions. Nonrecourse Deductions for any fiscal year or
other period shall be specially allocated to the Members in accordance with their Percentage
Interests.

36

 

     (e) Member Nonrecourse Deductions. Any Member Nonrecourse Deductions for any
fiscal year or other period shall be specially allocated to the Member who bears the
economic risk of loss with respect to the Member Nonrecourse Debt to which such Member
Nonrecourse Deductions are attributable in accordance with Regulations Section 1.704-2(i).

     (f) Section 754 Adjustment. To the extent an adjustment to the adjusted tax
basis of any Company asset pursuant to Code Section 734(b) or Code Section 743(b) is
required, pursuant to Regulations Section 1.704-1(b)(2)(iv)(m), to be taken into account in
determining Capital Accounts, the amount of such adjustment to the Capital Accounts shall be
treated as an item of gain (if the adjustment increases the basis of the asset) or loss (if
the adjustment decreases such basis) and such gain or loss shall be specially allocated to
the Members in a manner consistent with the manner in which their Capital Accounts are
required to be adjusted pursuant to such Section of the Regulations.

     SECTION B.3. Curative Allocations.

     (a) The allocations set forth in Section B.2 hereof (the “Regulatory
Allocations”) are intended to comply with certain regulatory requirements, including the
requirements of Regulations Sections 1.704-1(b) and 1.704-2. The Regulatory Allocations
shall be taken into account in the reasonable discretion of the Managers in allocating other
items of income, gain, loss and deduction among the Members so that to the extent possible
without violating the requirements giving rise to the Regulatory Allocations, the net amount
of such allocations of other items and the Regulatory Allocations to each Member shall be
equal to the net amount that would have been allocated to each such Member if the Regulatory
Allocations had not occurred.

     (b) Any income, gain, loss, or deduction realized as a direct or indirect result of the
issuance of a Company interest by the Company to a Member (the “Issuance Items”)
shall be allocated among the Members so that, to the extent possible, the net amount of such
Issuance Items, together with all other allocations under this agreement to each Member,
shall be equal to the net amount that would have been allocated to each such Member if the
Issuance Items had not been realized.

     SECTION B.4. Overriding Allocations for Contributed Property. In the event of
a contribution of property other than cash to the Company, income, gain, loss and deduction with
respect to such contributed property shall be shared among the Members for tax purposes so as to
take account of the variation between the basis of the property to the Company and its fair market
value at the time of contribution in accordance with Code Section 704(c) and Regulations
thereunder, with the Managers having authority to make any elections or choose any methods
thereunder; provided, that the remedial allocation method under Regulation Section 1.704-3(d) shall
be used.

     SECTION B.5. Varying Interest in Company. Allocations to any Member whose Interest
changes during a Company fiscal year or to any Member who is a Member for less than

37

 

a full Company fiscal year shall be made in accordance with Code Section 706(d) and the Treasury
Regulations promulgated thereunder to take into account the Member’s varying Interest in the
Company during the Company fiscal year.

38

 

EXHIBIT C

TO

OPERATING AGREEMENT

OF

HMC REALTY, LLC

Description of Property

39

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]